[
  {
    "id": 27636,
    "drug": {
      "current_status": "MARKETED",
      "id": 19526,
      "drug_code": 80855,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256822,
          "ingredient": {
            "id": 3534,
            "ingredient_code": 20438,
            "en_name": "EPLERENONE",
            "fr_name": "Éplérénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02323052",
      "brand_name": "INSPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152537001"
    },
    "created_date": "2017-11-01T12:09:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02323052",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C03DA04",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "actual_start_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2018-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-17T14:14:18-04:00",
    "status": "resolved",
    "en_comments": "Additional inventory anticipated to be available by April 13th which is expected to fulfill current market demand.",
    "fr_comments": "La prochaine disponibilité de matériel soutenant la demande du marché est anticipé le 13 avril.",
    "en_drug_brand_name": "INSPRA",
    "en_drug_common_name": "INSPRA",
    "fr_drug_brand_name": "INSPRA",
    "fr_drug_common_name": "INSPRA",
    "en_ingredients": "EPLERENONE",
    "fr_ingredients": "Éplérénone",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3x10 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27643,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15248,
      "drug_code": 75769,
      "updated_date": "2025-05-15T04:10:34-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341758,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02272164",
      "brand_name": "RIVA-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2017-11-01T14:29:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272164",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-11-15T00:00:00-05:00",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2018-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-02T14:10:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-SOTALOL",
    "en_drug_common_name": "Sotalol 80mg",
    "fr_drug_brand_name": "Riva- Sotalol",
    "fr_drug_common_name": "Sotalol 80mg",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27651,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3310,
      "drug_code": 18418,
      "updated_date": "2025-05-15T03:44:41-04:00",
      "company": {
        "id": 442,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T03:22:00-04:00",
        "company_code": 8231,
        "mfr_code": "",
        "name": "AKORN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "1925 WEST FIELD CT",
        "province": "ILLINOIS",
        "country": "UNITED STATES",
        "city": "LAKE FOREST",
        "postal_code": "60045",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8300796,
          "ingredient": {
            "id": 1400,
            "ingredient_code": 5920,
            "en_name": "INDOCYANINE GREEN",
            "fr_name": "Vert d'indocyanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02014793",
      "brand_name": "IC-GREEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80676",
      "number_of_ais": "1",
      "ai_group_no": "0150962001"
    },
    "created_date": "2017-11-01T14:52:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02014793",
    "company_name": "AKORN INC",
    "atc_number": "V04CX",
    "atc_description": "OTHER DIAGNOSTIC AGENTS",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "estimated_end_date": "2018-02-08T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T17:38:16-05:00",
    "status": "resolved",
    "en_comments": "Manufacturer has stated the product will not be available in 2017.",
    "fr_comments": "Le produit ne va pas disponible pendant l'année 2017.",
    "en_drug_brand_name": "IC-GREEN",
    "en_drug_common_name": "indocyanine green",
    "fr_drug_brand_name": "IC-Green",
    "fr_drug_common_name": "Vert d'indocyanine",
    "en_ingredients": "INDOCYANINE GREEN",
    "fr_ingredients": "Vert d'indocyanine",
    "drug_strength": "25MG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "6 vials with 6 vials of diluent",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27654,
    "drug": {
      "current_status": "MARKETED",
      "id": 2290,
      "drug_code": 15163,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252009,
          "ingredient": {
            "id": 1108,
            "ingredient_code": 2282,
            "en_name": "DANAZOL",
            "fr_name": "Danazol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02018152",
      "brand_name": "CYCLOMEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76844",
      "number_of_ais": "1",
      "ai_group_no": "0110952002"
    },
    "created_date": "2017-11-01T15:16:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02018152",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "G03XA01",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2018-05-16T00:00:00-04:00",
    "actual_end_date": "2018-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-07T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Delay in manufacturing",
    "fr_comments": "délai de fabrication",
    "en_drug_brand_name": "CYCLOMEN",
    "en_drug_common_name": "Cyclome",
    "fr_drug_brand_name": "Cyclomen 100mg",
    "fr_drug_common_name": "Cyclomen",
    "en_ingredients": "DANAZOL",
    "fr_ingredients": "Danazol",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27657,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12624,
      "drug_code": 71409,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337899,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247167",
      "brand_name": "BIO-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2017-11-01T15:34:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247167",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2011-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-02-20T19:08:50-05:00",
    "status": "active_confirmed",
    "en_comments": "dormant",
    "en_drug_brand_name": "BIO-AMITRIPTYLINE",
    "en_drug_common_name": "Amytriptyline hydrochloride Tablets 25 mg",
    "fr_drug_brand_name": "Bio-AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE HYDROCHLORIDE Tablets 25 mg",
    "fr_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27660,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12628,
      "drug_code": 71411,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337900,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247168",
      "brand_name": "BIO-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2017-11-01T15:38:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247168",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2011-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T15:39:11-04:00",
    "status": "active_confirmed",
    "en_comments": "dormant",
    "en_drug_brand_name": "BIO-AMITRIPTYLINE",
    "en_drug_common_name": "Amitriptyline Hydrochloride 50mg",
    "fr_drug_brand_name": "Bio-AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE HYDROCHLORIDE Tablets 50 mg",
    "fr_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27663,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25262,
      "drug_code": 87747,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351956,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392194",
      "brand_name": "BIO-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2017-11-01T15:41:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392194",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2015-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T15:47:44-04:00",
    "status": "active_confirmed",
    "en_comments": "LOW VOLUME",
    "fr_comments": "FAIBLE VOLUME",
    "en_drug_brand_name": "BIO-ATENOLOL",
    "en_drug_common_name": "Atenolol Tablets 25 mg",
    "fr_drug_brand_name": "BIO-ATENOLOL",
    "fr_drug_common_name": "Atenolol Tablets 25 mg",
    "fr_ingredients": "ATENOLOL",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27667,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25258,
      "drug_code": 87745,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351954,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392178",
      "brand_name": "BIO-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-11-01T15:50:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392178",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2015-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T15:51:55-04:00",
    "status": "active_confirmed",
    "en_comments": "FAIBLE VOLUME",
    "fr_comments": "FAIBLE VOLUME",
    "en_drug_brand_name": "BIO-ATENOLOL",
    "en_drug_common_name": "Atenolol Tablets 50 mg",
    "fr_drug_brand_name": "BIO-ATENOLOL",
    "fr_drug_common_name": "Atenolol Tablets 50 mg",
    "fr_ingredients": "ATENOLOL",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27670,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25260,
      "drug_code": 87746,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351955,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392186",
      "brand_name": "BIO-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847001"
    },
    "created_date": "2017-11-01T15:53:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392186",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2015-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T15:54:45-04:00",
    "status": "active_confirmed",
    "en_comments": "FAIBLE VOLUME",
    "fr_comments": "FAIBLE VOLUME",
    "en_drug_brand_name": "BIO-ATENOLOL",
    "en_drug_common_name": "Atenolol Tablets 100 mg",
    "fr_drug_brand_name": "BIO-ATENOLOL",
    "fr_drug_common_name": "Atenolol Tablets 100 mg",
    "fr_ingredients": "ATENOLOL",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27673,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7370,
      "drug_code": 49795,
      "updated_date": "2025-05-15T03:51:04-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8315359,
          "ingredient": {
            "id": 216,
            "ingredient_code": 7630,
            "en_name": "PREDNISOLONE",
            "fr_name": "Prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02230619",
      "brand_name": "PEDIAPRED",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106287004"
    },
    "created_date": "2017-11-01T15:56:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230619",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "H02AB06",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-01T18:30:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PEDIAPRED",
    "en_drug_common_name": "Pediapred oral liquid",
    "fr_drug_brand_name": "Pediapred",
    "fr_drug_common_name": "Pediapred Orale",
    "en_ingredients": "PREDNISOLONE",
    "fr_ingredients": "Prednisolone",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27675,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12634,
      "drug_code": 71416,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337906,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247173",
      "brand_name": "BIO-DIAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614002"
    },
    "created_date": "2017-11-01T15:56:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247173",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T15:58:28-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-DIAZEPAM",
    "en_drug_common_name": "Diazepam Tablets 2 mg",
    "fr_drug_brand_name": "BIO-DIAZEPAM",
    "fr_drug_common_name": "Diazepam Tablets 2 mg",
    "fr_ingredients": "DIAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27679,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8084,
      "drug_code": 5316,
      "updated_date": "2025-05-15T03:28:25-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8278283,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8278282,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00594377",
      "brand_name": "ALDACTAZIDE 50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60248",
      "number_of_ais": "2",
      "ai_group_no": "0201064002"
    },
    "created_date": "2017-11-01T17:04:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00594377",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C03EA01",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2018-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-23T16:38:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALDACTAZIDE 50",
    "en_drug_common_name": "ALDACTAZIDE",
    "fr_drug_brand_name": "ALDACTAZIDE 50",
    "fr_drug_common_name": "ALDACTAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nSPIRONOLACTONE",
    "fr_ingredients": "Hydrochlorothiazide\r\nSpironolactone",
    "drug_strength": "50MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 TAB/BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27681,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12636,
      "drug_code": 71417,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337907,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247174",
      "brand_name": "BIO-DIAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2017-11-01T17:05:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247174",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:05:57-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-DIAZEPAM",
    "en_drug_common_name": "Diazepam Tablets 5 mg",
    "fr_drug_brand_name": "BIO-DIAZEPAM",
    "fr_drug_common_name": "Diazepam Tablets 5 mg",
    "fr_ingredients": "DIAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27686,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12638,
      "drug_code": 71418,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337908,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247176",
      "brand_name": "BIO-DIAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614003"
    },
    "created_date": "2017-11-01T17:07:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247176",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:08:42-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-DIAZEPAM",
    "en_drug_common_name": "Diazepam Tablets 10 mg",
    "fr_drug_brand_name": "BIO-DIAZEPAM",
    "fr_drug_common_name": "Diazepam Tablets 10 mg",
    "fr_ingredients": "DIAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27689,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13084,
      "drug_code": 72453,
      "updated_date": "2025-05-15T04:07:40-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338817,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248126",
      "brand_name": "BIO-FLURAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108704002"
    },
    "created_date": "2017-11-01T17:11:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248126",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:12:50-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-FLURAZEPAM",
    "en_drug_common_name": "Flurazepam Hydrochloride Capsules 15 mg",
    "fr_drug_brand_name": "BIO-FLURAZEPAM",
    "fr_drug_common_name": "Flurazepam Hydrochloride Capsules 15 mg",
    "fr_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "drug_dosage_form_fr": "CAPS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "120",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27692,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13086,
      "drug_code": 72454,
      "updated_date": "2025-05-15T04:07:40-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338818,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248127",
      "brand_name": "BIO-FLURAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108704001"
    },
    "created_date": "2017-11-01T17:16:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248127",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:17:15-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-FLURAZEPAM",
    "en_drug_common_name": "Flurazepam Hydrochloride Capsules 30 mg",
    "fr_drug_brand_name": "BIO-FLURAZEPAM",
    "fr_drug_common_name": "Flurazepam Hydrochloride Capsules 30 mg",
    "fr_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "drug_dosage_form_fr": "CAPS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "120",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27695,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12742,
      "drug_code": 71616,
      "updated_date": "2025-05-15T04:06:59-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338154,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247371",
      "brand_name": "BIO-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101944002"
    },
    "created_date": "2017-11-01T17:21:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247371",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "actual_start_date": "2016-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T20:02:47-04:00",
    "status": "active_confirmed",
    "en_comments": "Quality Issues",
    "fr_comments": "Quality Issues",
    "en_drug_brand_name": "BIO-FUROSEMIDE",
    "en_drug_common_name": "Furosemide Tablets 20 mg",
    "fr_drug_brand_name": "BIO-FUROSEMIDE",
    "fr_drug_common_name": "Furosemide Tablets 20 mg",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27698,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12640,
      "drug_code": 71419,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337909,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247177",
      "brand_name": "BIO-OXAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102420003"
    },
    "created_date": "2017-11-01T17:29:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247177",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:33:19-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-OXAZEPAM",
    "en_drug_common_name": "Oxazepam Tablets 10 mg",
    "fr_drug_brand_name": "BIO-OXAZEPAM",
    "fr_drug_common_name": "Oxazepam Tablets 10 mg",
    "fr_ingredients": "OXAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27701,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12644,
      "drug_code": 71420,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337910,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247178",
      "brand_name": "BIO-OXAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102420002"
    },
    "created_date": "2017-11-01T17:36:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247178",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:37:01-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-OXAZEPAM",
    "en_drug_common_name": "Oxazepam Tablets 15 mg",
    "fr_drug_brand_name": "BIO-OXAZEPAM",
    "fr_drug_common_name": "Oxazepam Tablets 15 mg",
    "fr_ingredients": "OXAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27703,
    "drug": {
      "current_status": "MARKETED",
      "id": 2074,
      "drug_code": 14387,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251957,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02019892",
      "brand_name": "APO-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76002",
      "number_of_ais": "1",
      "ai_group_no": "0117649001"
    },
    "created_date": "2017-11-01T17:36:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02019892",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-03T14:52:18-05:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "en_drug_brand_name": "APO-ENALAPRIL TAB 10MG",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "APO-ENALAPRIL TAB 10MG",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL MALEATE",
    "fr_ingredients": "Maléate d'énalapril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27707,
    "drug": {
      "current_status": "MARKETED",
      "id": 2076,
      "drug_code": 14388,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251958,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02019906",
      "brand_name": "APO-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76003",
      "number_of_ais": "1",
      "ai_group_no": "0117649002"
    },
    "created_date": "2017-11-01T17:37:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02019906",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-07T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "en_drug_brand_name": "APO-ENALAPRIL TAB 20MG",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "APO-ENALAPRIL TAB 20MG",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL MALEATE",
    "fr_ingredients": "Maléate d'énalapril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27710,
    "drug": {
      "current_status": "MARKETED",
      "id": 2072,
      "drug_code": 14386,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251956,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02019884",
      "brand_name": "APO-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76001",
      "number_of_ais": "1",
      "ai_group_no": "0117649003"
    },
    "created_date": "2017-11-01T17:38:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02019884",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2017-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "500 BTL available",
    "en_drug_brand_name": "APO-ENALAPRIL TAB 5MG",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "APO-ENALAPRIL TAB 5MG",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL MALEATE",
    "fr_ingredients": "Maléate d'énalapril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27712,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12646,
      "drug_code": 71421,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337911,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247179",
      "brand_name": "BIO-OXAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102420001"
    },
    "created_date": "2017-11-01T17:38:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247179",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2012-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:39:52-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "BIO-OXAZEPAM",
    "en_drug_common_name": "Oxazepam Tablets 30 mg",
    "fr_drug_brand_name": "BIO-OXAZEPAM",
    "fr_drug_common_name": "Oxazepam Tablets 30 mg",
    "fr_ingredients": "OXAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27719,
    "drug": {
      "current_status": "DORMANT",
      "id": 2852,
      "drug_code": 1690,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365861,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00271152",
      "brand_name": "LEVATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43233",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2017-11-01T17:41:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00271152",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:42:53-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "LEVATE",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets 50 mg",
    "fr_drug_brand_name": "LEVATE",
    "fr_drug_common_name": "AMITRIPTYLINE HYDROCHLORIDE Tablets 50 mg",
    "fr_ingredients": "Amitriptyline Hydrochloride Tablets 50 mg",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27721,
    "drug": {
      "current_status": "MARKETED",
      "id": 16812,
      "drug_code": 77772,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255940,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02292378",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2017-11-01T17:42:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292378",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-19T15:31:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27733,
    "drug": {
      "current_status": "DORMANT",
      "id": 3786,
      "drug_code": 1929,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365890,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00306320",
      "brand_name": "LEVATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "45762",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2017-11-01T17:45:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00306320",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:47:21-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "LEVATE",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets 25 mg",
    "fr_drug_brand_name": "LEVATE",
    "fr_drug_common_name": "AMITRIPTYLINE HYDROCHLORIDE Tablets 25 mg",
    "fr_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27735,
    "drug": {
      "current_status": "DORMANT",
      "id": 18672,
      "drug_code": 79946,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368177,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313944",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2017-11-01T17:46:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313944",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-13T21:08:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27741,
    "drug": {
      "current_status": "MARKETED",
      "id": 5514,
      "drug_code": 3678,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250544,
          "ingredient": {
            "id": 174,
            "ingredient_code": 8174,
            "en_name": "SULFAMETHOXAZOLE",
            "fr_name": "Sulfaméthoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250543,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00445274",
      "brand_name": "SULFATRIM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55039",
      "number_of_ais": "2",
      "ai_group_no": "0208901001"
    },
    "created_date": "2017-11-01T17:47:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00445274",
    "company_name": "APOTEX INC",
    "atc_number": "J01EE01",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "anticipated_start_date": "2018-01-31T00:00:00-05:00",
    "estimated_end_date": "2018-04-02T00:00:00-04:00",
    "actual_start_date": "2018-01-15T00:00:00-05:00",
    "actual_end_date": "2018-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-15T12:33:04-04:00",
    "status": "resolved",
    "en_comments": "1000 BTL available",
    "en_drug_brand_name": "APO SULFATRIM TAB",
    "en_drug_common_name": "SULFATRIM",
    "fr_drug_brand_name": "APO SULFATRIM TABsu",
    "fr_drug_common_name": "SULFATRIM",
    "en_ingredients": "SULFAMETHOXAZOLE\r\nTRIMETHOPRIM",
    "fr_ingredients": "Sulfaméthoxazole\r\nTriméthoprime",
    "drug_strength": "400MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27744,
    "drug": {
      "current_status": "DORMANT",
      "id": 5286,
      "drug_code": 3413,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366151,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00405612",
      "brand_name": "LEVATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54280",
      "number_of_ais": "1",
      "ai_group_no": "0101524004"
    },
    "created_date": "2017-11-01T17:49:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00405612",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T17:51:15-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "LEVATE",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets 75 mg",
    "fr_drug_brand_name": "LEVATE",
    "fr_drug_common_name": "Amitriptyline Hydrochloride Tablets 75 mg",
    "fr_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27751,
    "drug": {
      "current_status": "DORMANT",
      "id": 6866,
      "drug_code": 4582,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366271,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00504742",
      "brand_name": "MAZEPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58154",
      "number_of_ais": "1",
      "ai_group_no": "0108674001"
    },
    "created_date": "2017-11-01T18:09:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00504742",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T18:10:18-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "MAZEPINE",
    "en_drug_common_name": "Carbamazepine Tablets 200 mg",
    "fr_drug_brand_name": "MAZEPINE",
    "fr_drug_common_name": "Carbamazepine Tablets 200 mg",
    "fr_ingredients": "CARBAMAZEPINE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27753,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15420,
      "drug_code": 76000,
      "updated_date": "2025-05-15T04:10:47-04:00",
      "company": {
        "id": 1216,
        "created_date": "2017-03-09T13:23:57-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 12463,
        "mfr_code": "",
        "name": "GENMED A DIVISION OF PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-800-387-4974\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8341990,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02274566",
      "brand_name": "GD-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072002"
    },
    "created_date": "2017-11-01T18:09:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274566",
    "company_name": "GENMED A DIVISION OF PFIZER CANADA INC",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2018-01-17T00:00:00-05:00",
    "actual_end_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-15T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GD-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "GD-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "300mg/15mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27757,
    "drug": {
      "current_status": "MARKETED",
      "id": 2596,
      "drug_code": 16210,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252099,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02084287",
      "brand_name": "NEURONTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78056",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-11-01T18:13:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02084287",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-12-19T00:00:00-05:00",
    "actual_end_date": "2018-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NEURONTIN CAP 400MG",
    "en_drug_common_name": "NEURONTIN",
    "fr_drug_brand_name": "NEURONTIN CAP 400MG",
    "fr_drug_common_name": "NEURONTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 capsules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27761,
    "drug": {
      "current_status": "DORMANT",
      "id": 5480,
      "drug_code": 3656,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366192,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414247",
      "brand_name": "OXPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54967",
      "number_of_ais": "1",
      "ai_group_no": "0102420003"
    },
    "created_date": "2017-11-01T18:16:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414247",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T18:17:28-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "OXPAM",
    "en_drug_common_name": "Oxazepam Tablets 10 mg",
    "fr_drug_brand_name": "OXPAM",
    "fr_drug_common_name": "Oxazepam Tablets 10 mg",
    "fr_ingredients": "OXAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27764,
    "drug": {
      "current_status": "DORMANT",
      "id": 5480,
      "drug_code": 3656,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366192,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414247",
      "brand_name": "OXPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54967",
      "number_of_ais": "1",
      "ai_group_no": "0102420003"
    },
    "created_date": "2017-11-01T18:20:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414247",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-01T18:21:41-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "OXPAM",
    "en_drug_common_name": "Oxazepam Tablets 10 mg",
    "fr_drug_brand_name": "OXPAM",
    "fr_drug_common_name": "Oxazepam Tablets 10 mg",
    "fr_ingredients": "OXAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27767,
    "drug": {
      "current_status": "MARKETED",
      "id": 15784,
      "drug_code": 76524,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255650,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279630",
      "brand_name": "APO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2017-11-01T18:31:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279630",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-01-19T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-03T12:26:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "APO-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27770,
    "drug": {
      "current_status": "MARKETED",
      "id": 8286,
      "drug_code": 5672,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250796,
          "ingredient": {
            "id": 2256,
            "ingredient_code": 10190,
            "en_name": "TRIAMTERENE",
            "fr_name": "Triamtérène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250795,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00441775",
      "brand_name": "APO TRIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61270",
      "number_of_ais": "2",
      "ai_group_no": "0201052001"
    },
    "created_date": "2017-11-01T18:35:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00441775",
    "company_name": "APOTEX INC",
    "atc_number": "C03EA01",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO TRIAZIDE",
    "en_drug_common_name": "TRIAZIDE",
    "fr_drug_brand_name": "APO TRIAZIDE",
    "fr_drug_common_name": "TRIAZIDE",
    "en_ingredients": "TRIAMTERENE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Triamtérène\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27773,
    "drug": {
      "current_status": "MARKETED",
      "id": 9640,
      "drug_code": 63385,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253725,
          "ingredient": {
            "id": 1002,
            "ingredient_code": 11385,
            "en_name": "TERBINAFINE",
            "fr_name": "Terbinafine (Chlorhydrate de terbinafine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239893",
      "brand_name": "APO-TERBINAFINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132855002"
    },
    "created_date": "2017-11-01T18:38:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239893",
    "company_name": "APOTEX INC",
    "atc_number": "D01BA02",
    "atc_description": "ANTIFUNGALS FOR SYSTEMIC USE",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-23T14:59:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TERBINAFINE",
    "en_drug_common_name": "TERBINAFINE",
    "fr_drug_brand_name": "APO-TERBINAFINE",
    "fr_drug_common_name": "TERBINAFINE",
    "en_ingredients": "TERBINAFINE",
    "fr_ingredients": "Terbinafine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27809,
    "drug": {
      "current_status": "MARKETED",
      "id": 22472,
      "drug_code": 84907,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258070,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364131",
      "brand_name": "APO-HYDROMORPHONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698006"
    },
    "created_date": "2017-11-02T11:50:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364131",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA03",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-31T19:11:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROMORPHONE",
    "en_drug_common_name": "HYDROMORPHONE HCL",
    "fr_drug_brand_name": "APO-HYDROMORPHONE",
    "fr_drug_common_name": "HYDROMORPHONE HCL",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27816,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5414,
      "drug_code": 35665,
      "updated_date": "2025-05-15T03:47:18-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8308596,
          "ingredient": {
            "id": 1956,
            "ingredient_code": 7508,
            "en_name": "AMCINONIDE",
            "fr_name": "Amcinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02192284",
      "brand_name": "CYCLOCORT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H2935",
      "number_of_ais": "1",
      "ai_group_no": "0113040001"
    },
    "created_date": "2017-11-02T14:07:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02192284",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D07AC11",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-01-31T20:09:41-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CYCLOCORT",
    "en_drug_common_name": "amcinonide cream",
    "fr_drug_brand_name": "CYCLOCORT",
    "fr_drug_common_name": "crème d'amcinonide",
    "en_ingredients": "AMCINONIDE",
    "fr_ingredients": "Amcinonide",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27869,
    "drug": {
      "current_status": "DORMANT",
      "id": 5482,
      "drug_code": 3657,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366193,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414255",
      "brand_name": "OXPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54968",
      "number_of_ais": "1",
      "ai_group_no": "0102420002"
    },
    "created_date": "2017-11-02T18:58:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414255",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T18:59:10-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "OXPAM",
    "en_drug_common_name": "Oxazepam Tablets 15 mg",
    "fr_drug_brand_name": "OXPAM",
    "fr_drug_common_name": "Oxazepam Tablets 15 mg",
    "fr_ingredients": "OXPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27872,
    "drug": {
      "current_status": "DORMANT",
      "id": 5482,
      "drug_code": 3657,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366193,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414255",
      "brand_name": "OXPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54968",
      "number_of_ais": "1",
      "ai_group_no": "0102420002"
    },
    "created_date": "2017-11-02T19:00:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414255",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:01:07-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "OXPAM",
    "en_drug_common_name": "Oxazepam Tablets 15 mg",
    "fr_drug_brand_name": "OXPAM",
    "fr_drug_common_name": "Oxazepam Tablets 15 mg",
    "fr_ingredients": "OXPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27875,
    "drug": {
      "current_status": "DORMANT",
      "id": 5484,
      "drug_code": 3658,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366194,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414263",
      "brand_name": "OXPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54969",
      "number_of_ais": "1",
      "ai_group_no": "0102420001"
    },
    "created_date": "2017-11-02T19:02:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414263",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:03:28-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "OXPAM",
    "en_drug_common_name": "Oxazepam Tablets 30 mg",
    "fr_drug_brand_name": "OXPAM",
    "fr_drug_common_name": "Oxazepam Tablets 30 mg",
    "fr_ingredients": "OXAZEPAM",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27878,
    "drug": {
      "current_status": "DORMANT",
      "id": 5484,
      "drug_code": 3658,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366194,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414263",
      "brand_name": "OXPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54969",
      "number_of_ais": "1",
      "ai_group_no": "0102420001"
    },
    "created_date": "2017-11-02T19:04:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414263",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:05:35-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "OXPAM",
    "en_drug_common_name": "Oxazepam Tablets 30 mg",
    "fr_drug_brand_name": "OXPAM",
    "fr_drug_common_name": "Oxazepam Tablets 30 mg",
    "fr_ingredients": "Oxazepam Tablets 30 mg",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27881,
    "drug": {
      "current_status": "DORMANT",
      "id": 6992,
      "drug_code": 4739,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366276,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00554308",
      "brand_name": "SLO-POT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58604",
      "number_of_ais": "1",
      "ai_group_no": "0100273010"
    },
    "created_date": "2017-11-02T19:09:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00554308",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:11:18-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SLO-POT",
    "en_drug_common_name": "Slow-Release Potassium Chloride Tablets 600 mg",
    "fr_drug_brand_name": "SLO-POT",
    "fr_drug_common_name": "Slow-Release Potassium Chloride Tablets 600 mg",
    "fr_ingredients": "POTASSIUM CHLORIDE",
    "drug_dosage_form_fr": "TABS (ER)",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27884,
    "drug": {
      "current_status": "DORMANT",
      "id": 6992,
      "drug_code": 4739,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366276,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00554308",
      "brand_name": "SLO-POT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58604",
      "number_of_ais": "1",
      "ai_group_no": "0100273010"
    },
    "created_date": "2017-11-02T19:12:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00554308",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:13:32-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SLO-POT",
    "en_drug_common_name": "Slow-Release Potassium Chloride Tablets 600 mg",
    "fr_drug_brand_name": "SLO-POT",
    "fr_drug_common_name": "Slow-Release Potassium Chloride Tablets 600 mg",
    "fr_ingredients": "POTASSIUM CHLORIDE",
    "drug_dosage_form_fr": "TABS (ER)",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27887,
    "drug": {
      "current_status": "DORMANT",
      "id": 6992,
      "drug_code": 4739,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366276,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00554308",
      "brand_name": "SLO-POT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58604",
      "number_of_ais": "1",
      "ai_group_no": "0100273010"
    },
    "created_date": "2017-11-02T19:14:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00554308",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:15:17-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SLO-POT",
    "en_drug_common_name": "Slow-Release Potassium Chloride Tablets 600 mg",
    "fr_drug_brand_name": "Slow-Release Potassium Chloride Tablets 600 mg",
    "fr_drug_common_name": "POTASSIUM CHLORIDE",
    "fr_ingredients": "POTASSIUM CHLORIDE",
    "drug_dosage_form_fr": "TABS (ER)",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27890,
    "drug": {
      "current_status": "DORMANT",
      "id": 6852,
      "drug_code": 4545,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366269,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414220",
      "brand_name": "SOM-PAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58004",
      "number_of_ais": "1",
      "ai_group_no": "0108704002"
    },
    "created_date": "2017-11-02T19:17:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414220",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:18:04-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SOM-PAM",
    "en_drug_common_name": "Flurazepam Hydrochloride Capsules 15 mg",
    "fr_drug_brand_name": "SOM-PAM",
    "fr_drug_common_name": "Flurazepam Hydrochloride Capsules 15 mg",
    "fr_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "drug_dosage_form_fr": "CAPS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27893,
    "drug": {
      "current_status": "DORMANT",
      "id": 6852,
      "drug_code": 4545,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366269,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414220",
      "brand_name": "SOM-PAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58004",
      "number_of_ais": "1",
      "ai_group_no": "0108704002"
    },
    "created_date": "2017-11-02T19:19:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414220",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:20:39-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SOM-PAM",
    "en_drug_common_name": "Flurazepam Hydrochloride Capsules 15 mg",
    "fr_drug_brand_name": "SOM-PAM",
    "fr_drug_common_name": "Flurazepam Hydrochloride Capsules 15 mg",
    "fr_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "drug_dosage_form_fr": "CAPS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27896,
    "drug": {
      "current_status": "DORMANT",
      "id": 6854,
      "drug_code": 4546,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366270,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414239",
      "brand_name": "SOM-PAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58005",
      "number_of_ais": "1",
      "ai_group_no": "0108704001"
    },
    "created_date": "2017-11-02T19:21:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414239",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:22:41-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SOM-PAM",
    "en_drug_common_name": "Flurazepam Hydrochloride Capsules 30 mg",
    "fr_drug_brand_name": "SOM-PAM",
    "fr_drug_common_name": "Flurazepam Hydrochloride Capsules 30 mg",
    "fr_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "drug_dosage_form_fr": "CAPS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27899,
    "drug": {
      "current_status": "DORMANT",
      "id": 6854,
      "drug_code": 4546,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366270,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00414239",
      "brand_name": "SOM-PAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58005",
      "number_of_ais": "1",
      "ai_group_no": "0108704001"
    },
    "created_date": "2017-11-02T19:23:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00414239",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:24:18-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "SOM-PAM",
    "en_drug_common_name": "Flurazepam Hydrochloride Capsules 30 mg",
    "fr_drug_brand_name": "SOM-PAM",
    "fr_drug_common_name": "Flurazepam Hydrochloride Capsules 30 mg",
    "fr_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "drug_dosage_form_fr": "CAPS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27902,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4868,
      "drug_code": 2738,
      "updated_date": "2025-05-15T03:25:26-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8273775,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00397423",
      "brand_name": "LOPRESOR 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51124",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2017-11-02T19:25:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00397423",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-12-20T00:00:00-05:00",
    "actual_start_date": "2017-12-17T00:00:00-05:00",
    "actual_end_date": "2017-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-09T19:15:11-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product will be discontinued - Still available Lopresor 50mg Tabs 500's (item #1659)",
    "fr_comments": "Produit discontinué.  Encore disponible  Lopresor 50mg 500's (code #1659)",
    "en_drug_brand_name": "LOPRESOR 50MG",
    "en_drug_common_name": "LOPRESOR 50 MG TABS 100'S",
    "fr_drug_brand_name": "LOPRESOR",
    "fr_drug_common_name": "LOPRESOR 50MG TABS 100'S",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27905,
    "drug": {
      "current_status": "DORMANT",
      "id": 2946,
      "drug_code": 1723,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365863,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00263893",
      "brand_name": "UROZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43516",
      "number_of_ais": "1",
      "ai_group_no": "0101048002"
    },
    "created_date": "2017-11-02T19:28:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00263893",
    "company_name": "BIOMED PHARMA",
    "estimated_end_date": "2025-02-01T00:00:00-05:00",
    "actual_start_date": "2014-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-02-15T14:32:18-05:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "UROZIDE",
    "en_drug_common_name": "Hydrochlorothiazide Tablets 25 mg",
    "fr_drug_brand_name": "UROZIDE",
    "fr_drug_common_name": "Hydrochlorothiazide Tablets 25 mg",
    "fr_ingredients": "HYDROCHLOROTHIAZIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27908,
    "drug": {
      "current_status": "DORMANT",
      "id": 3256,
      "drug_code": 1829,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365886,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00263907",
      "brand_name": "UROZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "44813",
      "number_of_ais": "1",
      "ai_group_no": "0101048001"
    },
    "created_date": "2017-11-02T19:30:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00263907",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:30:58-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "UROZIDE",
    "en_drug_common_name": "Hydrochlorothiazide Tablets 50 mg",
    "fr_drug_brand_name": "UROZIDE",
    "fr_drug_common_name": "Hydrochlorothiazide Tablets 50 mg",
    "fr_ingredients": "HYDROCHLOROTHIAZIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27911,
    "drug": {
      "current_status": "DORMANT",
      "id": 3256,
      "drug_code": 1829,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365886,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00263907",
      "brand_name": "UROZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "44813",
      "number_of_ais": "1",
      "ai_group_no": "0101048001"
    },
    "created_date": "2017-11-02T19:32:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00263907",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:33:04-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "UROZIDE",
    "en_drug_common_name": "Hydrochlorothiazide Tablets 50 mg",
    "fr_drug_brand_name": "UROZIDE",
    "fr_drug_common_name": "Hydrochlorothiazide Tablets 50 mg",
    "fr_ingredients": "HYDROCHLOROTHIAZIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27914,
    "drug": {
      "current_status": "DORMANT",
      "id": 3256,
      "drug_code": 1829,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365886,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00263907",
      "brand_name": "UROZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "44813",
      "number_of_ais": "1",
      "ai_group_no": "0101048001"
    },
    "created_date": "2017-11-02T19:34:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00263907",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:34:51-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "UROZIDE",
    "en_drug_common_name": "Hydrochlorothiazide Tablets 50 mg",
    "fr_drug_brand_name": "UROZIDE",
    "fr_drug_common_name": "Hydrochlorothiazide Tablets 50 mg",
    "fr_ingredients": "Hydrochlorothiazide Tablets 50 mg",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27917,
    "drug": {
      "current_status": "DORMANT",
      "id": 5202,
      "drug_code": 3311,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366136,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00405620",
      "brand_name": "UROZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53844",
      "number_of_ais": "1",
      "ai_group_no": "0101048003"
    },
    "created_date": "2017-11-02T19:36:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00405620",
    "company_name": "BIOMED PHARMA",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-02T19:36:59-04:00",
    "status": "active_confirmed",
    "en_comments": "DORMANT",
    "fr_comments": "DORMANT",
    "en_drug_brand_name": "UROZIDE",
    "en_drug_common_name": "Hydrochlorothiazide Tablets 100 mg",
    "fr_drug_brand_name": "UROZIDE",
    "fr_drug_common_name": "Hydrochlorothiazide Tablets 100 mg",
    "fr_ingredients": "HYDROCHLOROTHIAZIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 27924,
    "drug": {
      "current_status": "MARKETED",
      "id": 21324,
      "drug_code": 8373,
      "updated_date": "2025-12-03T00:30:25-05:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251081,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00773611",
      "brand_name": "TEGRETOL CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66803",
      "number_of_ais": "1",
      "ai_group_no": "0108674001"
    },
    "created_date": "2017-11-02T19:48:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00773611",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N03AF01",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-28T00:00:00-05:00",
    "estimated_end_date": "2017-12-07T00:00:00-05:00",
    "actual_end_date": "2017-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-13T23:36:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEGRETOL CR TAB 200MG",
    "en_drug_common_name": "TEGRETOL CR 200MG TABS 100'S",
    "fr_drug_brand_name": "TEGRETOL",
    "fr_drug_common_name": "TEGRETOL CR 200MG TABS 100'S",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27935,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30980,
      "drug_code": 93123,
      "updated_date": "2025-05-15T04:24:13-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8356194,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445964",
      "brand_name": "BIO-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2017-11-02T20:15:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445964",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-18T13:09:01-04:00",
    "status": "resolved",
    "en_comments": "LOW VOLUME",
    "fr_comments": "FAIBLE VOLUME",
    "en_drug_brand_name": "BIO-LOSARTAN",
    "en_drug_common_name": "Bio-LOSARTAN 25mg-100",
    "fr_drug_brand_name": "Bio-LOSARTAN",
    "fr_drug_common_name": "Bio-LOSARTAN 25mg-100",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27985,
    "drug": {
      "current_status": "MARKETED",
      "id": 856,
      "drug_code": 11893,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251586,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00812382",
      "brand_name": "CLOTRIMADERM TOPICAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72833",
      "number_of_ais": "1",
      "ai_group_no": "0110231001"
    },
    "created_date": "2017-11-03T09:55:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00812382",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D01AC01",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "estimated_end_date": "2019-02-01T00:00:00-05:00",
    "actual_start_date": "2018-12-10T00:00:00-05:00",
    "actual_end_date": "2019-01-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T21:42:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLOTRIMADERM CREAM 1%",
    "en_drug_common_name": "CLOTRIMADERM CREAM 1%",
    "fr_drug_brand_name": "CLOTRIMADERM CREAM 1%",
    "fr_drug_common_name": "CLOTRIMADERM CREAM 1%",
    "en_ingredients": "CLOTRIMAZOLE",
    "fr_ingredients": "Clotrimazole",
    "drug_strength": "1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "500G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28016,
    "drug": {
      "current_status": "MARKETED",
      "id": 8802,
      "drug_code": 60885,
      "updated_date": "2025-12-03T00:30:40-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253526,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253525,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "360",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02237548",
      "brand_name": "TWINRIX JUNIOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0265323001"
    },
    "created_date": "2017-11-03T17:54:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237548",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC20",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2017-12-07T00:00:00-05:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T17:50:25-05:00",
    "status": "resolved",
    "en_comments": "Doses reserved for Public programs, supply disruptions may be seen in the private market.",
    "fr_comments": "Doses réservées pour les programmes publics, des ruptures d’approvisionnement pourraient toucher le marché privé.",
    "en_drug_brand_name": "TWINRIX JUNIOR",
    "en_drug_common_name": "Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine",
    "fr_drug_brand_name": "TWINRIX Junior",
    "fr_drug_common_name": "Vaccin bivalent contre l’hépatite A (inactivé) et l’hépatite B (recombinant)",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED\r\nHEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactive\r\nAntigène de surface de l’hépatite B",
    "drug_strength": "360UNIT\r\n10MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28029,
    "drug": {
      "current_status": "MARKETED",
      "id": 15246,
      "drug_code": 75766,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255428,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02272121",
      "brand_name": "MYLAN-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437001"
    },
    "created_date": "2017-11-03T18:31:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272121",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2018-01-31T00:00:00-05:00",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2018-01-31T00:00:00-05:00",
    "actual_end_date": "2018-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-10T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "MYLAN-AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28038,
    "drug": {
      "current_status": "MARKETED",
      "id": 12686,
      "drug_code": 71486,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254642,
          "ingredient": {
            "id": 432,
            "ingredient_code": 1196,
            "en_name": "CLOZAPINE",
            "fr_name": "Clozapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247244",
      "brand_name": "GEN-CLOZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122583002"
    },
    "created_date": "2017-11-03T18:44:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247244",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH02",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-12-19T00:00:00-05:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-23T17:39:08-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "GEN-CLOZAPINE",
    "en_drug_common_name": "CLOZAPINE",
    "fr_drug_brand_name": "GEN-CLOZAPINE",
    "fr_drug_common_name": "CLOZAPINE",
    "en_ingredients": "CLOZAPINE",
    "fr_ingredients": "Clozapine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28041,
    "drug": {
      "current_status": "MARKETED",
      "id": 25780,
      "drug_code": 88165,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259302,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259301,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396610",
      "brand_name": "FREYA 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2017-11-03T18:46:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396610",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA09",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2019-02-01T00:00:00-05:00",
    "estimated_end_date": "2019-03-20T00:00:00-04:00",
    "actual_start_date": "2019-02-01T00:00:00-05:00",
    "actual_end_date": "2019-03-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-03-21T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FREYA 28",
    "en_drug_common_name": "FREYA 28",
    "fr_drug_brand_name": "FREYA 28",
    "fr_drug_common_name": "FREYA 28",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.15MG\r\n0.03MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28044,
    "drug": {
      "current_status": "MARKETED",
      "id": 14994,
      "drug_code": 75432,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255370,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02268922",
      "brand_name": "MYLAN-SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238001"
    },
    "created_date": "2017-11-03T18:47:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02268922",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N02CC01",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2018-05-14T00:00:00-04:00",
    "actual_end_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-03T15:06:22-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-SUMATRIPTAN",
    "en_drug_common_name": "SUMATRIPTAN",
    "fr_drug_brand_name": "MYLAN-SUMATRIPTAN",
    "fr_drug_common_name": "SUMATRIPTAN",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28047,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8936,
      "drug_code": 61287,
      "updated_date": "2025-05-15T03:56:53-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8325714,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237922",
      "brand_name": "MYLAN-VERAPAMIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846001"
    },
    "created_date": "2017-11-03T18:49:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237922",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08DA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2018-05-24T00:00:00-04:00",
    "estimated_end_date": "2018-07-20T00:00:00-04:00",
    "actual_start_date": "2018-05-25T00:00:00-04:00",
    "actual_end_date": "2018-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-19T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VERAPAMIL",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "MYLAN-VERAPAMIL",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "120MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28074,
    "drug": {
      "current_status": "MARKETED",
      "id": 6036,
      "drug_code": 4230,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250611,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00294748",
      "brand_name": "CALCIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57029",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2017-11-04T19:22:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00294748",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA07",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-02T19:28:08-05:00",
    "status": "resolved",
    "fr_comments": "Nous évaluons présentement nos options d'approvisionnement et nous confirmerons un échéancier pour la disponibilité du produit dans les prochains jours.",
    "en_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "Calcium Chloride LifeShield",
    "fr_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "fr_drug_common_name": "Calcium Chloride LifeShield",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28079,
    "drug": {
      "current_status": "MARKETED",
      "id": 31666,
      "drug_code": 94020,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261869,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453649",
      "brand_name": "DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2017-11-05T20:02:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453649",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-10-26T00:00:00-04:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-12T17:11:53-05:00",
    "status": "resolved",
    "en_comments": "Other pack size available",
    "fr_comments": "Autre format d'emballage disponible",
    "en_drug_brand_name": "DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28089,
    "drug": {
      "current_status": "MARKETED",
      "id": 24910,
      "drug_code": 87431,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259010,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388790",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2017-11-06T02:42:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388790",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-11-13T00:00:00-05:00",
    "estimated_end_date": "2018-04-03T00:00:00-04:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28092,
    "drug": {
      "current_status": "MARKETED",
      "id": 25014,
      "drug_code": 87522,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259052,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389746",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-11-06T02:52:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389746",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA03",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-09-20T00:00:00-04:00",
    "actual_end_date": "2018-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-26T22:03:48-04:00",
    "status": "resolved",
    "en_comments": "Other pack size available\r\nPackaging equipment change",
    "fr_comments": "Autre format d'emballage disponible\r\nChangement d'équipement d'emballage",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28095,
    "drug": {
      "current_status": "MARKETED",
      "id": 29394,
      "drug_code": 91411,
      "updated_date": "2025-05-15T02:34:29-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260664,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429667",
      "brand_name": "TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2017-11-06T02:59:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429667",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "G04CA02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2018-01-04T00:00:00-05:00",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T14:06:40-05:00",
    "status": "avoided_shortage",
    "en_comments": "Other pack size available",
    "fr_comments": "Autre format d'emballage disponible",
    "en_drug_brand_name": "TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN CR",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28098,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24558,
      "drug_code": 87158,
      "updated_date": "2025-05-15T04:20:17-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351609,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385988",
      "brand_name": "SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2017-11-06T03:12:48-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02385988",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T03:13:11-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SOTALOL",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28101,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24560,
      "drug_code": 87159,
      "updated_date": "2025-05-15T04:20:17-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351610,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385996",
      "brand_name": "SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2017-11-06T03:14:21-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02385996",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T03:14:43-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SOTALOL",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28134,
    "drug": {
      "current_status": "MARKETED",
      "id": 12246,
      "drug_code": 70478,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254513,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246315",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-11-06T15:10:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246315",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:45:27-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTINE",
    "fr_drug_common_name": "GABAPENTINE",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28137,
    "drug": {
      "current_status": "MARKETED",
      "id": 12246,
      "drug_code": 70478,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254513,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246315",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-11-06T15:12:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246315",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:45:51-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTINE",
    "fr_drug_common_name": "GABAPENTINE",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28140,
    "drug": {
      "current_status": "MARKETED",
      "id": 12248,
      "drug_code": 70479,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254514,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246316",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-11-06T15:14:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246316",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:46:09-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTINE",
    "fr_drug_common_name": "GABAPENTINE",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28145,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30580,
      "drug_code": 92639,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355930,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442027",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558003"
    },
    "created_date": "2017-11-06T15:22:36-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442027",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T15:23:16-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28148,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30584,
      "drug_code": 92640,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355931,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442035",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2017-11-06T15:25:10-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442035",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T15:25:33-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28151,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30584,
      "drug_code": 92640,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355931,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442035",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2017-11-06T15:26:59-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442035",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T15:27:10-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28154,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30586,
      "drug_code": 92641,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355932,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442043",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558004"
    },
    "created_date": "2017-11-06T15:27:51-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442043",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T15:28:19-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28157,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30586,
      "drug_code": 92641,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355932,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442043",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558004"
    },
    "created_date": "2017-11-06T15:29:13-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442043",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-12-12T18:24:14-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28160,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30588,
      "drug_code": 92642,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355933,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442051",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558002"
    },
    "created_date": "2017-11-06T15:30:43-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442051",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-06T15:31:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28163,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30588,
      "drug_code": 92642,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355933,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442051",
      "brand_name": "CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558002"
    },
    "created_date": "2017-11-06T15:31:45-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442051",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-12-12T18:24:58-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28166,
    "drug": {
      "current_status": "MARKETED",
      "id": 17466,
      "drug_code": 78508,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256155,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299712",
      "brand_name": "ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-11-06T15:42:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299712",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:56:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28169,
    "drug": {
      "current_status": "MARKETED",
      "id": 10598,
      "drug_code": 66188,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254015,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242463",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2017-11-06T15:44:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242463",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-09-21T00:00:00-04:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-21T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28174,
    "drug": {
      "current_status": "MARKETED",
      "id": 17466,
      "drug_code": 78508,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256155,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299712",
      "brand_name": "ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-11-06T15:46:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299712",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:49:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28179,
    "drug": {
      "current_status": "MARKETED",
      "id": 13440,
      "drug_code": 73123,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254871,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248755",
      "brand_name": "CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683001"
    },
    "created_date": "2017-11-06T15:50:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248755",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AG02",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2017-10-13T00:00:00-04:00",
    "actual_end_date": "2018-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-09-10T13:16:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28199,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12648,
      "drug_code": 71424,
      "updated_date": "2025-05-15T04:06:47-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337920,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247182",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2017-11-06T16:08:24-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247182",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-07T06:00:08-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28202,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12648,
      "drug_code": 71424,
      "updated_date": "2025-05-15T04:06:47-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337920,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247182",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2017-11-06T16:09:57-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247182",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-07T06:00:08-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28205,
    "drug": {
      "current_status": "MARKETED",
      "id": 9066,
      "drug_code": 61718,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253566,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238316",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-11-06T16:12:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238316",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-09-25T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:52:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28209,
    "drug": {
      "current_status": "MARKETED",
      "id": 9066,
      "drug_code": 61718,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253566,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238316",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-11-06T16:14:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238316",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-11-15T00:00:00-05:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:51:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28212,
    "drug": {
      "current_status": "MARKETED",
      "id": 9066,
      "drug_code": 61718,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253566,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238316",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-11-06T16:16:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238316",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:53:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28215,
    "drug": {
      "current_status": "MARKETED",
      "id": 9068,
      "drug_code": 61719,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253567,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238318",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847001"
    },
    "created_date": "2017-11-06T16:18:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238318",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:54:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28218,
    "drug": {
      "current_status": "MARKETED",
      "id": 9068,
      "drug_code": 61719,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253567,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238318",
      "brand_name": "ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847001"
    },
    "created_date": "2017-11-06T16:20:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238318",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-09-15T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-24T15:55:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28221,
    "drug": {
      "current_status": "MARKETED",
      "id": 5524,
      "drug_code": 36794,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 222,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8524,
        "mfr_code": "",
        "name": "B. BRAUN MEDICAL INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "824 TWELFTH AVENUE",
        "province": "PENNSYLVANIA",
        "country": "UNITED STATES",
        "city": "BETHLEHEM",
        "postal_code": "18018",
        "post_office_box": "",
        "contact_information": "Cindy Katsempris; \r\ncindy.katsempris@bbraunusa.com"
      },
      "drug_ingredients": [
        {
          "id": 8252855,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252854,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02209713",
      "brand_name": "HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4164",
      "number_of_ais": "2",
      "ai_group_no": "0220064001"
    },
    "created_date": "2017-11-06T16:23:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02209713",
    "company_name": "B. BRAUN MEDICAL INC",
    "atc_number": "B01AB51",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2019-12-16T00:00:00-05:00",
    "actual_start_date": "2019-11-09T00:00:00-05:00",
    "actual_end_date": "2019-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-12-19T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ",
    "en_drug_common_name": "Heparin Sodium in Dextrose",
    "fr_drug_brand_name": "HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ",
    "fr_drug_common_name": "Heparin Sodium in Dextrose",
    "en_ingredients": "DEXTROSE\r\nHEPARIN SODIUM",
    "fr_ingredients": "Dextrose\r\nHéparine sodique",
    "drug_strength": "5G\r\n4000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "500mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28224,
    "drug": {
      "current_status": "MARKETED",
      "id": 5524,
      "drug_code": 36794,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 222,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8524,
        "mfr_code": "",
        "name": "B. BRAUN MEDICAL INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "824 TWELFTH AVENUE",
        "province": "PENNSYLVANIA",
        "country": "UNITED STATES",
        "city": "BETHLEHEM",
        "postal_code": "18018",
        "post_office_box": "",
        "contact_information": "Cindy Katsempris; \r\ncindy.katsempris@bbraunusa.com"
      },
      "drug_ingredients": [
        {
          "id": 8252855,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252854,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02209713",
      "brand_name": "HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4164",
      "number_of_ais": "2",
      "ai_group_no": "0220064001"
    },
    "created_date": "2017-11-06T16:26:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02209713",
    "company_name": "B. BRAUN MEDICAL INC",
    "atc_number": "B01AB51",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-01-02T00:00:00-05:00",
    "actual_start_date": "2018-01-02T00:00:00-05:00",
    "actual_end_date": "2019-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-18T22:29:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ",
    "en_drug_common_name": "Heparin Sodium in Dextrose",
    "fr_drug_brand_name": "Heparin Sodium",
    "fr_drug_common_name": "Heparin Sodium",
    "en_ingredients": "DEXTROSE\r\nHEPARIN SODIUM",
    "fr_ingredients": "Dextrose\r\nHéparine sodique",
    "drug_strength": "5G\r\n4000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "500mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28226,
    "drug": {
      "current_status": "MARKETED",
      "id": 30646,
      "drug_code": 92690,
      "updated_date": "2025-05-15T02:34:52-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261257,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442566",
      "brand_name": "LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2017-11-06T16:28:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442566",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-13T00:00:00-05:00",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:43:41-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28229,
    "drug": {
      "current_status": "MARKETED",
      "id": 18206,
      "drug_code": 79472,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256389,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309122",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2017-11-06T16:37:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309122",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-12-04T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28232,
    "drug": {
      "current_status": "MARKETED",
      "id": 18208,
      "drug_code": 79473,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256390,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309130",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2017-11-06T16:38:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309130",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-11-10T00:00:00-05:00",
    "estimated_end_date": "2019-01-11T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2019-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-01-14T18:37:04-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28235,
    "drug": {
      "current_status": "MARKETED",
      "id": 5526,
      "drug_code": 36795,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 222,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8524,
        "mfr_code": "",
        "name": "B. BRAUN MEDICAL INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "824 TWELFTH AVENUE",
        "province": "PENNSYLVANIA",
        "country": "UNITED STATES",
        "city": "BETHLEHEM",
        "postal_code": "18018",
        "post_office_box": "",
        "contact_information": "Cindy Katsempris; \r\ncindy.katsempris@bbraunusa.com"
      },
      "drug_ingredients": [
        {
          "id": 8252857,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252856,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02209721",
      "brand_name": "HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4165",
      "number_of_ais": "2",
      "ai_group_no": "0220064003"
    },
    "created_date": "2017-11-06T16:48:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02209721",
    "company_name": "B. BRAUN MEDICAL INC",
    "atc_number": "B01AB51",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2017-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-11-16T02:32:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ",
    "en_drug_common_name": "Heparin Sodium in Dextrose",
    "fr_drug_brand_name": "Heparin Sodium",
    "fr_drug_common_name": "Heparin Sodium",
    "en_ingredients": "DEXTROSE\r\nHEPARIN SODIUM",
    "fr_ingredients": "Dextrose\r\nHéparine sodique",
    "drug_strength": "5G\r\n10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28238,
    "drug": {
      "current_status": "MARKETED",
      "id": 2820,
      "drug_code": 16794,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 222,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8524,
        "mfr_code": "",
        "name": "B. BRAUN MEDICAL INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "824 TWELFTH AVENUE",
        "province": "PENNSYLVANIA",
        "country": "UNITED STATES",
        "city": "BETHLEHEM",
        "postal_code": "18018",
        "post_office_box": "",
        "contact_information": "Cindy Katsempris; \r\ncindy.katsempris@bbraunusa.com"
      },
      "drug_ingredients": [
        {
          "id": 8252158,
          "ingredient": {
            "id": 278,
            "ingredient_code": 4759,
            "en_name": "SODIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de sodium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "410",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252157,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252156,
          "ingredient": {
            "id": 220,
            "ingredient_code": 10021,
            "en_name": "CITRIC ACID",
            "fr_name": "Acide citrique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "93",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252155,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01935941",
      "brand_name": "HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78716",
      "number_of_ais": "4",
      "ai_group_no": "0423088001"
    },
    "created_date": "2017-11-06T16:53:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01935941",
    "company_name": "B. BRAUN MEDICAL INC",
    "atc_number": "B01AB51",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-01-02T00:00:00-05:00",
    "actual_start_date": "2018-01-02T00:00:00-05:00",
    "actual_end_date": "2019-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-18T22:28:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML",
    "en_drug_common_name": "Heparin Sodium in Dextrose",
    "fr_drug_brand_name": "Heparin Sodium",
    "fr_drug_common_name": "Heparin Sodium",
    "en_ingredients": "CITRIC ACID\r\nDEXTROSE\r\nSODIUM PHOSPHATE DIBASIC\r\nHEPARIN SODIUM",
    "fr_ingredients": "Acide citrique\r\nDextrose\r\nPhosphate de sodium dibasique\r\nHéparine sodique",
    "drug_strength": "93MG\r\n5G\r\n410MG\r\n5000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "500mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28244,
    "drug": {
      "current_status": "MARKETED",
      "id": 2930,
      "drug_code": 17199,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8252189,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "275",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00887056",
      "brand_name": "NAPROXEN-NA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79350",
      "number_of_ais": "1",
      "ai_group_no": "0113934001"
    },
    "created_date": "2017-11-06T17:05:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00887056",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Cessation de vente.",
    "en_drug_brand_name": "NAPROXEN-NA",
    "en_drug_common_name": "NAPROXEN-NA",
    "fr_drug_brand_name": "NAPROXEN-NA",
    "fr_drug_common_name": "NAPROXEN-NA",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "275MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28267,
    "drug": {
      "current_status": "MARKETED",
      "id": 26546,
      "drug_code": 88848,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259583,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403692",
      "brand_name": "PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-11-06T17:14:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403692",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-10-11T00:00:00-04:00",
    "actual_end_date": "2017-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-01-18T13:02:11-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PREGABALINE",
    "fr_drug_common_name": "PREGABALINE",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28269,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25532,
      "drug_code": 87958,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8352209,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8352208,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394413",
      "brand_name": "LOSARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2017-11-06T17:14:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394413",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "hc_updated_date": "2023-07-11T14:46:11-04:00",
    "actual_start_date": "2018-11-06T00:00:00-05:00",
    "actual_end_date": "2023-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-11T14:46:13-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "fr_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "en_drug_brand_name": "LOSARTAN-HCTZ",
    "en_drug_common_name": "LOSARTAN-HCTZ",
    "fr_drug_brand_name": "LOSARTAN-HCTZ",
    "fr_drug_common_name": "LOSARTAN-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28273,
    "drug": {
      "current_status": "MARKETED",
      "id": 26546,
      "drug_code": 88848,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259583,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403692",
      "brand_name": "PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-11-06T17:15:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403692",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-12-04T00:00:00-05:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-30T05:00:10-04:00",
    "status": "resolved",
    "en_comments": "500 count format unavailable for an extended period\r\nWill discontinue this format for the time being",
    "fr_comments": "Format 500 non disponible pour une période prolongée\r\nFormat discontinué pour le moment",
    "en_drug_brand_name": "PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PREGABALINE",
    "fr_drug_common_name": "PREGABALINE",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28276,
    "drug": {
      "current_status": "MARKETED",
      "id": 26548,
      "drug_code": 88849,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259584,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403706",
      "brand_name": "PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2017-11-06T17:17:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403706",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-10-15T00:00:00-04:00",
    "actual_end_date": "2017-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-01-18T13:03:22-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PREGABALINE",
    "fr_drug_common_name": "PREGABALINE",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28279,
    "drug": {
      "current_status": "MARKETED",
      "id": 26548,
      "drug_code": 88849,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259584,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403706",
      "brand_name": "PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2017-11-06T17:18:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403706",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2017-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-23T06:00:09-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PREGABALINE",
    "fr_drug_common_name": "PREGABALINE",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28284,
    "drug": {
      "current_status": "MARKETED",
      "id": 276,
      "drug_code": 10748,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251380,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251379,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00611174",
      "brand_name": "LOTRIDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70771",
      "number_of_ais": "2",
      "ai_group_no": "0216399001"
    },
    "created_date": "2017-11-06T17:38:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00611174",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D01AC20",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "anticipated_start_date": "2017-11-13T00:00:00-05:00",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-11-09T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-05T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTRIDERM CREAM",
    "en_drug_common_name": "Clotrimazole and Betamethasone Dipropionate Cream",
    "fr_drug_brand_name": "LOTRIDERM CRÈME",
    "fr_drug_common_name": "Crème de Clotrimazole et de Dipropionate de Bétaméthasone",
    "en_ingredients": "BETAMETHASONE\r\nCLOTRIMAZOLE",
    "fr_ingredients": "Bétaméthasone\r\nClotrimazole",
    "drug_strength": "0.05%\r\n1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28287,
    "drug": {
      "current_status": "MARKETED",
      "id": 28026,
      "drug_code": 90201,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260192,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417383",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2017-11-06T17:47:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417383",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-26T21:38:05-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 28294,
    "drug": {
      "current_status": "MARKETED",
      "id": 9030,
      "drug_code": 61606,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253559,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238213",
      "brand_name": "PROPECIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110002"
    },
    "created_date": "2017-11-06T18:31:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238213",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D11AX10",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2018-01-05T00:00:00-05:00",
    "estimated_end_date": "2018-02-16T00:00:00-05:00",
    "actual_start_date": "2018-01-05T00:00:00-05:00",
    "actual_end_date": "2018-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-17T06:00:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROPECIA",
    "en_drug_common_name": "Finasteride tablets",
    "fr_drug_brand_name": "PROPECIA",
    "fr_drug_common_name": "Comprimés de Finastéride",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28297,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7782,
      "drug_code": 50850,
      "updated_date": "2025-05-15T03:51:55-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8316719,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02231510",
      "brand_name": "CLIMARA 100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457037"
    },
    "created_date": "2017-11-06T19:22:12-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02231510",
    "company_name": "BAYER INC",
    "atc_number": "G03CA03",
    "atc_description": "ESTROGENS",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "To be discontinued",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-14T18:56:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLIMARA 100",
    "en_drug_common_name": "Estradiol - 17B",
    "fr_drug_brand_name": "Climara 100",
    "fr_drug_common_name": "Estradiol - 17B",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "7.6MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "4's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28316,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13702,
      "drug_code": 73542,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8339771,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8339770,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02250616",
      "brand_name": "CLIMARA PRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250024002"
    },
    "created_date": "2017-11-06T19:55:17-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02250616",
    "company_name": "BAYER INC",
    "atc_number": "G03FA11",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "discontinuation_date": "2017-11-30T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-01-10T16:48:32-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLIMARA PRO",
    "en_drug_common_name": "estradiol-17 beta and levonorgestrel transdermal system",
    "fr_drug_brand_name": "Climara Pro",
    "fr_drug_common_name": "estradiol-17 beta and levonorgestrel timbre",
    "en_ingredients": "ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Estradiol\r\nLévonorgestrel",
    "drug_strength": "4.40MG\r\n1.39MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "4's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28364,
    "drug": {
      "current_status": "MARKETED",
      "id": 11810,
      "drug_code": 69384,
      "updated_date": "2025-12-03T00:30:49-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254382,
          "ingredient": {
            "id": 2508,
            "ingredient_code": 7485,
            "en_name": "TESTOSTERONE",
            "fr_name": "Testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245345",
      "brand_name": "ANDROGEL",
      "brand_name_fr": "",
      "descriptor": "2.5 G GEL PER PACK",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106405004"
    },
    "created_date": "2017-11-06T21:14:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245345",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "G03BA03",
    "atc_description": "ANDROGENS",
    "anticipated_start_date": "2018-11-22T00:00:00-05:00",
    "estimated_end_date": "2018-12-17T00:00:00-05:00",
    "actual_start_date": "2018-11-30T00:00:00-05:00",
    "actual_end_date": "2018-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-12-13T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ANDROGEL",
    "en_drug_common_name": "ANDROGEL",
    "fr_drug_brand_name": "ANDROGEL",
    "fr_drug_common_name": "ANDROGEL",
    "en_ingredients": "TESTOSTERONE",
    "fr_ingredients": "Testostérone",
    "drug_strength": "1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "2.5 g, 30 sachet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28368,
    "drug": {
      "current_status": "MARKETED",
      "id": 6138,
      "drug_code": 42847,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252985,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184443",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9014",
      "number_of_ais": "1",
      "ai_group_no": "0104545006"
    },
    "created_date": "2017-11-06T21:17:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184443",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA01",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2017-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-20T19:14:17-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "KADIAN",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "KADIAN",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28375,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2722,
      "drug_code": 16587,
      "updated_date": "2025-12-03T01:07:51-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8297397,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02041448",
      "brand_name": "ATIVAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78485",
      "number_of_ais": "1",
      "ai_group_no": "0110731002"
    },
    "created_date": "2017-11-06T22:08:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02041448",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05BA06",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2017-12-14T00:00:00-05:00",
    "estimated_end_date": "2017-12-06T00:00:00-05:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T19:44:39-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ATIVAN",
    "en_drug_common_name": "ATIVAN",
    "fr_drug_brand_name": "ATIVAN",
    "fr_drug_common_name": "ATIVAN",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 TAB/BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28440,
    "drug": {
      "current_status": "MARKETED",
      "id": 20624,
      "drug_code": 82365,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257290,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338009",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2017-11-07T15:59:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338009",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-12-22T00:00:00-05:00",
    "estimated_end_date": "2018-03-26T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-20T12:45:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28503,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17354,
      "drug_code": 784,
      "updated_date": "2025-12-03T00:58:46-05:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8270848,
          "ingredient": {
            "id": 3410,
            "ingredient_code": 10039,
            "en_name": "THIOTHIXENE",
            "fr_name": "Thiothixène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00024449",
      "brand_name": "NAVANE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "29748",
      "number_of_ais": "1",
      "ai_group_no": "0102100002"
    },
    "created_date": "2017-11-07T17:55:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00024449",
    "company_name": "ERFA CANADA 2012 INC",
    "anticipated_start_date": "2017-11-07T00:00:00-05:00",
    "actual_start_date": "2017-11-07T00:00:00-05:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-14T18:49:54-04:00",
    "status": "resolved",
    "en_comments": "PRODUCT DISCONTINUED.",
    "fr_comments": "PRODUIT DISCONTINUE",
    "en_drug_brand_name": "NAVANE CAP 5MG",
    "en_drug_common_name": "TIOTIXENE",
    "fr_drug_brand_name": "Navane 5 mg",
    "fr_drug_common_name": "TIOTIXENE",
    "fr_ingredients": "TIOTIXENE",
    "drug_dosage_form_fr": "CAPSULE",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100 TABLETS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28534,
    "drug": {
      "current_status": "MARKETED",
      "id": 18880,
      "drug_code": 80137,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256595,
          "ingredient": {
            "id": 2958,
            "ingredient_code": 12699,
            "en_name": "ALFUZOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'alfuzosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315866",
      "brand_name": "APO-ALFUZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146806001"
    },
    "created_date": "2017-11-07T19:10:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315866",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA01",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T15:58:35-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALFUZOSIN",
    "en_drug_common_name": "ALFUZOSIN",
    "fr_drug_brand_name": "APO-ALFUZOSIN",
    "fr_drug_common_name": "ALFUZOSIN",
    "en_ingredients": "ALFUZOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'alfuzosine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28539,
    "drug": {
      "current_status": "DORMANT",
      "id": 25610,
      "drug_code": 88024,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368857,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8368856,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395126",
      "brand_name": "APO-CANDESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181002"
    },
    "created_date": "2017-11-07T19:14:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395126",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-26T18:22:16-05:00",
    "status": "resolved",
    "en_comments": "product is discontinued",
    "en_drug_brand_name": "APO-CANDESARTAN/HCTZ",
    "en_drug_common_name": "CANDESARTAN + HCTZ",
    "fr_drug_brand_name": "APO-CANDESARTAN/HCTZ",
    "fr_drug_common_name": "CANDESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "12.5MG\r\n32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28546,
    "drug": {
      "current_status": "DORMANT",
      "id": 2284,
      "drug_code": 15118,
      "updated_date": "2025-12-03T02:32:15-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366849,
          "ingredient": {
            "id": 672,
            "ingredient_code": 11107,
            "en_name": "DOXEPIN",
            "fr_name": "Doxépine (Chlorhydrate de doxépine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02049996",
      "brand_name": "APO-DOXEPIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76799",
      "number_of_ais": "1",
      "ai_group_no": "0107703006"
    },
    "created_date": "2017-11-07T19:18:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02049996",
    "company_name": "APOTEX INC",
    "atc_number": "N06AA12",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2017-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-08T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXEPIN",
    "en_drug_common_name": "DOXEPIN",
    "fr_drug_brand_name": "APO-DOXEPIN",
    "fr_drug_common_name": "DOXEPIN",
    "en_ingredients": "DOXEPIN",
    "fr_ingredients": "DOXEPIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28553,
    "drug": {
      "current_status": "MARKETED",
      "id": 31600,
      "drug_code": 93916,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261827,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "36",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452766",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548005"
    },
    "created_date": "2017-11-07T19:23:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452766",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-10T13:13:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "36MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28556,
    "drug": {
      "current_status": "MARKETED",
      "id": 26680,
      "drug_code": 88976,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259615,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02404923",
      "brand_name": "APO-MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242001"
    },
    "created_date": "2017-11-07T19:26:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404923",
    "company_name": "APOTEX INC",
    "atc_number": "J01MA14",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-27T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MOXIFLOXACIN",
    "en_drug_common_name": "MOXIFLOXACIN",
    "fr_drug_brand_name": "APO-MOXIFLOXACIN",
    "fr_drug_common_name": "MOXIFLOXACIN",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "MOXIFLOXACIN",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28564,
    "drug": {
      "current_status": "MARKETED",
      "id": 15968,
      "drug_code": 76748,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255703,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281821",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-11-07T19:33:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281821",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-15T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-11T13:05:59-05:00",
    "status": "resolved",
    "en_comments": "100 BTL is available",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28567,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1560,
      "drug_code": 13375,
      "updated_date": "2025-05-15T03:39:36-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8291375,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02007959",
      "brand_name": "COUMADIN TAB 4MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74739",
      "number_of_ais": "1",
      "ai_group_no": "0104597003"
    },
    "created_date": "2017-11-07T19:35:34-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02007959",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2018-06-29T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The bottles of 100's will continue to be available",
    "fr_supply_disruption_mitigation": "Les bouteilles de 100 seront toujours disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T12:48:42-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 4MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "Coumadin 4mg",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 250's only",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28570,
    "drug": {
      "current_status": "MARKETED",
      "id": 18868,
      "drug_code": 80118,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256586,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315653",
      "brand_name": "MINT-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2017-11-07T20:37:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315653",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-11-07T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-04T16:11:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-TOPIRAMATE",
    "en_drug_common_name": "Mint- Topiramate",
    "fr_drug_brand_name": "Mint- Topiramate",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28573,
    "drug": {
      "current_status": "MARKETED",
      "id": 4766,
      "drug_code": 2568,
      "updated_date": "2025-12-03T00:30:20-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250428,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00382825",
      "brand_name": "RIVOTRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50354",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2017-11-07T20:42:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00382825",
    "company_name": "HOFFMANN-LA ROCHE LIMITED",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-17T00:00:00-05:00",
    "estimated_end_date": "2017-12-13T00:00:00-05:00",
    "actual_start_date": "2017-11-09T00:00:00-05:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-13T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Unanticipated demand increased due to competitor shortage.",
    "fr_comments": "La demande imprévue a augmenté en raison de la pénurie de concurrents.",
    "en_drug_brand_name": "RIVOTRIL 0.5TAB",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "Rivotril",
    "fr_drug_common_name": "Clonazépam",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28591,
    "drug": {
      "current_status": "DORMANT",
      "id": 4112,
      "drug_code": 19933,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367035,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216140",
      "brand_name": "PMS-LITHIUM CARBONATE - CAP 300MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82232",
      "number_of_ais": "1",
      "ai_group_no": "0101163002"
    },
    "created_date": "2017-11-08T15:54:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216140",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2017-11-07T00:00:00-05:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T14:41:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LITHIUM CARBONATE - CAP 300MG",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "LITHIUM CARBONATE",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28616,
    "drug": {
      "current_status": "MARKETED",
      "id": 15244,
      "drug_code": 75765,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255427,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02272113",
      "brand_name": "MYLAN-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2017-11-08T17:10:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272113",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2018-01-29T00:00:00-05:00",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2018-01-22T00:00:00-05:00",
    "actual_end_date": "2018-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-10T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "MYLAN-AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28619,
    "drug": {
      "current_status": "MARKETED",
      "id": 28858,
      "drug_code": 90967,
      "updated_date": "2025-12-03T00:32:34-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260478,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02425009",
      "brand_name": "CONTINGENCY ONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125218004"
    },
    "created_date": "2017-11-08T17:11:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02425009",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AD01",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2018-01-31T00:00:00-05:00",
    "estimated_end_date": "2018-05-14T00:00:00-04:00",
    "actual_start_date": "2018-02-02T00:00:00-05:00",
    "actual_end_date": "2018-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-31T18:03:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CONTINGENCY ONE",
    "en_drug_common_name": "CONTINGENCY ONE",
    "fr_drug_brand_name": "CONTINGENCY ONE",
    "fr_drug_common_name": "CONTINGENCY ONE",
    "en_ingredients": "LEVONORGESTREL",
    "fr_ingredients": "Lévonorgestrel",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28642,
    "drug": {
      "current_status": "MARKETED",
      "id": 23026,
      "drug_code": 85612,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8258325,
          "ingredient": {
            "id": 3734,
            "ingredient_code": 20882,
            "en_name": "LINAGLIPTIN",
            "fr_name": "Linagliptine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370921",
      "brand_name": "TRAJENTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152946001"
    },
    "created_date": "2017-11-08T20:22:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370921",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BH05",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-11-10T00:00:00-05:00",
    "estimated_end_date": "2017-11-21T00:00:00-05:00",
    "actual_start_date": "2017-11-14T00:00:00-05:00",
    "actual_end_date": "2017-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-22T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "TRAJENTA 5MG TABLETS 3 X 10 REMAINS AVAILABLE",
    "fr_comments": "TRAJENTA 5MG COMPRIMÉS 3 X 10 RESTE DISPONIBLE",
    "en_drug_brand_name": "TRAJENTA",
    "en_drug_common_name": "Trajenta",
    "fr_drug_brand_name": "Trajenta",
    "fr_drug_common_name": "Trajenta",
    "en_ingredients": "LINAGLIPTIN",
    "fr_ingredients": "Linagliptine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28645,
    "drug": {
      "current_status": "MARKETED",
      "id": 23866,
      "drug_code": 86529,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258590,
          "ingredient": {
            "id": 2406,
            "ingredient_code": 11431,
            "en_name": "TOPOTECAN",
            "fr_name": "Topotécane (Chlorhydrate de topotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02379422",
      "brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "CHLORHYDRATE DE TOPOTÉCAN POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132984002"
    },
    "created_date": "2017-11-08T20:42:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379422",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01XX17",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2017-11-07T00:00:00-05:00",
    "estimated_end_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2017-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-21T21:17:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "TOPOTECAN",
    "fr_drug_brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
    "fr_drug_common_name": "TOPOTECAN",
    "en_ingredients": "TOPOTECAN",
    "fr_ingredients": "TOPOTECAN",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5x4mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28664,
    "drug": {
      "current_status": "MARKETED",
      "id": 7296,
      "drug_code": 49332,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253269,
          "ingredient": {
            "id": 154,
            "ingredient_code": 3776,
            "en_name": "METOCLOPRAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de métoclopramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230431",
      "brand_name": "PMS-METOCLOPRAMIDE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109394003"
    },
    "created_date": "2017-11-08T21:22:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230431",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "A03FA01",
    "atc_description": "PROPULSIVES",
    "anticipated_start_date": "2017-12-24T00:00:00-05:00",
    "estimated_end_date": "2017-12-28T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-04T18:55:42-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "METONIA",
    "en_drug_common_name": "METONIA 5mg TABS 100",
    "fr_drug_brand_name": "METONIA",
    "fr_drug_common_name": "METONIA 5mg TABS 100",
    "en_ingredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de métoclopramide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28686,
    "drug": {
      "current_status": "MARKETED",
      "id": 4970,
      "drug_code": 2858,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250460,
          "ingredient": {
            "id": 652,
            "ingredient_code": 20269,
            "en_name": "FLUPHENAZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de fluphénazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00405345",
      "brand_name": "FLUPHENAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51677",
      "number_of_ais": "1",
      "ai_group_no": "0106171001"
    },
    "created_date": "2017-11-09T13:19:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00405345",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05AB02",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-03-09T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-09T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUPHENAZINE",
    "en_drug_common_name": "FLUPHENAZINE",
    "fr_drug_brand_name": "FLUPHENAZINE",
    "fr_drug_common_name": "FLUPHENAZINE",
    "en_ingredients": "FLUPHENAZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de fluphénazine",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28689,
    "drug": {
      "current_status": "MARKETED",
      "id": 15966,
      "drug_code": 76747,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255702,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281813",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2017-11-09T13:25:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281813",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-10T13:37:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28695,
    "drug": {
      "current_status": "MARKETED",
      "id": 11060,
      "drug_code": 6720,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 17010,
        "created_date": "2021-01-09T23:00:04-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 18043,
        "mfr_code": "",
        "name": "GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ARABELLASTR 17",
        "province": "--",
        "country": "GERMANY",
        "city": "MUNICH",
        "postal_code": "81925",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250935,
          "ingredient": {
            "id": 328,
            "ingredient_code": 7219,
            "en_name": "DIPYRIDAMOLE",
            "fr_name": "Dipyridamole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00637734",
      "brand_name": "PERSANTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63903",
      "number_of_ais": "1",
      "ai_group_no": "0106621005"
    },
    "created_date": "2017-11-09T13:43:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00637734",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "B01AC07",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2017-11-13T00:00:00-05:00",
    "estimated_end_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2018-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-03T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "INCREASED DEMAND DUE TO COMPETITOR STOCK OUT",
    "fr_comments": "AUGMENTATION DE LA DEMANDE EN RAISON DE LA SITUATION DES CONCURRENTS",
    "en_drug_brand_name": "PERSANTINE",
    "en_drug_common_name": "Persantine",
    "fr_drug_brand_name": "PERSANTINE",
    "fr_drug_common_name": "PERSANTINE",
    "en_ingredients": "DIPYRIDAMOLE",
    "fr_ingredients": "Dipyridamole",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 X 10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28700,
    "drug": {
      "current_status": "MARKETED",
      "id": 13136,
      "drug_code": 72539,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254780,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248203",
      "brand_name": "APO-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2017-11-09T13:56:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248203",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE03",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-03T13:29:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "APO-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28705,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1526,
      "drug_code": 13305,
      "updated_date": "2025-05-15T03:39:31-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8291260,
          "ingredient": {
            "id": 850,
            "ingredient_code": 925,
            "en_name": "CLODRONATE DISODIUM",
            "fr_name": "Clodronate disodique (Clodronate disodique tetrahydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01984845",
      "brand_name": "BONEFOS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74653",
      "number_of_ais": "1",
      "ai_group_no": "0122982001"
    },
    "created_date": "2017-11-09T14:50:01-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01984845",
    "company_name": "BAYER INC",
    "atc_number": "M05BA02",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "discontinuation_date": "2018-03-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-04-02T14:14:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BONEFOS",
    "en_drug_common_name": "clodronate disodium",
    "fr_drug_brand_name": "Bonefos",
    "fr_drug_common_name": "Clodronate disodique capsule",
    "en_ingredients": "CLODRONATE DISODIUM",
    "fr_ingredients": "Clodronate disodique",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28707,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1524,
      "drug_code": 13304,
      "updated_date": "2025-05-15T03:39:31-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8291259,
          "ingredient": {
            "id": 850,
            "ingredient_code": 925,
            "en_name": "CLODRONATE DISODIUM",
            "fr_name": "Clodronate disodique (Clodronate disodique tetrahydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01984837",
      "brand_name": "BONEFOS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74652",
      "number_of_ais": "1",
      "ai_group_no": "0122982003"
    },
    "created_date": "2017-11-09T14:54:14-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01984837",
    "company_name": "BAYER INC",
    "atc_number": "M05BA02",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "discontinuation_date": "2018-12-27T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-01-04T18:47:44-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "BONEFOS",
    "en_drug_common_name": "clodronate disodium",
    "fr_drug_brand_name": "Bonefos",
    "fr_drug_common_name": "Clodronate disodique",
    "en_ingredients": "CLODRONATE DISODIUM",
    "fr_ingredients": "Clodronate disodique",
    "drug_strength": "60MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28709,
    "drug": {
      "current_status": "MARKETED",
      "id": 9052,
      "drug_code": 61678,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253564,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238282",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2017-11-09T15:17:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238282",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-02-28T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T13:27:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 250 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28726,
    "drug": {
      "current_status": "MARKETED",
      "id": 11514,
      "drug_code": 68273,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254283,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244305",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-11-09T15:35:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244305",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-12-18T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-19T19:25:37-05:00",
    "status": "resolved",
    "en_comments": "500 BTL is available",
    "en_drug_brand_name": "APO-GABAPENTIN CAPSULES",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO-GABAPENTIN CAPSULES",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28733,
    "drug": {
      "current_status": "MARKETED",
      "id": 12846,
      "drug_code": 71959,
      "updated_date": "2025-12-03T00:30:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254689,
          "ingredient": {
            "id": 2756,
            "ingredient_code": 6417,
            "en_name": "METHADONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthadone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247698",
      "brand_name": "METADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144621002"
    },
    "created_date": "2017-11-09T19:26:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247698",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N07BC02",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-27T18:44:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METADOL",
    "en_drug_common_name": "Mathadone",
    "fr_drug_brand_name": "Metadol",
    "fr_drug_common_name": "Methadone",
    "en_ingredients": "METHADONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthadone",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28736,
    "drug": {
      "current_status": "MARKETED",
      "id": 11202,
      "drug_code": 6755,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250938,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00594652",
      "brand_name": "STATEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63972",
      "number_of_ais": "1",
      "ai_group_no": "0104545003"
    },
    "created_date": "2017-11-09T19:29:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00594652",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AA01",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "STATEX TAB 5MG",
    "en_drug_common_name": "Morphine",
    "fr_drug_brand_name": "Statex",
    "fr_drug_common_name": "Morphine",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Control Pack (4x25 tabs)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28780,
    "drug": {
      "current_status": "MARKETED",
      "id": 16166,
      "drug_code": 76957,
      "updated_date": "2025-12-03T00:31:09-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255767,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284006",
      "brand_name": "PMS-ALENDRONATE-FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-11-09T21:49:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284006",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T13:57:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ALENDRONATE-FC",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "PMS-ALENDRONATE-FC",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28783,
    "drug": {
      "current_status": "MARKETED",
      "id": 10618,
      "drug_code": 66199,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254022,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242472",
      "brand_name": "PMS-AMIODARONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593001"
    },
    "created_date": "2017-11-09T21:50:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242472",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C01BD01",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-AMIODARONE",
    "en_drug_common_name": "AMIODARONE",
    "fr_drug_brand_name": "PMS-AMIODARONE",
    "fr_drug_common_name": "AMIODARONE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28786,
    "drug": {
      "current_status": "MARKETED",
      "id": 12342,
      "drug_code": 70768,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254547,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246581",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2017-11-09T21:51:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246581",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T13:03:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28789,
    "drug": {
      "current_status": "MARKETED",
      "id": 2172,
      "drug_code": 14587,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251987,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02048728",
      "brand_name": "PMS-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76238",
      "number_of_ais": "1",
      "ai_group_no": "0111558004"
    },
    "created_date": "2017-11-09T21:52:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02048728",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-02-20T00:00:00-05:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-20T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CLONAZEPAM TAB 1.0MG",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "PMS-CLONAZEPAM TAB 1.0MG",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28792,
    "drug": {
      "current_status": "MARKETED",
      "id": 4074,
      "drug_code": 19827,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252574,
          "ingredient": {
            "id": 1182,
            "ingredient_code": 2143,
            "en_name": "CYCLOBENZAPRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclobenzaprine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02212048",
      "brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82125",
      "number_of_ais": "1",
      "ai_group_no": "0112363001"
    },
    "created_date": "2017-11-09T21:56:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212048",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M03BX08",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2017-11-13T00:00:00-05:00",
    "estimated_end_date": "2018-04-26T00:00:00-04:00",
    "actual_start_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
    "en_drug_common_name": "CYCLOBENZAPRINE",
    "fr_drug_brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
    "fr_drug_common_name": "CYCLOBENZAPRINE",
    "en_ingredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclobenzaprine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28797,
    "drug": {
      "current_status": "DORMANT",
      "id": 15656,
      "drug_code": 76369,
      "updated_date": "2025-05-15T06:55:34-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367959,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278111",
      "brand_name": "PMS-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885002"
    },
    "created_date": "2017-11-09T21:58:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278111",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J05AB09",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T11:45:38-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "PMS-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28832,
    "drug": {
      "current_status": "MARKETED",
      "id": 2154,
      "drug_code": 14567,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251983,
          "ingredient": {
            "id": 1092,
            "ingredient_code": 2251,
            "en_name": "LOPERAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lopéramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02016095",
      "brand_name": "PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76214",
      "number_of_ais": "1",
      "ai_group_no": "0111332002"
    },
    "created_date": "2017-11-10T15:52:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02016095",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07DA03",
    "atc_description": "ANTIPROPULSIVES",
    "anticipated_start_date": "2017-11-16T00:00:00-05:00",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-12T19:35:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML",
    "en_drug_common_name": "LOPERAMIDE",
    "fr_drug_brand_name": "PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML",
    "fr_drug_common_name": "LOPERAMIDE",
    "en_ingredients": "LOPERAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lopéramide",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "230",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28835,
    "drug": {
      "current_status": "MARKETED",
      "id": 13502,
      "drug_code": 73226,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254886,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248855",
      "brand_name": "PMS-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923005"
    },
    "created_date": "2017-11-10T15:53:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248855",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "estimated_end_date": "2018-06-20T00:00:00-04:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-29T13:52:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-METOPROLOL-L",
    "en_drug_common_name": "METOPROLOL-L",
    "fr_drug_brand_name": "PMS-METOPROLOL-L",
    "fr_drug_common_name": "METOPROLOL-L",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28841,
    "drug": {
      "current_status": "MARKETED",
      "id": 32218,
      "drug_code": 9973,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251251,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00792667",
      "brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69548",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2017-11-10T15:57:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00792667",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07AA02",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "estimated_end_date": "2018-01-26T00:00:00-05:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-19T16:30:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "en_drug_common_name": "NYSTATIN",
    "fr_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "fr_drug_common_name": "NYSTATIN",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28844,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10594,
      "drug_code": 66173,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332471,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242454",
      "brand_name": "PMS-RANITIDINE 300 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150001"
    },
    "created_date": "2017-11-10T15:58:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242454",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA02",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "hc_updated_date": "2018-12-07T15:12:27-05:00",
    "anticipated_start_date": "2017-11-20T00:00:00-05:00",
    "estimated_end_date": "2018-02-05T00:00:00-05:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-07T15:12:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RANITIDINE 300 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 300 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "100",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28847,
    "drug": {
      "current_status": "MARKETED",
      "id": 6784,
      "drug_code": 44264,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253181,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182971",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "METHOTREXATE INJECTABLE USP",
      "descriptor": "PRESERVATIVE-FREE (PHARMACY BULK VIAL)",
      "pediatric_flag": false,
      "accession_number": "T9988",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2017-11-10T17:42:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182971",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01BA01",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2018-01-24T00:00:00-05:00",
    "actual_end_date": "2018-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-20T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Please note that only 1 lot with an expiry date of 2/28/2018 remains available.",
    "fr_comments": "Veuillez noter qu’un seul lot dont la date de péremption est le 2/28/2018 demeure disponible.",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "Methotrexate",
    "fr_drug_brand_name": "METHOTREXATE INJECTION USP",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 x 20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28851,
    "drug": {
      "current_status": "MARKETED",
      "id": 6784,
      "drug_code": 44264,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253181,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182971",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "METHOTREXATE INJECTABLE USP",
      "descriptor": "PRESERVATIVE-FREE (PHARMACY BULK VIAL)",
      "pediatric_flag": false,
      "accession_number": "T9988",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2017-11-10T17:47:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182971",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01BA01",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2017-12-22T00:00:00-05:00",
    "actual_end_date": "2018-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-04T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "Methotrexate",
    "fr_drug_brand_name": "METHOTREXATE INJECTION USP",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "Each - 40 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28882,
    "drug": {
      "current_status": "MARKETED",
      "id": 29340,
      "drug_code": 91345,
      "updated_date": "2025-12-03T00:32:39-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260640,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429012",
      "brand_name": "DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2017-11-10T19:30:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429012",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "G04CB02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "estimated_end_date": "2018-01-29T00:00:00-05:00",
    "actual_start_date": "2017-12-08T00:00:00-05:00",
    "actual_end_date": "2018-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-30T15:11:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DUTASTERIDE",
    "en_drug_common_name": "DUTASTERIDE",
    "fr_drug_brand_name": "DUTASTERIDE",
    "fr_drug_common_name": "DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28887,
    "drug": {
      "current_status": "MARKETED",
      "id": 20918,
      "drug_code": 82912,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257400,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02343681",
      "brand_name": "OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2017-11-10T19:41:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02343681",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-12-25T00:00:00-05:00",
    "actual_start_date": "2017-12-04T00:00:00-05:00",
    "actual_end_date": "2018-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-31T16:08:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28890,
    "drug": {
      "current_status": "MARKETED",
      "id": 20920,
      "drug_code": 82913,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257401,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02343703",
      "brand_name": "OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-11-10T19:43:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02343703",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-02-16T00:00:00-05:00",
    "actual_start_date": "2018-02-07T00:00:00-05:00",
    "actual_end_date": "2018-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-31T16:09:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28893,
    "drug": {
      "current_status": "MARKETED",
      "id": 18212,
      "drug_code": 79475,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256392,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309157",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169004"
    },
    "created_date": "2017-11-10T19:46:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309157",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-11-27T00:00:00-05:00",
    "estimated_end_date": "2018-12-04T00:00:00-05:00",
    "actual_start_date": "2017-12-02T00:00:00-05:00",
    "actual_end_date": "2018-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-12-04T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28900,
    "drug": {
      "current_status": "MARKETED",
      "id": 31006,
      "drug_code": 93138,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261458,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02446111",
      "brand_name": "RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2017-11-10T19:59:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446111",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N02CC04",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "estimated_end_date": "2018-02-23T00:00:00-05:00",
    "actual_start_date": "2017-12-06T00:00:00-05:00",
    "actual_end_date": "2018-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-02-26T22:04:16-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN ODT",
    "fr_drug_brand_name": "RIZATRIPTAN ODT",
    "fr_drug_common_name": "RIZATRIPTAN ODT",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28908,
    "drug": {
      "current_status": "MARKETED",
      "id": 53519,
      "drug_code": 95553,
      "updated_date": "2025-12-03T00:33:27-05:00",
      "company": {
        "id": 10750,
        "created_date": "2018-12-05T03:00:11-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16507,
        "mfr_code": "",
        "name": "IPSEN BIOPHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 500",
        "street_name": "5050 SATELLITE DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 0G1",
        "post_office_box": "",
        "contact_information": "medinfoandsafetycanada@ipsen.com \r\n1(855) 215-2288"
      },
      "drug_ingredients": [
        {
          "id": 8262670,
          "ingredient": {
            "id": 32873,
            "ingredient_code": 22885,
            "en_name": "IRINOTECAN",
            "fr_name": "Irinotécan (Octasulfate de sucrose d'Irinotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02467135",
      "brand_name": "ONIVYDE",
      "brand_name_fr": "",
      "descriptor": "LIPOSOMES FOR INJECTION. SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0159330001"
    },
    "created_date": "2017-11-10T20:49:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467135",
    "company_name": "BAXALTA CANADA CORPORATION",
    "atc_number": "L01XX19",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2017-11-07T00:00:00-05:00",
    "estimated_end_date": "2017-12-11T00:00:00-05:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-07T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "For emergency supply, please contact Baxalta customer service at +1 844 423 2090.",
    "fr_comments": "Pour l'approvisionnement d'urgence, veuillez contacter le service à la clientèle de Baxalta au +1 844 423 2090.",
    "en_drug_brand_name": "ONIVYDE",
    "en_drug_common_name": "Irinotecan Liposome for Injection",
    "fr_drug_brand_name": "ONIVYDE",
    "fr_drug_common_name": "Liposome d'Irinotecan pour l'injection",
    "en_ingredients": "IRINOTECAN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'irinotécan",
    "drug_strength": "43MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "Vials of 43g/10ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 28996,
    "drug": {
      "current_status": "DORMANT",
      "id": 10472,
      "drug_code": 65751,
      "updated_date": "2025-12-03T02:32:18-05:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367440,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242077",
      "brand_name": "RIVA-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2017-11-13T16:59:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242077",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-17T00:00:00-05:00",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-02T14:05:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-CLONAZEPAM",
    "en_drug_common_name": "Clonazepam 0.5mg",
    "fr_drug_brand_name": "Riva- Clonazepam",
    "fr_drug_common_name": "Clonazepam 0.5mg",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 & 500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29008,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19676,
      "drug_code": 81032,
      "updated_date": "2025-05-15T04:14:33-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346955,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324881",
      "brand_name": "FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885002"
    },
    "created_date": "2017-11-13T17:38:00-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324881",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J05AB09",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2017-11-13T00:00:00-05:00",
    "decision_reversal": true,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-14T20:43:58-05:00",
    "status": "reversed",
    "en_drug_brand_name": "FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29028,
    "drug": {
      "current_status": "MARKETED",
      "id": 8406,
      "drug_code": 5825,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250839,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00628158",
      "brand_name": "APO-AMOXI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61603",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2017-11-13T18:32:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00628158",
    "company_name": "APOTEX INC",
    "atc_number": "J01CA04",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-02-12T00:00:00-05:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T13:18:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI PWR FOR SUSP 250MG/5ML",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "APO-AMOXI PWR FOR SUSP 250MG/5ML",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 ML & 500 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29031,
    "drug": {
      "current_status": "MARKETED",
      "id": 12990,
      "drug_code": 72244,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254745,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247934",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683004"
    },
    "created_date": "2017-11-13T18:33:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247934",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG02",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-27T21:20:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29036,
    "drug": {
      "current_status": "MARKETED",
      "id": 22182,
      "drug_code": 84559,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257941,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360624",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-11-13T18:42:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360624",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-08-20T00:00:00-04:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-15T11:54:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29039,
    "drug": {
      "current_status": "MARKETED",
      "id": 10028,
      "drug_code": 64499,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253820,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240908",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2017-11-13T18:46:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240908",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-06T19:34:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29043,
    "drug": {
      "current_status": "MARKETED",
      "id": 28914,
      "drug_code": 91003,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260501,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02425386",
      "brand_name": "RIVA-CELECOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2017-11-13T18:48:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02425386",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "M01AH01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-11-13T00:00:00-05:00",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2017-12-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T16:00:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-CELECOX",
    "en_drug_common_name": "Celcox 100mg",
    "fr_drug_brand_name": "Riva-Celecox",
    "fr_drug_common_name": "Celecox 100mg",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29048,
    "drug": {
      "current_status": "MARKETED",
      "id": 14912,
      "drug_code": 75307,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255340,
          "ingredient": {
            "id": 1558,
            "ingredient_code": 4732,
            "en_name": "ADENOSINE",
            "fr_name": "Adénosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02267659",
      "brand_name": "ADENOSINE INJECTION",
      "brand_name_fr": "ADÉNOSINE INJECTABLE",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113219001"
    },
    "created_date": "2017-11-13T18:57:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267659",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "C01EB10",
    "atc_description": "OTHER CARDIAC PREPARATIONS",
    "estimated_end_date": "2018-01-05T00:00:00-05:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2017-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-01T14:13:16-05:00",
    "status": "resolved",
    "en_comments": "Product on backorder, code K051002 Adenosine 3mg/mL 2mL Prefilled Syringe available for substitution.",
    "fr_comments": "Rupture de stock, code K051002 Seringue préremplie d'adénosine 3mg / mL 2mL disponible pour la substitution.",
    "en_drug_brand_name": "ADENOSINE INJECTION",
    "en_drug_common_name": "Adenosine Injection",
    "fr_drug_brand_name": "Adénosine",
    "fr_drug_common_name": "Adénosine injectable",
    "en_ingredients": "ADENOSINE",
    "fr_ingredients": "Adénosine",
    "drug_strength": "3MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "3mg/mL 2mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29052,
    "drug": {
      "current_status": "MARKETED",
      "id": 30248,
      "drug_code": 92309,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8261052,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02438690",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732007"
    },
    "created_date": "2017-11-13T19:12:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438690",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA07",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "30DOSE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29055,
    "drug": {
      "current_status": "MARKETED",
      "id": 26034,
      "drug_code": 88411,
      "updated_date": "2025-12-03T00:32:10-05:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8259394,
          "ingredient": {
            "id": 36162,
            "ingredient_code": 23895,
            "en_name": "VARICELLA VIRUS LIVE ATTENUATED",
            "fr_name": "Virus de la varicelle, vivant, atténué (souche Oka/Merck)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.99",
          "strength_unit": "Log10 PFU",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8259393,
          "ingredient": {
            "id": 36214,
            "ingredient_code": 23944,
            "en_name": "MEASLES VIRUS LIVE ATTENUATED",
            "fr_name": "Virus de la rougeole vivant, atténué (souche Edmonston)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.00",
          "strength_unit": "Log10 TCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8259392,
          "ingredient": {
            "id": 36216,
            "ingredient_code": 23942,
            "en_name": "RUBELLA VIRUS LIVE ATTENUATED",
            "fr_name": "Virus de la rubéole vivant, atténué (souche Wistar RA27/3)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.00",
          "strength_unit": "Log10 TCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8259391,
          "ingredient": {
            "id": 36215,
            "ingredient_code": 23943,
            "en_name": "MUMPS VIRUS LIVE ATTENUATED",
            "fr_name": "Virus des oreillons vivant, atténué (souche Jeryl Lynn)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.30",
          "strength_unit": "Log10 TCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02399229",
      "brand_name": "PROQUAD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0466265001"
    },
    "created_date": "2017-11-13T19:15:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399229",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BD54",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2017-12-01T00:00:00-05:00",
    "estimated_end_date": "2017-12-08T00:00:00-05:00",
    "actual_end_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-30T22:14:23-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PROQUAD",
    "en_drug_common_name": "measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection",
    "fr_drug_brand_name": "PROQUAD",
    "fr_drug_common_name": "vaccin à virus vivants contre la rougeole, les oreillons, la rubéole et la varicelle poudre lyophilisée pour injection",
    "en_ingredients": "MUMPS VIRUS VACCINE LIVE ATTENUATED\r\nVARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED\r\nRUBELLA VIRUS VACCINE LIVE ATTENUATED\r\nMEASLES VIRUS VACCINE LIVE ATTENUATED",
    "fr_ingredients": "MUMPS VIRUS VACCINE LIVE ATTENUATED\r\nVARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED\r\nRUBELLA VIRUS VACCINE LIVE ATTENUATED\r\nMEASLES VIRUS VACCINE LIVE ATTENUATED",
    "drug_strength": "4.30Log10 TCID50\r\n3.99Log10 PFU\r\n3.00Log10 TCID50\r\n3.00Log10 TCID50",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "0.5ML 10 X 1 DOSE VIAL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29071,
    "drug": {
      "current_status": "DORMANT",
      "id": 11214,
      "drug_code": 67589,
      "updated_date": "2025-12-03T02:32:19-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367498,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02243659",
      "brand_name": "CLINDA-T",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830004"
    },
    "created_date": "2017-11-13T20:46:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243659",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D10AF01",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "actual_start_date": "2017-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-12T17:57:56-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "CLINDA-T",
    "en_drug_common_name": "CLINDA-T",
    "fr_drug_brand_name": "CLINDA-T",
    "fr_drug_common_name": "CLINDA-T",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "na",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "na",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29079,
    "drug": {
      "current_status": "MARKETED",
      "id": 9304,
      "drug_code": 62447,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253633,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02238998",
      "brand_name": "RHO-NITRO PUMPSPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2017-11-14T02:24:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238998",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01DA02",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-05T23:40:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RHO-NITRO PUMPSPRAY",
    "en_drug_common_name": "RHO NITRO",
    "fr_drug_brand_name": "RHO NITRO",
    "fr_drug_common_name": "RHO NITRO",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "METERED-DOSE PUMP",
    "drug_dosage_form_fr": "Pompe à dose mesurée",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "200 DOSES",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29082,
    "drug": {
      "current_status": "MARKETED",
      "id": 16532,
      "drug_code": 77349,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255877,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288109",
      "brand_name": "SANDOZ ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-11-14T02:32:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288109",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-09-28T00:00:00-04:00",
    "actual_end_date": "2017-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T02:43:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 4'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29085,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29358,
      "drug_code": 91361,
      "updated_date": "2025-05-15T04:22:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8354988,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8354987,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429160",
      "brand_name": "SANDOZ ALENDRONATE/CHOLECALCIFEROL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251575002"
    },
    "created_date": "2017-11-14T02:36:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429160",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M05BB03",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T21:31:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ALENDRONATE/CHOLECALCIFEROL",
    "en_drug_common_name": "ALENDRONATE VITAMIN D",
    "fr_drug_brand_name": "ALENDRONATE VITAMINE D",
    "fr_drug_common_name": "ALENDRONATE VITAMINE D",
    "en_ingredients": "ALENDRONIC ACID\r\nVITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "70MG\r\n5600UNIT",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 4'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29088,
    "drug": {
      "current_status": "MARKETED",
      "id": 19684,
      "drug_code": 81039,
      "updated_date": "2025-12-03T00:31:26-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256872,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324970",
      "brand_name": "SANDOZ ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2017-11-14T02:38:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324970",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-10-13T00:00:00-04:00",
    "actual_end_date": "2017-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T02:46:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29091,
    "drug": {
      "current_status": "MARKETED",
      "id": 15472,
      "drug_code": 76059,
      "updated_date": "2025-12-03T00:31:05-05:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8255536,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02275082",
      "brand_name": "ODAN BUPROPION SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140003"
    },
    "created_date": "2017-11-14T02:41:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02275082",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06AX12",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T02:47:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ BUPROPION SR",
    "en_drug_common_name": "BUPROPION",
    "fr_drug_brand_name": "BUPROPION",
    "fr_drug_common_name": "BUPROPION",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29094,
    "drug": {
      "current_status": "MARKETED",
      "id": 19904,
      "drug_code": 81228,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256957,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326957",
      "brand_name": "SANDOZ CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220001"
    },
    "created_date": "2017-11-14T02:45:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326957",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2017-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T02:48:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 3 X 10'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29097,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30660,
      "drug_code": 92698,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355965,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442639",
      "brand_name": "SDZ CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2017-11-14T02:48:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442639",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AH01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-02-23T00:00:00-05:00",
    "actual_start_date": "2017-09-19T00:00:00-04:00",
    "actual_end_date": "2018-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-03-02T21:51:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SDZ CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29100,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12078,
      "drug_code": 70039,
      "updated_date": "2025-05-15T04:04:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8336482,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245919",
      "brand_name": "SANDOZ DILTIAZEM T",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2017-11-14T02:50:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245919",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C08DB01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-15T02:03:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DILTIAZEM T",
    "en_drug_common_name": "DILTIAZEM T",
    "fr_drug_brand_name": "DILTIAZEM T",
    "fr_drug_common_name": "DILTIAZEM T",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29105,
    "drug": {
      "current_status": "MARKETED",
      "id": 30372,
      "drug_code": 92433,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261098,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439948",
      "brand_name": "SANDOZ DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2017-11-14T02:56:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439948",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-11-15T00:00:00-05:00",
    "actual_start_date": "2017-10-25T00:00:00-04:00",
    "actual_end_date": "2017-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:04:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29108,
    "drug": {
      "current_status": "MARKETED",
      "id": 28802,
      "drug_code": 90912,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260451,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424444",
      "brand_name": "SANDOZ DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2017-11-14T03:02:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-13T20:14:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DUTASTERIDE CAPSULE",
    "en_drug_common_name": "DUTASTERIDE",
    "fr_drug_brand_name": "DUTASTERIDE",
    "fr_drug_common_name": "DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29111,
    "drug": {
      "current_status": "MARKETED",
      "id": 28802,
      "drug_code": 90912,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260451,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424444",
      "brand_name": "SANDOZ DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2017-11-14T03:09:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2018-03-09T00:00:00-05:00",
    "actual_start_date": "2017-09-11T00:00:00-04:00",
    "actual_end_date": "2018-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-13T20:17:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DUTASTERIDE CAPSULE",
    "en_drug_common_name": "DUTASTERIDE",
    "fr_drug_brand_name": "DUTASTERIDE",
    "fr_drug_common_name": "DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29114,
    "drug": {
      "current_status": "MARKETED",
      "id": 20056,
      "drug_code": 81399,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257058,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328461",
      "brand_name": "SANDOZ IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2017-11-14T03:12:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328461",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:06:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29117,
    "drug": {
      "current_status": "MARKETED",
      "id": 52271,
      "drug_code": 94974,
      "updated_date": "2025-12-03T00:33:20-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262383,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461994",
      "brand_name": "SANDOZ LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843002"
    },
    "created_date": "2017-11-14T03:18:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461994",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-13T20:20:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29122,
    "drug": {
      "current_status": "DORMANT",
      "id": 30852,
      "drug_code": 92980,
      "updated_date": "2025-05-15T06:55:55-04:00",
      "company": {
        "id": 17092,
        "created_date": "2021-07-08T04:00:06-04:00",
        "updated_date": "2025-05-15T06:55:18-04:00",
        "company_code": 18096,
        "mfr_code": "",
        "name": "ATHENA PHARMACEUTIQUES SAS",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ESPACE ARNOLD DE VILLE, 12 RUE GEORGES BLANDON",
        "province": "--",
        "country": "FRANCE",
        "city": "LOUVECIENNES",
        "postal_code": "78430",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369318,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444682",
      "brand_name": "ATHENA-ONDANSETRON ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120001"
    },
    "created_date": "2017-11-14T03:24:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444682",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A04AA01",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-10-03T00:00:00-04:00",
    "actual_end_date": "2017-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:23:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ONDANSETRON ODT",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "ONDANSETRON",
    "fr_drug_common_name": "ONDANSETRON",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 10'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29129,
    "drug": {
      "current_status": "MARKETED",
      "id": 25114,
      "drug_code": 87625,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259101,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390868",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121008"
    },
    "created_date": "2017-11-14T03:47:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390868",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-05-18T00:00:00-04:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T02:46:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29132,
    "drug": {
      "current_status": "MARKETED",
      "id": 25110,
      "drug_code": 87623,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259099,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390833",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2017-11-14T03:49:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390833",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-02-05T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-06T06:00:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29155,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18682,
      "drug_code": 79952,
      "updated_date": "2025-05-15T04:13:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8345806,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314002",
      "brand_name": "SANDOZ QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2017-11-14T14:18:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314002",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T22:03:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29160,
    "drug": {
      "current_status": "MARKETED",
      "id": 26984,
      "drug_code": 89242,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259720,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02407728",
      "brand_name": "SANDOZ QUETIAPINE XRT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2017-11-14T14:21:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407728",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-15T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T18:56:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ QUETIAPINE XRT",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29168,
    "drug": {
      "current_status": "MARKETED",
      "id": 20676,
      "drug_code": 82438,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257315,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338734",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-11-14T14:27:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338734",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-13T20:25:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29171,
    "drug": {
      "current_status": "MARKETED",
      "id": 20678,
      "drug_code": 82439,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257316,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338742",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2017-11-14T14:29:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338742",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-03-09T00:00:00-05:00",
    "actual_start_date": "2017-11-09T00:00:00-05:00",
    "actual_end_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-03-23T18:41:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29174,
    "drug": {
      "current_status": "MARKETED",
      "id": 20680,
      "drug_code": 82440,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257317,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338750",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2017-11-14T14:30:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338750",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-07-13T00:00:00-04:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-12T19:58:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29177,
    "drug": {
      "current_status": "MARKETED",
      "id": 20674,
      "drug_code": 82437,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257314,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338726",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2017-11-14T14:32:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338726",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:51:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 2 X 15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29180,
    "drug": {
      "current_status": "MARKETED",
      "id": 27540,
      "drug_code": 89783,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259953,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413159",
      "brand_name": "SANDOZ TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2017-11-14T14:37:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413159",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04BD07",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:52:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE",
    "fr_drug_brand_name": "TOLTERODINE",
    "fr_drug_common_name": "TOLTERODINE",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29183,
    "drug": {
      "current_status": "MARKETED",
      "id": 27540,
      "drug_code": 89783,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259953,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413159",
      "brand_name": "SANDOZ TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2017-11-14T14:39:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413159",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04BD07",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:53:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE",
    "fr_drug_brand_name": "TOLTERODINE",
    "fr_drug_common_name": "tolterodine",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29186,
    "drug": {
      "current_status": "MARKETED",
      "id": 27372,
      "drug_code": 89614,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259903,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02411520",
      "brand_name": "SANDOZ MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242003"
    },
    "created_date": "2017-11-14T15:47:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411520",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01AE07",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-09-25T00:00:00-04:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T03:10:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MOXIFLOXACIN",
    "en_drug_common_name": "MOXIFLOXACIN",
    "fr_drug_brand_name": "MOXIFLOXACIN",
    "fr_drug_common_name": "MOXIFLOXACIN",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "MOXIFLOXACIN",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "500'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29189,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6018,
      "drug_code": 42145,
      "updated_date": "2025-05-15T03:48:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8311839,
          "ingredient": {
            "id": 52,
            "ingredient_code": 8520,
            "en_name": "POLYMYXIN B",
            "fr_name": "Polymyxine B (Sulfate de polymyxine b)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        },
        {
          "id": 8311838,
          "ingredient": {
            "id": 1232,
            "ingredient_code": 8502,
            "en_name": "BACITRACIN",
            "fr_name": "Bacitracine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "01942921",
      "brand_name": "POLYTOPIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "M2368",
      "number_of_ais": "2",
      "ai_group_no": "0205854001"
    },
    "created_date": "2017-11-14T15:49:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01942921",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "D06AX05",
    "atc_description": "ANTIBIOTICS FOR TOPICAL USE",
    "actual_start_date": "2017-09-04T00:00:00-04:00",
    "actual_end_date": "2018-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-04-01T13:58:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "POLYTOPIC",
    "en_drug_common_name": "POLYTOPIC",
    "fr_drug_brand_name": "POLYTOPIC",
    "fr_drug_common_name": "POLYTOPIC",
    "en_ingredients": "BACITRACIN\r\nPOLYMYXIN B",
    "fr_ingredients": "Bacitracine\r\nPolymyxine B",
    "drug_strength": "500UNIT\r\n10000UNIT",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29192,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29598,
      "drug_code": 91629,
      "updated_date": "2025-05-15T04:22:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355218,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02431815",
      "brand_name": "SANDOZ TOPIRAMATE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2017-11-14T15:51:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02431815",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-11-09T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-13T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TOPIRAMATE TABLETS",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29195,
    "drug": {
      "current_status": "MARKETED",
      "id": 31784,
      "drug_code": 94216,
      "updated_date": "2025-05-15T02:35:24-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8261958,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02455358",
      "brand_name": "TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2017-11-14T16:48:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02455358",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-11-14T00:00:00-05:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-07T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29198,
    "drug": {
      "current_status": "MARKETED",
      "id": 28404,
      "drug_code": 90530,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260296,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260295,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420732",
      "brand_name": "SANDOZ CANDESARTAN PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181002"
    },
    "created_date": "2017-11-14T18:11:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420732",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-01-11T00:00:00-05:00",
    "actual_start_date": "2017-11-09T00:00:00-05:00",
    "actual_end_date": "2018-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T18:50:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN PLUS",
    "en_drug_common_name": "CANDESARTAN HCT",
    "fr_drug_brand_name": "CANDESARTAN HCT",
    "fr_drug_common_name": "CANDESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "12.5MG\r\n32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29201,
    "drug": {
      "current_status": "MARKETED",
      "id": 28406,
      "drug_code": 90531,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260298,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260297,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420740",
      "brand_name": "SANDOZ CANDESARTAN PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181003"
    },
    "created_date": "2017-11-14T18:12:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420740",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-11-09T00:00:00-05:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-03-24T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN PLUS",
    "en_drug_common_name": "CANDESARTAN HCT",
    "fr_drug_brand_name": "CANDESARTAN HCT",
    "fr_drug_common_name": "CANDESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "25MG\r\n32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29204,
    "drug": {
      "current_status": "MARKETED",
      "id": 50624,
      "drug_code": 92810,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261321,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443414",
      "brand_name": "SANDOZ OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2017-11-14T18:17:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443414",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2018-05-11T00:00:00-04:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T02:43:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLMESARTAN",
    "en_drug_common_name": "OLMERSARTAN",
    "fr_drug_brand_name": "OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 3 X 10'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29207,
    "drug": {
      "current_status": "MARKETED",
      "id": 30536,
      "drug_code": 92570,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8261204,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02441306",
      "brand_name": "JENCYCLA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106372001"
    },
    "created_date": "2017-11-14T18:20:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441306",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03AC01",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2017-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-15T23:15:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JENCYCLA",
    "en_drug_common_name": "JENCYCLA",
    "fr_drug_brand_name": "JENCYCLA",
    "fr_drug_common_name": "JENCYCLA",
    "en_ingredients": "NORETHINDRONE",
    "fr_ingredients": "Noréthindrone",
    "drug_strength": "0.35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS 28'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29231,
    "drug": {
      "current_status": "MARKETED",
      "id": 10600,
      "drug_code": 66189,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254016,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242464",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506005"
    },
    "created_date": "2017-11-15T12:57:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242464",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-09-21T00:00:00-04:00",
    "actual_start_date": "2017-11-14T00:00:00-05:00",
    "actual_end_date": "2018-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-21T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29269,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1280,
      "drug_code": 12846,
      "updated_date": "2025-05-15T03:39:04-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8290580,
          "ingredient": {
            "id": 712,
            "ingredient_code": 6469,
            "en_name": "GOLD SODIUM THIOMALATE",
            "fr_name": "Aurothiomalate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01927612",
      "brand_name": "MYOCHRYSINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74073",
      "number_of_ais": "1",
      "ai_group_no": "0107427002"
    },
    "created_date": "2017-11-15T15:13:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01927612",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "M01CB01",
    "atc_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "estimated_end_date": "2019-09-30T00:00:00-04:00",
    "actual_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2019-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-06-10T19:04:14-04:00",
    "status": "resolved",
    "en_comments": "The continued global shortage of Myochrysine is due to manufacturing issues with the active ingredient. Consequently Sanofi has decided to discontinue all three strengths of Myochrysine globally.",
    "fr_comments": "La rupture d’inventaire mondiale de Myochrysine est dû à des problèmes de fabrication avec l’ingrédient actif.  Par conséquent Sanofi-aventis Canada vous informe que les trois présentations de Myochrysine sont abandonnées mondialement.",
    "en_drug_brand_name": "MYOCHRYSINE",
    "en_drug_common_name": "Myochrisine 25mg/1ml",
    "fr_drug_brand_name": "Myochrisine",
    "fr_drug_common_name": "Myochrisine 25mg/1ml",
    "en_ingredients": "GOLD SODIUM THIOMALATE",
    "fr_ingredients": "Aurothiomalate de sodium",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29274,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1278,
      "drug_code": 12845,
      "updated_date": "2025-05-15T03:39:04-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8290579,
          "ingredient": {
            "id": 712,
            "ingredient_code": 6469,
            "en_name": "GOLD SODIUM THIOMALATE",
            "fr_name": "Aurothiomalate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01927604",
      "brand_name": "MYOCHRYSINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74072",
      "number_of_ais": "1",
      "ai_group_no": "0107427001"
    },
    "created_date": "2017-11-15T15:21:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01927604",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "M01CB01",
    "atc_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "estimated_end_date": "2019-09-30T00:00:00-04:00",
    "actual_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2019-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-06-10T19:02:07-04:00",
    "status": "resolved",
    "en_comments": "The continued global shortage of Myochrysine is due to manufacturing issues with the active ingredient. Consequently Sanofi has decided to discontinue all three strengths of Myochrysine globally.",
    "fr_comments": "La rupture d’inventaire mondiale de Myochrysine est dû à des problèmes de fabrication avec l’ingrédient actif.  Par conséquent Sanofi-aventis Canada vous informe que les trois présentations de Myochrysine sont abandonnées mondialement",
    "en_drug_brand_name": "MYOCHRYSINE",
    "en_drug_common_name": "Myochrisine 50mg/1ml",
    "fr_drug_brand_name": "Myochrisine",
    "fr_drug_common_name": "Myochrisine 50mg/1ml",
    "en_ingredients": "GOLD SODIUM THIOMALATE",
    "fr_ingredients": "Aurothiomalate de sodium",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29285,
    "drug": {
      "current_status": "MARKETED",
      "id": 762,
      "drug_code": 11752,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251565,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01919342",
      "brand_name": "LUVOX",
      "brand_name_fr": "LUVOX",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72652",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2017-11-15T19:03:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01919342",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N06AB08",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-16T18:38:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LUVOX",
    "en_drug_common_name": "LUVOX",
    "fr_drug_brand_name": "LUVOX",
    "fr_drug_common_name": "LUVOX",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2x15",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29300,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5250,
      "drug_code": 3374,
      "updated_date": "2025-05-15T03:26:07-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8274768,
          "ingredient": {
            "id": 1930,
            "ingredient_code": 7410,
            "en_name": "ETHYNODIOL DIACETATE",
            "fr_name": "Diacétate d'éthynodiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8274767,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00471526",
      "brand_name": "DEMULEN 30 (28 DAY PACK)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54080",
      "number_of_ais": "2",
      "ai_group_no": "0206451001"
    },
    "created_date": "2017-11-15T21:21:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00471526",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "G03AA01",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "actual_start_date": "2018-02-28T00:00:00-05:00",
    "actual_end_date": "2018-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-10T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEMULEN 30 (28 DAY PACK)",
    "en_drug_common_name": "DEMULEN",
    "fr_drug_brand_name": "DEMULEN 30 (28 DAY PACK)",
    "fr_drug_common_name": "DEMULEN 30",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nETHYNODIOL DIACETATE",
    "fr_ingredients": "Éthinylestradiol\r\nDiacétate d'éthynodiol",
    "drug_strength": "30MCG\r\n2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29307,
    "drug": {
      "current_status": "MARKETED",
      "id": 694,
      "drug_code": 115,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250114,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037818",
      "brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM AVEC BACTÉRIOSTATIQUE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "03696",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2017-11-15T21:27:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037818",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05CB01",
    "atc_description": "IRRIGATING SOLUTIONS",
    "actual_start_date": "2018-01-31T00:00:00-05:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE",
    "fr_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "fr_drug_common_name": "SODIUM CHLORIDE",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "25x10mL PVL MD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29312,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13668,
      "drug_code": 73507,
      "updated_date": "2025-05-15T04:08:20-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8339734,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02250276",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "CEFTRIAXONE SODIQUE POUR INJECTION BP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292001"
    },
    "created_date": "2017-11-15T21:31:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250276",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01DD04",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2017-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-21T16:43:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION, BP",
    "en_drug_common_name": "Ceftriaxone sodium",
    "fr_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION, BP",
    "fr_drug_common_name": "CEFTRIAXONE SODIUM",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CEFTRIAXONE",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10x250mg vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29321,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13672,
      "drug_code": 73510,
      "updated_date": "2025-05-15T04:08:20-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8339737,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02250306",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "CEFTRIAXONE SODIQUE POUR INJECTION BP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292002"
    },
    "created_date": "2017-11-15T21:33:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250306",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01DD04",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2017-11-21T00:00:00-05:00",
    "actual_end_date": "2018-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-26T13:49:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION, BP",
    "en_drug_common_name": "Ceftriaxone sodium",
    "fr_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION, BP",
    "fr_drug_common_name": "CEFTRIAXONE SODIUM",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CEFTRIAXONE",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10x2g vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29348,
    "drug": {
      "current_status": "MARKETED",
      "id": 22184,
      "drug_code": 84560,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257942,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360632",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2017-11-16T00:55:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360632",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-02-28T00:00:00-05:00",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T13:22:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29395,
    "drug": {
      "current_status": "MARKETED",
      "id": 6918,
      "drug_code": 4703,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250663,
          "ingredient": {
            "id": 174,
            "ingredient_code": 8174,
            "en_name": "SULFAMETHOXAZOLE",
            "fr_name": "Sulfaméthoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250662,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00550086",
      "brand_name": "SEPTRA INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58498",
      "number_of_ais": "2",
      "ai_group_no": "0208901005"
    },
    "created_date": "2017-11-16T13:21:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00550086",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "J01EE01",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "estimated_end_date": "2018-01-19T00:00:00-05:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SEPTRA INJECTION",
    "en_drug_common_name": "Septra® Injection",
    "fr_drug_brand_name": "Septra®",
    "fr_drug_common_name": "Septra® Injection",
    "en_ingredients": "SULFAMETHOXAZOLE\r\nTRIMETHOPRIM",
    "fr_ingredients": "Sulfaméthoxazole\r\nTriméthoprime",
    "drug_strength": "80MG\r\n16MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 amps",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29404,
    "drug": {
      "current_status": "MARKETED",
      "id": 11872,
      "drug_code": 69618,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254400,
          "ingredient": {
            "id": 2956,
            "ingredient_code": 12253,
            "en_name": "FONDAPARINUX SODIUM",
            "fr_name": "Fondaparinux sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245531",
      "brand_name": "ARIXTRA",
      "brand_name_fr": "ARIXTRA",
      "descriptor": "0.5ML SINGLE USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146781001"
    },
    "created_date": "2017-11-16T14:50:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245531",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AX05",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-03-31T00:00:00-04:00",
    "estimated_end_date": "2018-07-23T00:00:00-04:00",
    "actual_start_date": "2018-03-31T00:00:00-04:00",
    "actual_end_date": "2018-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-14T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ARIXTRA",
    "en_drug_common_name": "Arixtra® 2.5mg",
    "fr_drug_brand_name": "Arixtra®",
    "fr_drug_common_name": "Arixtra® 2.5mg",
    "en_ingredients": "FONDAPARINUX SODIUM",
    "fr_ingredients": "Fondaparinux sodique",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 PF syringes",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29407,
    "drug": {
      "current_status": "MARKETED",
      "id": 14250,
      "drug_code": 74328,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255138,
          "ingredient": {
            "id": 2956,
            "ingredient_code": 12253,
            "en_name": "FONDAPARINUX SODIUM",
            "fr_name": "Fondaparinux sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.6",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258056",
      "brand_name": "ARIXTRA",
      "brand_name_fr": "ARIXTRA",
      "descriptor": "0.6ML SINGLE USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146781002"
    },
    "created_date": "2017-11-16T14:52:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258056",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AX05",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2017-12-31T00:00:00-05:00",
    "estimated_end_date": "2018-07-23T00:00:00-04:00",
    "actual_start_date": "2017-12-31T00:00:00-05:00",
    "actual_end_date": "2018-07-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-21T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ARIXTRA",
    "en_drug_common_name": "Arixtra® 7.5mg",
    "fr_drug_brand_name": "Arixtra®",
    "fr_drug_common_name": "Arixtra® 7.5mg",
    "en_ingredients": "FONDAPARINUX SODIUM",
    "fr_ingredients": "Fondaparinux sodique",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "10 PF syringes",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29428,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2236,
      "drug_code": 14758,
      "updated_date": "2025-05-15T03:40:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8294142,
          "ingredient": {
            "id": 966,
            "ingredient_code": 11447,
            "en_name": "CROMOLYN SODIUM",
            "fr_name": "Cromolyne sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02046113",
      "brand_name": "PMS-SODIUM CROMOGLYCATE",
      "brand_name_fr": "",
      "descriptor": "NEBULIZER SOLUTION",
      "pediatric_flag": false,
      "accession_number": "76430",
      "number_of_ais": "1",
      "ai_group_no": "0108810003"
    },
    "created_date": "2017-11-16T17:38:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02046113",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BC01",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2017-11-16T00:00:00-05:00",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2017-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-12T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SODIUM CROMOGLYCATE",
    "en_drug_common_name": "pms-SOD CROMOGLYCATE 1% NEBUL SOL 50x2mL",
    "fr_drug_brand_name": "pms-SOD CROMOGLYCATE",
    "fr_drug_common_name": "pms-SOD CROMOGLYCATE 1% NEBUL SOL 50x2mL",
    "en_ingredients": "CROMOLYN SODIUM",
    "fr_ingredients": "Cromolyne sodique",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nORAL",
    "drug_route_fr": "Inhalation\r\nOrale",
    "drug_package_quantity": "50x2mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29438,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22958,
      "drug_code": 85519,
      "updated_date": "2025-12-03T01:29:12-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350403,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8350402,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02370174",
      "brand_name": "PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "FOR I.V. INFUSION ONLY. SINGLE-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919006"
    },
    "created_date": "2017-11-16T19:17:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370174",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "actual_start_date": "2022-11-16T00:00:00-05:00",
    "actual_end_date": "2023-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-27T01:36:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN/TAZOBACTAM",
    "fr_drug_brand_name": "PIPERACILLIN/TAZOBACTAM",
    "fr_drug_common_name": "PIPERACILLIN/TAZOBACTAM",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "PIPERACILLIN/TAZOBACTAM",
    "drug_strength": "4G\r\n0.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29441,
    "drug": {
      "current_status": "MARKETED",
      "id": 13092,
      "drug_code": 72459,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254769,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248130",
      "brand_name": "TEVA-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2017-11-16T19:19:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC13",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-01-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RATIO-MOMETASONE",
    "en_drug_common_name": "MOMETASONE",
    "fr_drug_brand_name": "RATIO-MOMETASONE",
    "fr_drug_common_name": "MOMETASONE",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29444,
    "drug": {
      "current_status": "MARKETED",
      "id": 16364,
      "drug_code": 77145,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255830,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285967",
      "brand_name": "TEVA-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2017-11-16T19:20:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285967",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-11-12T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-11-09T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "TEVA-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29447,
    "drug": {
      "current_status": "MARKETED",
      "id": 18738,
      "drug_code": 80012,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256551,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314592",
      "brand_name": "TEVA-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2017-11-16T19:21:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314592",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA09",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-01-17T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T21:31:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "TEVA-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxetine",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29450,
    "drug": {
      "current_status": "MARKETED",
      "id": 15100,
      "drug_code": 75561,
      "updated_date": "2025-05-15T02:31:41-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255395,
          "ingredient": {
            "id": 1586,
            "ingredient_code": 141,
            "en_name": "BICALUTAMIDE",
            "fr_name": "Bicalutamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02270226",
      "brand_name": "TEVA-BICALUTAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127996001"
    },
    "created_date": "2017-11-16T19:22:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02270226",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BB03",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2018-01-15T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-13T11:04:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BICALUTAMIDE",
    "en_drug_common_name": "BICALUTAMIDE",
    "fr_drug_brand_name": "TEVA-BICALUTAMIDE",
    "fr_drug_common_name": "BICALUTAMIDE",
    "en_ingredients": "BICALUTAMIDE",
    "fr_ingredients": "Bicalutamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29453,
    "drug": {
      "current_status": "MARKETED",
      "id": 7262,
      "drug_code": 49155,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253257,
          "ingredient": {
            "id": 2338,
            "ingredient_code": 1901,
            "en_name": "MEXILETINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mexilétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230359",
      "brand_name": "TEVA-MEXILETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116151001"
    },
    "created_date": "2017-11-16T19:23:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230359",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C01BB02",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2018-01-15T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T21:33:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MEXILETINE",
    "en_drug_common_name": "MEXILETINE",
    "fr_drug_brand_name": "TEVA-MEXILETINE",
    "fr_drug_common_name": "MEXILETINE",
    "en_ingredients": "MEXILETINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mexilétine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29456,
    "drug": {
      "current_status": "MARKETED",
      "id": 22214,
      "drug_code": 84620,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257950,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361159",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-11-16T19:29:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361159",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-01-19T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T21:33:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "TEVA-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29459,
    "drug": {
      "current_status": "MARKETED",
      "id": 21044,
      "drug_code": 83276,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8257470,
          "ingredient": {
            "id": 2888,
            "ingredient_code": 12152,
            "en_name": "MENINGOCOCCAL GROUP C OLIGOSACCHARIDE",
            "fr_name": "Oligosaccharide du méningocoque de groupe C"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257469,
          "ingredient": {
            "id": 3642,
            "ingredient_code": 20581,
            "en_name": "MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE",
            "fr_name": "Oligosaccharide du méningocoque de groupe Y"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257468,
          "ingredient": {
            "id": 3640,
            "ingredient_code": 20580,
            "en_name": "MENINGOCOCCAL GROUP A OLIGOSACCHARIDE",
            "fr_name": "Oligosaccharide du méningocoque de groupe A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257467,
          "ingredient": {
            "id": 3644,
            "ingredient_code": 20582,
            "en_name": "MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE",
            "fr_name": "Oligosaccharide du méningocoque de groupe W-135"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257466,
          "ingredient": {
            "id": 2890,
            "ingredient_code": 12153,
            "en_name": "CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN",
            "fr_name": "Protéine crm-197 de corynébactérium diphtheriae"
          },
          "ingredient_supplied_ind": "I",
          "strength": "47",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02347393",
      "brand_name": "MENVEO",
      "brand_name_fr": "",
      "descriptor": "1 VIAL LYOPH. MEN. A CONJUGATE & 1 VIAL  SOL. MEN. CWY CONJUGATE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "5",
      "ai_group_no": "0552705002"
    },
    "created_date": "2017-11-16T19:32:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347393",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07AH08",
    "atc_description": "BACTERIAL VACCINES",
    "estimated_end_date": "2018-01-18T00:00:00-05:00",
    "actual_start_date": "2017-12-06T00:00:00-05:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-19T15:46:16-05:00",
    "status": "resolved",
    "en_comments": "Menveo 5 dose format still available. Supply disruptions may be seen in the private market.",
    "fr_comments": "Menveo en boîtes de 5 doses est toujours offert. Des ruptures d’approvisionnement pourraient toucher le marché privé.",
    "en_drug_brand_name": "MENVEO",
    "en_drug_common_name": "Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine",
    "fr_drug_brand_name": "MENVEO",
    "fr_drug_common_name": "Vaccin oligosaccharidique contre le méningocoque des groupes A, C, W-135 et Y conjugué au CRM197",
    "en_ingredients": "MENINGOCOCCAL GROUP C OLIGOSACCHARIDE\r\nCORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN\r\nMENINGOCOCCAL GROUP A OLIGOSACCHARIDE\r\nMENINGOCOCCAL GROUP Y OLIGOSACCHARIDE\r\nMENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE",
    "fr_ingredients": "Oligosaccharide du méningocoque de groupe C\r\nProtéine crm-197 de corynébactérium diphtheriae\r\nOligosaccharide du méningocoque de groupe A\r\nOligosaccharide du méningocoque de groupe Y\r\nOligosaccharide du méningocoque de groupe W-135",
    "drug_strength": "5MCG\r\n47MCG\r\n10MCG\r\n5MCG\r\n5MCG",
    "drug_dosage_form": "SOLUTION\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Solution\r\nPoudre pour solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29497,
    "drug": {
      "current_status": "MARKETED",
      "id": 1690,
      "drug_code": 13630,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 1806,
        "created_date": "2017-03-09T13:25:49-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 14884,
        "mfr_code": "",
        "name": "BAVARIAN NORDIC AS",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "PHILIP HEYMANS ALLE 3",
        "province": "--",
        "country": "DENMARK",
        "city": "HELLERUP",
        "postal_code": "2900",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251791,
          "ingredient": {
            "id": 36168,
            "ingredient_code": 23912,
            "en_name": "SALMONELLA TYPHI TY21A LIVE ATTENUATED",
            "fr_name": "Salmonella typhi ty21A vivant atténué"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000000000",
          "strength_unit": "CFU",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00885975",
      "brand_name": "VIVOTIF",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75058",
      "number_of_ais": "1",
      "ai_group_no": "0165582001"
    },
    "created_date": "2017-11-17T16:09:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00885975",
    "company_name": "PAXVAX BERNA GMBH",
    "atc_number": "J07AP01",
    "atc_description": "BACTERIAL VACCINES",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2017-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-12T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Supply released on 11. December 2017",
    "fr_comments": "Approvisionnement libérée le 11 Décembre 2017",
    "en_drug_brand_name": "VIVOTIF",
    "en_drug_common_name": "Typhoid vaccine live oral attenuated Ty21a vaccine",
    "fr_drug_brand_name": "Vivotif",
    "fr_drug_common_name": "Vaccin antityphoïdique vivant oral atténué Ty21a",
    "en_ingredients": "TYPHOID VACCINE",
    "fr_ingredients": "Vivant atténué S.typhi Ty21a",
    "drug_strength": "10B",
    "drug_dosage_form": "CAPSULE (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Capsule (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Single foil blister with 4 enteric-coated capsules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29500,
    "drug": {
      "current_status": "MARKETED",
      "id": 15130,
      "drug_code": 75597,
      "updated_date": "2025-05-15T02:31:41-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255401,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02270609",
      "brand_name": "PMS-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243003"
    },
    "created_date": "2017-11-17T16:22:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02270609",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AB04",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-15T19:10:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "PMS-CITALOPRAM",
    "fr_drug_common_name": "CITALOPRAM",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAME",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29506,
    "drug": {
      "current_status": "MARKETED",
      "id": 2176,
      "drug_code": 14589,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251988,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02048736",
      "brand_name": "PMS-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76240",
      "number_of_ais": "1",
      "ai_group_no": "0111558002"
    },
    "created_date": "2017-11-17T16:25:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02048736",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-12-18T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-18T15:02:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CLONAZEPAM TAB 2MG",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "PMS-CLONAZEPAM TAB 2MG",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29509,
    "drug": {
      "current_status": "MARKETED",
      "id": 25268,
      "drug_code": 87751,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259157,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259156,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392232",
      "brand_name": "PMS-LOSARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2017-11-17T16:34:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392232",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-03-06T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2018-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-22T13:16:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LOSARTAN-HCTZ",
    "en_drug_common_name": "LOSARTAN HCTZ",
    "fr_drug_brand_name": "PMS-LOSARTAN-HCTZ",
    "fr_drug_common_name": "LOSARTAN HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29512,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19352,
      "drug_code": 80626,
      "updated_date": "2025-12-03T01:26:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8346606,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02320851",
      "brand_name": "PMS-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2017-11-17T16:35:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320851",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC01",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-11-16T00:00:00-05:00",
    "actual_start_date": "2017-12-14T00:00:00-05:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T20:54:18-04:00",
    "status": "resolved",
    "en_comments": "Product Disc in Sap",
    "fr_comments": "Product Disc in Sap",
    "en_drug_brand_name": "PMS-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "PMS-OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29515,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22026,
      "drug_code": 84396,
      "updated_date": "2025-05-15T04:17:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349461,
          "ingredient": {
            "id": 2632,
            "ingredient_code": 11811,
            "en_name": "RALOXIFENE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de raloxifène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02358921",
      "brand_name": "PMS-RALOXIFENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151607001"
    },
    "created_date": "2017-11-17T16:38:33-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02358921",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G03XC01",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "discontinuation_date": "2017-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO REMAINING SUPPLY",
    "en_discontinuation_comments": "IN DISCONTINUATION PROCESS",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-17T16:38:45-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-RALOXIFENE",
    "en_drug_common_name": "RALOXIFENE",
    "fr_drug_brand_name": "PMS-RALOXIFENE",
    "fr_drug_common_name": "RALOXIFENE",
    "en_ingredients": "RALOXIFENE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de raloxifène",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29518,
    "drug": {
      "current_status": "MARKETED",
      "id": 5426,
      "drug_code": 35783,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252835,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02194031",
      "brand_name": "ARISTOCORT R",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3070",
      "number_of_ais": "1",
      "ai_group_no": "0106310002"
    },
    "created_date": "2017-11-17T16:41:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194031",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D07AB09",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2017-11-24T00:00:00-05:00",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-01T16:36:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ARISTOCORT R",
    "en_drug_common_name": "ARISTOCORT R",
    "fr_drug_brand_name": "ARISTOCORT R",
    "fr_drug_common_name": "ARISTOCORT R",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "na",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29521,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9394,
      "drug_code": 62657,
      "updated_date": "2025-05-15T03:58:24-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8327776,
          "ingredient": {
            "id": 2644,
            "ingredient_code": 12127,
            "en_name": "HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE",
            "fr_name": "Conjugué PRP d'Haemophilus influenzae de type B-anatoxine tétanique (PRP-T)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02239200",
      "brand_name": "HIBERIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153511001"
    },
    "created_date": "2017-11-17T16:41:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239200",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07AG51",
    "atc_description": "BACTERIAL VACCINES",
    "estimated_end_date": "2017-12-07T00:00:00-05:00",
    "actual_start_date": "2017-11-16T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T17:39:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HIBERIX",
    "en_drug_common_name": "Haemophilus influenzae type b (Hib) conjugate vaccine",
    "fr_drug_brand_name": "HIBERIX",
    "fr_drug_common_name": "Vaccin conjugué anti-Haemophilus influenzae de type b (Hib)",
    "en_ingredients": "HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE",
    "fr_ingredients": "Conjugué PRP d'Haemophilus influenzae de type B-anatoxine tétanique (PRP-T)",
    "drug_strength": "10MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29526,
    "drug": {
      "current_status": "MARKETED",
      "id": 20530,
      "drug_code": 82246,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257268,
          "ingredient": {
            "id": 3610,
            "ingredient_code": 20556,
            "en_name": "BESIFLOXACIN",
            "fr_name": "Bésifloxacine (Chlorhydrate de Bésifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02336847",
      "brand_name": "BESIVANCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152666001"
    },
    "created_date": "2017-11-17T16:59:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02336847",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01AE08",
    "atc_description": "ANTIINFECTIVES",
    "actual_start_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2018-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-09T19:48:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BESIVANCE",
    "en_drug_common_name": "BESIVANCE",
    "fr_drug_brand_name": "BESIVANCE",
    "fr_drug_common_name": "BESIVANCE",
    "en_ingredients": "BESIFLOXACIN",
    "fr_ingredients": "Bésifloxacine",
    "drug_strength": "0.6%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 29649,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17824,
      "drug_code": 78876,
      "updated_date": "2025-05-15T04:13:14-04:00",
      "company": {
        "id": 1364,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13829,
        "mfr_code": "",
        "name": "ACCEL PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "119 LABROSSE AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE CLAIRE",
        "postal_code": "H9R 1A3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344853,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303450",
      "brand_name": "ACCEL PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541002"
    },
    "created_date": "2017-11-17T18:23:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303450",
    "company_name": "ACCEL PHARMA INC",
    "atc_number": "A10BG03",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-11-17T00:00:00-05:00",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2018-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-20T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product will be available March 19th",
    "fr_comments": "le produit est disponible le 19 mars, 2018",
    "en_drug_brand_name": "ACCEL PIOGLITAZONE",
    "en_drug_common_name": "ACCEL PIOGLITAZONE",
    "fr_drug_brand_name": "ACCEL PIOGLITAZONE",
    "fr_drug_common_name": "ACCEL PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "pioglitazone",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29702,
    "drug": {
      "current_status": "MARKETED",
      "id": 8446,
      "drug_code": 590,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250163,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250162,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001805",
      "brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:200000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23891",
      "number_of_ais": "2",
      "ai_group_no": "0201284002"
    },
    "created_date": "2017-11-20T15:38:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001805",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB52",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2018-06-01T00:00:00-04:00",
    "actual_start_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-04T19:43:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:200000",
    "en_drug_common_name": "Xylocaine® 1% w/epi.1:200M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 1% w/epi.1:200M 10x20mL MD Vial",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "10MG\r\n5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29705,
    "drug": {
      "current_status": "MARKETED",
      "id": 23260,
      "drug_code": 85829,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258406,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.005",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8258405,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02373130",
      "brand_name": "XYLOCAINE 2% WITH EPINEPHRINE 1:200000",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0201284006"
    },
    "created_date": "2017-11-20T15:39:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373130",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB52",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2018-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-04T19:52:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE 2% WITH EPINEPHRINE 1:200000",
    "en_drug_common_name": "Xylocaine® 2% w/epi.1:200M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 2% w/epi.1:200M 10x20mL MD Vial",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "20MG\r\n0.005MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29727,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5850,
      "drug_code": 4008,
      "updated_date": "2025-05-15T03:26:51-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8275800,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8275799,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00513997",
      "brand_name": "SINEMET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56348",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2017-11-20T16:42:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00513997",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2018-01-11T00:00:00-05:00",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2018-01-12T00:00:00-05:00",
    "actual_end_date": "2018-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-10T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SINEMET 100/25",
    "en_drug_common_name": "levodopa and carbidopa tablets",
    "fr_drug_brand_name": "Sinemet",
    "fr_drug_common_name": "comprimés de levodopa and carbidopa",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29730,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1922,
      "drug_code": 14082,
      "updated_date": "2025-05-15T03:40:14-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8292805,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8292804,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02028786",
      "brand_name": "SINEMET CR 100/25",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75589",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2017-11-20T16:45:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02028786",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "estimated_end_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-13T17:46:15-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SINEMET CR 100/25",
    "en_drug_common_name": "levodopa and carbidopa controlled release tablets",
    "fr_drug_brand_name": "SINEMET CR",
    "fr_drug_common_name": "comprimés de lévodopa et de carbidopa à libération prolongée",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29736,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9852,
      "drug_code": 63981,
      "updated_date": "2025-05-15T03:59:44-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8329578,
          "ingredient": {
            "id": 2706,
            "ingredient_code": 11894,
            "en_name": "EPROSARTAN",
            "fr_name": "Éprosartan (Mésylate d'éprosartan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02240432",
      "brand_name": "TEVETEN",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137701002"
    },
    "created_date": "2017-11-20T17:50:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240432",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09CA02",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2017-12-04T00:00:00-05:00",
    "actual_end_date": "2018-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-06T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVETEN",
    "en_drug_common_name": "TEVETEN",
    "fr_drug_brand_name": "TEVETEN",
    "fr_drug_common_name": "TEVETEN",
    "en_ingredients": "EPROSARTAN",
    "fr_ingredients": "EPROSARTAN",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2x14",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29739,
    "drug": {
      "current_status": "MARKETED",
      "id": 3956,
      "drug_code": 19601,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252522,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172100",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 100MCG",
      "pediatric_flag": false,
      "accession_number": "81898",
      "number_of_ais": "1",
      "ai_group_no": "0107794024"
    },
    "created_date": "2017-11-20T17:52:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172100",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA01",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-23T17:09:00-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "SYNTHROID",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "SYNTHROID",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29743,
    "drug": {
      "current_status": "MARKETED",
      "id": 3942,
      "drug_code": 19594,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252515,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172119",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 125MCG",
      "pediatric_flag": false,
      "accession_number": "81891",
      "number_of_ais": "1",
      "ai_group_no": "0107794021"
    },
    "created_date": "2017-11-20T17:58:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172119",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA01",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-23T17:08:38-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "SYNTHROID",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "SYNTHROID",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "125MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29772,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27020,
      "drug_code": 89263,
      "updated_date": "2025-05-15T04:21:14-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353236,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02407922",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315009"
    },
    "created_date": "2017-11-20T18:46:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407922",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T14:41:29-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 51671",
    "fr_comments": "discontinued in ID 51671",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "fr_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "fr_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "Vancomycin",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10VL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29777,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27018,
      "drug_code": 89262,
      "updated_date": "2025-05-15T04:21:14-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353235,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02407914",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315003"
    },
    "created_date": "2017-11-20T18:47:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407914",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T14:38:01-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 51668",
    "fr_comments": "discontinued in ID 51668",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "fr_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "fr_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "Vancomycin",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10VL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29798,
    "drug": {
      "current_status": "MARKETED",
      "id": 3950,
      "drug_code": 19598,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252519,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172127",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 150MCG",
      "pediatric_flag": false,
      "accession_number": "81895",
      "number_of_ais": "1",
      "ai_group_no": "0107794023"
    },
    "created_date": "2017-11-20T19:08:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172127",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA01",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-23T17:08:15-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "SYNTHROID",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "SYNTHROID",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "150MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29835,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30020,
      "drug_code": 92076,
      "updated_date": "2025-05-15T04:23:29-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8355520,
          "ingredient": {
            "id": 1946,
            "ingredient_code": 2184,
            "en_name": "RIBAVIRIN",
            "fr_name": "Ribavirine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436426",
      "brand_name": "MODERIBA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111643003"
    },
    "created_date": "2017-11-20T20:01:08-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02436426",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "J05AB04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last batch available expires on 30-JUN-2018. Orders can be shipped at customers request.\r\nPer AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.",
    "fr_supply_disruption_mitigation": "Le dernier lot disponible expire le 30-Juin-2018. Des commandes peuvent être envoyées sur demande de nos clients.\r\nConformément à la politique de retour d’AbbVie, nous vous demandons de nous retourner les produits seulement à la date de péremption, et cela pour l’ensemble des stocks restants.",
    "en_discontinuation_comments": "This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.",
    "fr_discontinuation_comments": "Cette décision fait suite à la récente approbation des comprimés MAVIRET par Santé Canada. Ce nouvel antiviral pangénotypique d’AbbVie, indiqué pour le traitement des adultes atteints d’une infection chronique par le virus de l’hépatite C (VHC), remplacera HOLKIRA PAK, TECHNIVIE et MODERIBA sur le marché canadien.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-07T21:05:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MODERIBA",
    "en_drug_common_name": "MODERIBA  600mg",
    "fr_drug_brand_name": "MODERIBA",
    "fr_drug_common_name": "MODERIBA 600MG",
    "en_ingredients": "RIBAVIRIN",
    "fr_ingredients": "Ribavirine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56 tablets per bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29839,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 31168,
      "drug_code": 93326,
      "updated_date": "2025-05-15T04:24:18-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8356298,
          "ingredient": {
            "id": 2202,
            "ingredient_code": 4,
            "en_name": "RITONAVIR",
            "fr_name": "Ritonavir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8356297,
          "ingredient": {
            "id": 4028,
            "ingredient_code": 22554,
            "en_name": "OMBITASVIR",
            "fr_name": "Ombitasvir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8356296,
          "ingredient": {
            "id": 4032,
            "ingredient_code": 22556,
            "en_name": "PARITAPREVIR",
            "fr_name": "Paritaprévir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02447711",
      "brand_name": "TECHNIVIE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0357510001"
    },
    "created_date": "2017-11-20T20:09:14-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02447711",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "J05AX67",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot available expired on JUN-30-2018. Orders can be shipped at customer request.\r\nPer AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.",
    "fr_supply_disruption_mitigation": "Le dernier lot disponible expire le 30 juin 2018. Des commandes peuvent être envoyées sur demande de nos clients.\r\nConformément à la politique de retour d’AbbVie, nous vous demandons de nous retourner les produits seulement à la date de péremption, et cela pour l’ensemble des stocks restants.",
    "en_discontinuation_comments": "This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.",
    "fr_discontinuation_comments": "Cette décision fait suite à la récente approbation des comprimés MAVIRET par Santé Canada. Ce nouvel antiviral pangénotypique d’AbbVie, indiqué pour le traitement des adultes atteints d’une infection chronique par le virus de l’hépatite C (VHC), remplacera HOLKIRA PAK, TECHNIVIE et MODERIBA sur le marché canadien.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-07T21:10:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TECHNIVIE",
    "en_drug_common_name": "TECHNIVIE 12.5/75/50 MG",
    "fr_drug_brand_name": "TECHNIVIE",
    "fr_drug_common_name": "TECHNIVIE 12.5/75/50 MG",
    "en_ingredients": "Ombitasvir\r\nParitaprevir\r\nRITONAVIR",
    "fr_ingredients": "Paritaprévir\r\nRitonavir",
    "drug_strength": "12.5MG\r\n75MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 inner cartonsx7blisters",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29854,
    "drug": {
      "current_status": "MARKETED",
      "id": 21522,
      "drug_code": 83905,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257683,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353849",
      "brand_name": "MYLAN-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2017-11-20T20:48:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353849",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC03",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-02T18:42:25-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "MYLAN-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29863,
    "drug": {
      "current_status": "MARKETED",
      "id": 32068,
      "drug_code": 9611,
      "updated_date": "2025-05-15T02:30:46-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251199,
          "ingredient": {
            "id": 1334,
            "ingredient_code": 4028,
            "en_name": "SODIUM POLYSTYRENE SULFONATE",
            "fr_name": "Polystyrène sulfonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00769541",
      "brand_name": "SOLYSTAT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68821",
      "number_of_ais": "1",
      "ai_group_no": "0108701001"
    },
    "created_date": "2017-11-20T21:23:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00769541",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "V03AE01",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2017-12-18T00:00:00-05:00",
    "estimated_end_date": "2018-03-12T00:00:00-04:00",
    "actual_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-13T17:28:10-04:00",
    "status": "resolved",
    "en_comments": "Limited stock available",
    "fr_comments": "Limited stock available",
    "en_drug_brand_name": "SOLYSTAT",
    "en_drug_common_name": "SOLYSTAT 250mg/mL U.D.SUSP 60mL",
    "fr_drug_brand_name": "SOLYSTAT",
    "fr_drug_common_name": "SOLYSTAT 250mg/mL U.D.SUSP 60mL",
    "en_ingredients": "SODIUM POLYSTYRENE SULFONATE",
    "fr_ingredients": "Polystyrène sulfonate de sodium",
    "drug_strength": "250MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29874,
    "drug": {
      "current_status": "MARKETED",
      "id": 648,
      "drug_code": 11423,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251529,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "01912755",
      "brand_name": "PDP-ERYTHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72094",
      "number_of_ais": "1",
      "ai_group_no": "0105708001"
    },
    "created_date": "2017-11-20T21:29:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01912755",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "S01AA17",
    "atc_description": "ANTIINFECTIVES",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2017-12-21T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-16T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-ERYTHROMYCIN",
    "en_drug_common_name": "pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD",
    "fr_drug_brand_name": "pdp-ERYTHROMYCIN",
    "fr_drug_common_name": "pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "1x50g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29895,
    "drug": {
      "current_status": "DORMANT",
      "id": 21438,
      "drug_code": 83827,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368459,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353040",
      "brand_name": "ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2017-11-21T14:53:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353040",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC04",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-11-21T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-16T06:00:08-05:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE TABS",
    "fr_drug_brand_name": "ROPINIROLE",
    "fr_drug_common_name": "ROPINIROLE COMPRIMES",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29904,
    "drug": {
      "current_status": "MARKETED",
      "id": 19774,
      "drug_code": 81116,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256905,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325802",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2017-11-21T15:38:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325802",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2018-08-03T00:00:00-04:00",
    "actual_end_date": "2018-12-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-12-25T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29907,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30016,
      "drug_code": 92074,
      "updated_date": "2025-05-15T04:23:29-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8355518,
          "ingredient": {
            "id": 1946,
            "ingredient_code": 2184,
            "en_name": "RIBAVIRIN",
            "fr_name": "Ribavirine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436396",
      "brand_name": "MODERIBA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111643004"
    },
    "created_date": "2017-11-21T15:40:29-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02436396",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "J05AB04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2018-07-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot available on market expired on Sept. 30th, 2018.\r\nPer AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.",
    "fr_supply_disruption_mitigation": "Le dernier lot disponible sur le marché expire le 30 septembre 2018.\r\nConformément à la politique de retour d’AbbVie, nous vous demandons de nous retourner les produits seulement à la date de péremption, et cela pour l’ensemble des stocks restants.",
    "en_discontinuation_comments": "This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.",
    "fr_discontinuation_comments": "Cette décision fait suite à la récente approbation des comprimés MAVIRET par Santé Canada. Ce nouvel antiviral pangénotypique d’AbbVie, indiqué pour le traitement des adultes atteints d’une infection chronique par le virus de l’hépatite C (VHC), remplacera HOLKIRA PAK, TECHNIVIE et MODERIBA sur le marché canadien.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-30T18:07:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MODERIBA",
    "en_drug_common_name": "MODERIBA TABLETS 200MG",
    "fr_drug_brand_name": "MODERIBA",
    "fr_drug_common_name": "MODERIBA TABLETS 200MG",
    "en_ingredients": "RIBAVIRIN",
    "fr_ingredients": "Ribavirine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "168 tabs/bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29937,
    "drug": {
      "current_status": "MARKETED",
      "id": 21812,
      "drug_code": 84196,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257790,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356848",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2017-11-21T18:05:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356848",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-30T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol-l 100mg",
    "fr_drug_brand_name": "JAMP-METOPROLOL-L",
    "fr_drug_common_name": "METOPROLOL-L",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29941,
    "drug": {
      "current_status": "MARKETED",
      "id": 21812,
      "drug_code": 84196,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257790,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356848",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2017-11-21T18:09:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356848",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-30T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol-l",
    "fr_drug_brand_name": "JAMP-METOPROLOL-L",
    "fr_drug_common_name": "METOPROLOL-L",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29946,
    "drug": {
      "current_status": "MARKETED",
      "id": 21808,
      "drug_code": 84194,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257788,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356813",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923005"
    },
    "created_date": "2017-11-21T18:13:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356813",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol-l",
    "fr_drug_brand_name": "Jamp Metoprolol-l",
    "fr_drug_common_name": "Metoprolol-l",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29949,
    "drug": {
      "current_status": "MARKETED",
      "id": 28566,
      "drug_code": 90683,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260364,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422115",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2017-11-21T18:14:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422115",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2018-01-19T00:00:00-05:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-09T00:51:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29952,
    "drug": {
      "current_status": "MARKETED",
      "id": 21808,
      "drug_code": 84194,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257788,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356813",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923005"
    },
    "created_date": "2017-11-21T18:15:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356813",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol-l",
    "fr_drug_brand_name": "Jamp-Metoprolol-l",
    "fr_drug_common_name": "Metoprolol-l",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29957,
    "drug": {
      "current_status": "MARKETED",
      "id": 2276,
      "drug_code": 15106,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251999,
          "ingredient": {
            "id": 672,
            "ingredient_code": 11107,
            "en_name": "DOXEPIN",
            "fr_name": "Doxépine (Chlorhydrate de doxépine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02050005",
      "brand_name": "APO-DOXEPIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76787",
      "number_of_ais": "1",
      "ai_group_no": "0107703001"
    },
    "created_date": "2017-11-21T18:17:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02050005",
    "company_name": "APOTEX INC",
    "atc_number": "N06AA12",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-01-02T00:00:00-05:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2017-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-08T11:59:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXEPIN",
    "en_drug_common_name": "DOXEPIN",
    "fr_drug_brand_name": "APO-DOXEPIN",
    "fr_drug_common_name": "DOXEPIN",
    "en_ingredients": "DOXEPIN",
    "fr_ingredients": "DOXEPIN",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29960,
    "drug": {
      "current_status": "MARKETED",
      "id": 26908,
      "drug_code": 89182,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259696,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02407124",
      "brand_name": "APO-GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED RELEASE BREAKABLE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2017-11-21T18:18:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407124",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB09",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-03-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-21T12:42:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "APO-GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29963,
    "drug": {
      "id": 30902,
      "drug_code": 93042,
      "updated_date": "2025-12-03T02:32:38-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369320,
          "ingredient": {
            "id": 1834,
            "ingredient_code": 7234,
            "en_name": "QUININE SULFATE",
            "fr_name": "Sulfate de quinine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445190",
      "brand_name": "JAMP QUININE",
      "brand_name_fr": "JAMP-QUININE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106604001"
    },
    "created_date": "2017-11-21T18:20:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445190",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "P01BC01",
    "atc_description": "ANTIMALARIALS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T14:12:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-QUININE",
    "en_drug_common_name": "Quinine 200mg",
    "fr_drug_brand_name": "JAMP-QUININE",
    "fr_drug_common_name": "QUININE 200 mg",
    "en_ingredients": "QUININE SULFATE",
    "fr_ingredients": "Sulfate de quinine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29966,
    "drug": {
      "id": 30902,
      "drug_code": 93042,
      "updated_date": "2025-12-03T02:32:38-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369320,
          "ingredient": {
            "id": 1834,
            "ingredient_code": 7234,
            "en_name": "QUININE SULFATE",
            "fr_name": "Sulfate de quinine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445190",
      "brand_name": "JAMP QUININE",
      "brand_name_fr": "JAMP-QUININE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106604001"
    },
    "created_date": "2017-11-21T18:23:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445190",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "P01BC01",
    "atc_description": "ANTIMALARIALS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-QUININE",
    "en_drug_common_name": "Quinine 200mg",
    "fr_drug_brand_name": "JAMP-QUININE",
    "fr_drug_common_name": "QUININE 200 mg",
    "en_ingredients": "QUININE SULFATE",
    "fr_ingredients": "Sulfate de quinine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29969,
    "drug": {
      "current_status": "MARKETED",
      "id": 2490,
      "drug_code": 15925,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252072,
          "ingredient": {
            "id": 1184,
            "ingredient_code": 11182,
            "en_name": "MINOCYCLINE",
            "fr_name": "Minocycline (Chlorhydrate de minocycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02084104",
      "brand_name": "MINOCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77688",
      "number_of_ais": "1",
      "ai_group_no": "0131309002"
    },
    "created_date": "2017-11-21T18:23:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02084104",
    "company_name": "APOTEX INC",
    "atc_number": "J01AA08",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2018-02-02T00:00:00-05:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-06T14:33:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MINOCYCLINE CAP 100MG",
    "en_drug_common_name": "MINOCYCLINE",
    "fr_drug_brand_name": "APO-MINOCYCLINE CAP 100MG",
    "fr_drug_common_name": "MINOCYCLINE",
    "en_ingredients": "MINOCYCLINE",
    "fr_ingredients": "MINOCYCLINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29975,
    "drug": {
      "current_status": "DORMANT",
      "id": 30904,
      "drug_code": 93043,
      "updated_date": "2025-12-03T02:32:38-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369321,
          "ingredient": {
            "id": 1834,
            "ingredient_code": 7234,
            "en_name": "QUININE SULFATE",
            "fr_name": "Sulfate de quinine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445204",
      "brand_name": "JAMP QUININE",
      "brand_name_fr": "JAMP-QUININE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106604002"
    },
    "created_date": "2017-11-21T18:28:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445204",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "P01BC01",
    "atc_description": "ANTIMALARIALS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T14:40:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-QUININE",
    "en_drug_common_name": "Quinine 300mg",
    "fr_drug_brand_name": "JAMP-QUININE",
    "fr_drug_common_name": "QUININE 300 mg",
    "en_ingredients": "QUININE SULFATE",
    "fr_ingredients": "Sulfate de quinine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29978,
    "drug": {
      "current_status": "DORMANT",
      "id": 30904,
      "drug_code": 93043,
      "updated_date": "2025-12-03T02:32:38-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369321,
          "ingredient": {
            "id": 1834,
            "ingredient_code": 7234,
            "en_name": "QUININE SULFATE",
            "fr_name": "Sulfate de quinine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445204",
      "brand_name": "JAMP QUININE",
      "brand_name_fr": "JAMP-QUININE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106604002"
    },
    "created_date": "2017-11-21T18:29:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445204",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "P01BC01",
    "atc_description": "ANTIMALARIALS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T14:11:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-QUININE",
    "en_drug_common_name": "Quinine 300mg",
    "fr_drug_brand_name": "JAMP-QUININE",
    "fr_drug_common_name": "QUININE 300 mg",
    "en_ingredients": "QUININE SULFATE",
    "fr_ingredients": "Sulfate de quinine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 29983,
    "drug": {
      "current_status": "DORMANT",
      "id": 14190,
      "drug_code": 7426,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366484,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00733059",
      "brand_name": "APO-RANITIDINE TABLET 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65394",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-11-21T18:31:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00733059",
    "company_name": "APOTEX INC",
    "atc_number": "A02BA02",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2018-10-01T00:00:00-04:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-29T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30002,
    "drug": {
      "current_status": "MARKETED",
      "id": 22374,
      "drug_code": 84766,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258015,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362651",
      "brand_name": "MINT-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2017-11-21T18:54:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362651",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2017-11-21T00:00:00-05:00",
    "estimated_end_date": "2018-01-12T00:00:00-05:00",
    "actual_start_date": "2017-11-21T00:00:00-05:00",
    "actual_end_date": "2018-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-01-11T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-AMLODIPINE",
    "en_drug_common_name": "Amlodipine",
    "fr_drug_brand_name": "Mint- Amlodipine",
    "fr_drug_common_name": "Amlodipine",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "Amlodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "250 Count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30005,
    "drug": {
      "current_status": "DORMANT",
      "id": 28096,
      "drug_code": 90253,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369050,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417936",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2017-11-21T19:13:34-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417936",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T19:27:31-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "Reddy Atorvastatin",
    "fr_drug_common_name": "Atorvastatin Calcium Tablets",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatin",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30011,
    "drug": {
      "current_status": "DORMANT",
      "id": 31492,
      "drug_code": 93818,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369366,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451824",
      "brand_name": "JAMP-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485003"
    },
    "created_date": "2017-11-21T19:57:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451824",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-TADALAFIL",
    "en_drug_common_name": "Tadalafil 2.5mg",
    "fr_drug_brand_name": "Jamp-Tadalafil",
    "fr_drug_common_name": "Tadalafil",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "7 x 4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30014,
    "drug": {
      "current_status": "MARKETED",
      "id": 31494,
      "drug_code": 93819,
      "updated_date": "2025-05-15T02:35:14-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261764,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451832",
      "brand_name": "JAMP-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2017-11-21T20:01:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451832",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T14:09:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-TADALAFIL",
    "en_drug_common_name": "Jamp-Tadalafil",
    "fr_drug_brand_name": "Jamp-Tadalafil",
    "fr_drug_common_name": "Tadalafil",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "7 x 4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30017,
    "drug": {
      "current_status": "MARKETED",
      "id": 31496,
      "drug_code": 93820,
      "updated_date": "2025-05-15T02:35:14-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261765,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451840",
      "brand_name": "JAMP-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2017-11-21T20:06:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451840",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-13T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-TADALAFIL",
    "en_drug_common_name": "Tadalafil 10mg",
    "fr_drug_brand_name": "Jamp-Tadalafil",
    "fr_drug_common_name": "Tadalafil 10mg",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 x 4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30022,
    "drug": {
      "current_status": "MARKETED",
      "id": 31280,
      "drug_code": 93493,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261597,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449110",
      "brand_name": "JAMP-VITAMIN D",
      "brand_name_fr": "JAMP-VITAMINE D",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524010"
    },
    "created_date": "2017-11-21T20:09:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449110",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A11CC05",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-17T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-VITAMIN D",
    "en_drug_common_name": "Vitamine D 50000 UI",
    "fr_drug_brand_name": "JAMP-VITAMIN D",
    "fr_drug_common_name": "Vitamine D 50000 UI",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "50000UNIT",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30025,
    "drug": {
      "current_status": "DORMANT",
      "id": 21362,
      "drug_code": 83763,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368427,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352362",
      "brand_name": "JAMP-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618005"
    },
    "created_date": "2017-11-21T20:12:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352362",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N04BC04",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2019-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-08T16:14:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-ROPINIROLE",
    "en_drug_common_name": "Ropinirole 5mg",
    "fr_drug_brand_name": "Jamp-Ropinirole",
    "fr_drug_common_name": "Ropinirole 5mg",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "Ropinirole",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30028,
    "drug": {
      "current_status": "MARKETED",
      "id": 22542,
      "drug_code": 85042,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258093,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365529",
      "brand_name": "JAMP PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541002"
    },
    "created_date": "2017-11-21T20:15:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365529",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A10BG03",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2019-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-08T16:08:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-PIOGLITAZONE",
    "en_drug_common_name": "Pioglitazone 30mg",
    "fr_drug_brand_name": "Jamp-Pioglitazone",
    "fr_drug_common_name": "Pioglitazone 30mg",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "Pioglitazone",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30031,
    "drug": {
      "current_status": "MARKETED",
      "id": 22544,
      "drug_code": 85043,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258094,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365537",
      "brand_name": "JAMP PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541003"
    },
    "created_date": "2017-11-21T20:17:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365537",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A10BG03",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2019-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-08T16:10:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-PIOGLITAZONE",
    "en_drug_common_name": "Pioglitazone 45mg",
    "fr_drug_brand_name": "JAMP-PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE 45mg",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30034,
    "drug": {
      "current_status": "DORMANT",
      "id": 22826,
      "drug_code": 85359,
      "updated_date": "2025-05-15T06:55:43-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368644,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368617",
      "brand_name": "JAMP-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2017-11-21T20:21:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02368617",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-17T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SOTALOL",
    "en_drug_common_name": "Sotalol 80mg",
    "fr_drug_brand_name": "JAMP-SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30037,
    "drug": {
      "current_status": "DORMANT",
      "id": 22826,
      "drug_code": 85359,
      "updated_date": "2025-05-15T06:55:43-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368644,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368617",
      "brand_name": "JAMP-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2017-11-21T20:24:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02368617",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SOTALOL",
    "en_drug_common_name": "Sotalol",
    "fr_drug_brand_name": "JAMP-SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30040,
    "drug": {
      "current_status": "DORMANT",
      "id": 22828,
      "drug_code": 85360,
      "updated_date": "2025-05-15T06:55:43-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368645,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368625",
      "brand_name": "JAMP-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2017-11-21T20:27:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02368625",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2018-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SOTALOL",
    "en_drug_common_name": "Sotalol",
    "fr_drug_brand_name": "JAMP-SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30043,
    "drug": {
      "current_status": "DORMANT",
      "id": 28096,
      "drug_code": 90253,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369050,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417936",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2017-11-21T20:38:32-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417936",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:44:52-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30045,
    "drug": {
      "current_status": "DORMANT",
      "id": 28098,
      "drug_code": 90254,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369051,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417944",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2017-11-21T20:42:48-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417944",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:43:54-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30050,
    "drug": {
      "current_status": "DORMANT",
      "id": 28098,
      "drug_code": 90254,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369051,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417944",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2017-11-21T20:47:11-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417944",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:47:49-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30053,
    "drug": {
      "current_status": "DORMANT",
      "id": 28100,
      "drug_code": 90255,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369052,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417952",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2017-11-21T20:48:46-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417952",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:49:18-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30056,
    "drug": {
      "current_status": "DORMANT",
      "id": 28100,
      "drug_code": 90255,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369052,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417952",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2017-11-21T20:50:13-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417952",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:51:00-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30059,
    "drug": {
      "current_status": "DORMANT",
      "id": 28102,
      "drug_code": 90256,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369053,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417960",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2017-11-21T20:51:51-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417960",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:52:27-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30062,
    "drug": {
      "current_status": "DORMANT",
      "id": 28102,
      "drug_code": 90256,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369053,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417960",
      "brand_name": "REDDY-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2017-11-21T20:53:35-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417960",
    "company_name": "DR REDDYS LABORATORIES LTD",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NA",
    "en_discontinuation_comments": "NA",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-21T20:54:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "REDDY-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin Calcium Tablets",
    "fr_drug_brand_name": "REDDY-Atorvastatin",
    "fr_drug_common_name": "COMPRIMÉS D’ATORVASTATINE CALCIQUE",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "atorvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30073,
    "drug": {
      "current_status": "MARKETED",
      "id": 20254,
      "drug_code": 817,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250195,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037796",
      "brand_name": "SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "30210",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2017-11-21T21:24:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037796",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA03",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2018-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-19T18:41:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE",
    "fr_drug_brand_name": "CHLORURE DE SODIUM POUR INJECTION USP",
    "fr_drug_common_name": "CHLORURE DE SODIUM",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAPERITONEAL\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntrapéritonéale\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "25x10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30084,
    "drug": {
      "current_status": "MARKETED",
      "id": 13602,
      "drug_code": 73417,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254915,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249332",
      "brand_name": "APO-METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2017-11-22T12:47:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249332",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-02-02T00:00:00-05:00",
    "actual_start_date": "2017-11-21T00:00:00-05:00",
    "actual_end_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-25T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30093,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13786,
      "drug_code": 73669,
      "updated_date": "2025-05-15T04:08:31-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8339860,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251787",
      "brand_name": "CIPRO XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207009"
    },
    "created_date": "2017-11-22T13:36:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251787",
    "company_name": "BAYER INC",
    "atc_number": "J01MA02",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "anticipated_start_date": "2017-11-27T00:00:00-05:00",
    "estimated_end_date": "2018-04-16T00:00:00-04:00",
    "actual_end_date": "2018-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-10T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is now available in the market.",
    "en_drug_brand_name": "CIPRO XL",
    "en_drug_common_name": "Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release",
    "fr_drug_brand_name": "Cipro XL",
    "fr_drug_common_name": "Ciprofloxacine",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30104,
    "drug": {
      "current_status": "MARKETED",
      "id": 30898,
      "drug_code": 93029,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261418,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445085",
      "brand_name": "FINASTERIDE",
      "brand_name_fr": "FINASTERIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110002"
    },
    "created_date": "2017-11-22T14:46:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445085",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "D11AX10",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-11-06T00:00:00-05:00",
    "actual_end_date": "2018-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-16T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "30 pack size available",
    "fr_comments": "30 paquets disponibles",
    "en_drug_brand_name": "FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE TAB",
    "fr_drug_brand_name": "FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE COMPRIMES",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30107,
    "drug": {
      "current_status": "MARKETED",
      "id": 30896,
      "drug_code": 93028,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261417,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445077",
      "brand_name": "FINASTERIDE",
      "brand_name_fr": "FINASTERIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2017-11-22T14:48:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445077",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CB01",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2018-01-31T00:00:00-05:00",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_end_date": "2018-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-29T13:34:41-05:00",
    "status": "avoided_shortage",
    "en_comments": "100 pack size available",
    "fr_comments": "100 paquets disponibles",
    "en_drug_brand_name": "FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE TABS",
    "fr_drug_brand_name": "FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE COMPRIMES",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30110,
    "drug": {
      "current_status": "MARKETED",
      "id": 21468,
      "drug_code": 83848,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257669,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353261",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-11-22T14:51:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353261",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-29T00:00:00-05:00",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2017-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-22T13:58:56-05:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN CAP",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30115,
    "drug": {
      "current_status": "MARKETED",
      "id": 18646,
      "drug_code": 79917,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256527,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313677",
      "brand_name": "PRO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938006"
    },
    "created_date": "2017-11-22T15:44:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313677",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "PRO-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30124,
    "drug": {
      "current_status": "MARKETED",
      "id": 760,
      "drug_code": 11751,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251564,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01919369",
      "brand_name": "LUVOX",
      "brand_name_fr": "LUVOX",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72651",
      "number_of_ais": "1",
      "ai_group_no": "0122450001"
    },
    "created_date": "2017-11-22T18:19:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01919369",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N06AB08",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LUVOX",
    "en_drug_common_name": "LUVOX",
    "fr_drug_brand_name": "LUVOX",
    "fr_drug_common_name": "LUVOX",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2x15",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30127,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6376,
      "drug_code": 43291,
      "updated_date": "2025-05-15T03:49:51-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8312893,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02220636",
      "brand_name": "OXYBUTYNINE-5 - TAB 5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9622",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2017-11-22T18:47:39-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02220636",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04BD04",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-23T06:00:07-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "OXYBUTYNINE-5  -  TAB 5MG",
    "en_drug_common_name": "OXYBUTYNINE",
    "fr_drug_brand_name": "OXYBUTYNINE-5 - TAB 5MG",
    "fr_drug_common_name": "OXYBUTYNINE",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30132,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7080,
      "drug_code": 47956,
      "updated_date": "2025-05-15T03:50:21-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8313921,
          "ingredient": {
            "id": 582,
            "ingredient_code": 8231,
            "en_name": "BUTALBITAL",
            "fr_name": "Butalbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8313920,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8313919,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229736",
      "brand_name": "PRONAL TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0301241001"
    },
    "created_date": "2017-11-22T18:52:31-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02229736",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02BA71",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "discontinuation_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-23T06:00:07-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRONAL TABLETS",
    "en_drug_common_name": "ACETYLSALICYLIC ACID BUTALBITAL",
    "fr_drug_brand_name": "PRONAL TABLET",
    "fr_drug_common_name": "ACETYLSALICYLIC ACID BUTALBITAL",
    "en_ingredients": "ACETYLSALICYLIC ACID\r\nBUTALBITAL\r\nCAFFEINE",
    "fr_ingredients": "Acide acétylsalicylique\r\nButalbital\r\nCaféine",
    "drug_strength": "330MG\r\n50MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30191,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28720,
      "drug_code": 90845,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354577,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423758",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/5ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2017-11-22T20:58:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423758",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD08",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-02-20T00:00:00-05:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-30T19:04:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10x5mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30195,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17998,
      "drug_code": 79144,
      "updated_date": "2025-12-03T01:25:33-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8345098,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02305895",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE, MULTIDOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896001"
    },
    "created_date": "2017-11-22T21:01:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305895",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N01BB01",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T20:50:47-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MARCAINE",
    "en_drug_common_name": "MARCAINE 0.25%",
    "fr_drug_brand_name": "MARCAINE",
    "fr_drug_common_name": "MARCAINE 0.25%",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "1x50mL GVL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30198,
    "drug": {
      "current_status": "DORMANT",
      "id": 3016,
      "drug_code": 1746,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365881,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037974",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "DEXTROSE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43678",
      "number_of_ais": "1",
      "ai_group_no": "0102181001"
    },
    "created_date": "2017-11-22T21:05:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037974",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "B05BA03",
    "atc_description": "I.V. SOLUTIONS",
    "actual_start_date": "2018-01-19T00:00:00-05:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-05T14:19:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "50% DEXTROSE INJECTION USP",
    "en_drug_common_name": "50% DEXTROSE",
    "fr_drug_brand_name": "50% DEXTROSE INJECTION USP",
    "fr_drug_common_name": "50% DEXTROSE",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "25x50mL GVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30228,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27646,
      "drug_code": 89876,
      "updated_date": "2025-12-03T01:31:46-05:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353777,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414090",
      "brand_name": "RAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2017-11-22T23:33:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414090",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T16:10:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-OLANZAPINE ODT",
    "en_drug_common_name": "RAN-OLANZAPINE ODT",
    "fr_drug_brand_name": "RAN-OLANZAPINE ODT",
    "fr_drug_common_name": "RAN-OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30231,
    "drug": {
      "current_status": "MARKETED",
      "id": 28746,
      "drug_code": 90870,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260427,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423979",
      "brand_name": "TARO-ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162001"
    },
    "created_date": "2017-11-22T23:35:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423979",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A02BC05",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "estimated_end_date": "2018-03-09T00:00:00-05:00",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T16:51:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ESOMEPRAZOLE",
    "en_drug_common_name": "RAN-ESOMEPRAZOLE",
    "fr_drug_brand_name": "RAN-ESOMEPRAZOLE",
    "fr_drug_common_name": "RAN-ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30234,
    "drug": {
      "current_status": "MARKETED",
      "id": 20086,
      "drug_code": 81485,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257081,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02329166",
      "brand_name": "TARO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2017-11-22T23:38:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329166",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:59:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-SIMVASTATIN",
    "en_drug_common_name": "RAN-SIMVASTATIN",
    "fr_drug_brand_name": "RAN-SIMVASTATIN",
    "fr_drug_common_name": "RAN-SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30237,
    "drug": {
      "current_status": "DORMANT",
      "id": 16948,
      "drug_code": 77958,
      "updated_date": "2025-12-03T02:32:23-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368062,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02294230",
      "brand_name": "TARO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550003"
    },
    "created_date": "2017-11-22T23:39:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02294230",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA03",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "estimated_end_date": "2018-01-26T00:00:00-05:00",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:38:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-LISINOPRIL",
    "en_drug_common_name": "RAN-LISINOPRIL",
    "fr_drug_brand_name": "RAN-LISINOPRIL",
    "fr_drug_common_name": "RAN-LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30240,
    "drug": {
      "current_status": "MARKETED",
      "id": 31532,
      "drug_code": 93853,
      "updated_date": "2025-05-15T06:55:57-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369370,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452103",
      "brand_name": "TARO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2017-11-22T23:42:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452103",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-02-01T00:00:00-05:00",
    "actual_start_date": "2018-02-01T00:00:00-05:00",
    "actual_end_date": "2018-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:49:51-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-TADALAFIL",
    "en_drug_common_name": "RAN-TADALAFIL",
    "fr_drug_brand_name": "RAN-TADALAFIL",
    "fr_drug_common_name": "RAN-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30258,
    "drug": {
      "current_status": "MARKETED",
      "id": 6526,
      "drug_code": 43455,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253087,
          "ingredient": {
            "id": 2192,
            "ingredient_code": 8,
            "en_name": "DESFLURANE",
            "fr_name": "Desflurane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "V/V",
          "base": false
        }
      ],
      "din": "02227428",
      "brand_name": "SUPRANE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9794",
      "number_of_ais": "1",
      "ai_group_no": "0128744001"
    },
    "created_date": "2017-11-23T14:37:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02227428",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "N01AB07",
    "atc_description": "ANESTHETICS, GENERAL",
    "anticipated_start_date": "2017-11-22T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-16T06:00:08-05:00",
    "status": "resolved",
    "en_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "fr_comments": "Pour toute autre question concernant ce produit, veuillez contacter le service à la clientèle de Baxter au 1-888-719-9955 ou l'information médicale au 1-855-584-1368.",
    "en_drug_brand_name": "SUPRANE",
    "en_drug_common_name": "Desflurane, USP",
    "fr_drug_brand_name": "SUPRANE",
    "fr_drug_common_name": "Desflurane, USP",
    "en_ingredients": "DESFLURANE",
    "fr_ingredients": "Desflurane",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "240mL bottle,   6 units/Case",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30269,
    "drug": {
      "current_status": "MARKETED",
      "id": 276,
      "drug_code": 10748,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251380,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251379,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00611174",
      "brand_name": "LOTRIDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70771",
      "number_of_ais": "2",
      "ai_group_no": "0216399001"
    },
    "created_date": "2017-11-23T15:16:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00611174",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D01AC20",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "anticipated_start_date": "2017-11-23T00:00:00-05:00",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-11-23T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-05T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTRIDERM CREAM",
    "en_drug_common_name": "Clotrimazole and Betamethasone Dipropionate Cream",
    "fr_drug_brand_name": "LOTRIDERM CRÈME",
    "fr_drug_common_name": "Crème de Clotrimazole et de Dipropionate de Bétaméthasone",
    "en_ingredients": "BETAMETHASONE\r\nCLOTRIMAZOLE",
    "fr_ingredients": "Bétaméthasone\r\nClotrimazole",
    "drug_strength": "0.05%\r\n1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30305,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13168,
      "drug_code": 72598,
      "updated_date": "2025-05-15T04:07:45-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8338943,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248261",
      "brand_name": "MYLAN-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-11-23T18:41:45-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248261",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:11-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "MYLAN-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30312,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7532,
      "drug_code": 50228,
      "updated_date": "2025-05-15T03:51:20-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8315811,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230950",
      "brand_name": "MYLAN-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2017-11-23T18:47:13-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02230950",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:11-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "MYLAN-CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30319,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21280,
      "drug_code": 83680,
      "updated_date": "2025-05-15T04:17:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348896,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02351536",
      "brand_name": "MYLAN-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2017-11-23T18:49:50-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02351536",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "B01AC04",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2018-03-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 30326. Last Lot # 3076593 and Expires 31 May-2018",
    "fr_discontinuation_comments": "Discontinued in shortage ID 30326. Last Lot # 3076593 and Expires 31 May-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-02T06:00:09-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "MYLAN-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30326,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21280,
      "drug_code": 83680,
      "updated_date": "2025-05-15T04:17:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348896,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02351536",
      "brand_name": "MYLAN-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2017-11-23T18:51:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351536",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "B01AC04",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-02T15:35:18-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 30319",
    "fr_comments": "discontinued in ID 30319",
    "en_drug_brand_name": "MYLAN-CLOPIDOGREL",
    "en_drug_common_name": "MYLAN-CLOPIDOGREL",
    "fr_drug_brand_name": "MYLAN-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30337,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28672,
      "drug_code": 90802,
      "updated_date": "2025-05-15T04:22:21-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8354537,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423278",
      "brand_name": "MYLAN-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2017-11-23T18:56:16-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02423278",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AH01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in ID shortage 134. Last Lot 3087719 Expires 31-Mar-2019",
    "fr_discontinuation_comments": "Discontinued in ID shortage 134. Last Lot 3087719 Expires 31-Mar-2019",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "MYLAN-CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30342,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24080,
      "drug_code": 86705,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351313,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381273",
      "brand_name": "MYLAN-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-11-23T18:58:48-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02381273",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2018-04-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 30347. Mar-2018 last lot 3056799 expires 31-jun-2018",
    "fr_discontinuation_comments": "Discontinued in shortage ID 30347. Mar-2018 last lot 3056799 expires 31-jun-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30347,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24080,
      "drug_code": 86705,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351313,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381273",
      "brand_name": "MYLAN-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-11-23T18:59:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381273",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:10-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 30342. Mar-2018 last lot 3056799 expires 31-jun-2018",
    "fr_comments": "Discontinued in ID 30342. Mar-2018 last lot 3056799 expires 31-jun-2018",
    "en_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30350,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24084,
      "drug_code": 86707,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351315,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381303",
      "brand_name": "MYLAN-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2017-11-23T19:01:30-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02381303",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2018-05-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 30353. Last lot 3056912 Expires 31-Jul-2018",
    "fr_discontinuation_comments": "Discontinued in shortage ID 30353. Last lot 3056912 Expires 31-Jul-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-02T17:40:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30353,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24084,
      "drug_code": 86707,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351315,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381303",
      "brand_name": "MYLAN-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2017-11-23T19:02:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381303",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-05-01T00:00:00-04:00",
    "actual_start_date": "2018-05-01T00:00:00-04:00",
    "actual_end_date": "2018-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-05T20:44:50-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 30350.",
    "fr_comments": "Discontinued in ID 30350.",
    "en_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30356,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10652,
      "drug_code": 66269,
      "updated_date": "2025-05-15T04:01:56-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8332510,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242521",
      "brand_name": "MYLAN-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2017-11-23T19:04:19-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242521",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-02-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last lot 3052596 Expires 28-Feb-19. Resolved/Discontinued in ID 30359",
    "fr_discontinuation_comments": "Last lot 3052596 Expires 28-Feb-19. Resolved/Discontinued in ID 30356",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:22:00-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "MYLAN-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30359,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10652,
      "drug_code": 66269,
      "updated_date": "2025-05-15T04:01:56-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8332510,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242521",
      "brand_name": "MYLAN-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2017-11-23T19:05:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242521",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-07-02T00:00:00-04:00",
    "actual_start_date": "2018-01-25T00:00:00-05:00",
    "actual_end_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-15T19:21:11-05:00",
    "status": "avoided_shortage",
    "en_comments": "Discontinued in ID 30356",
    "fr_comments": "Discontinued in ID 30356",
    "en_drug_brand_name": "MYLAN-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "MYLAN-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30362,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15672,
      "drug_code": 76396,
      "updated_date": "2025-05-15T04:11:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342513,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278359",
      "brand_name": "MYLAN-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-11-23T19:07:49-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02278359",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2018-03-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 30365. Last lot 602909 Expires 30-Sep-18",
    "fr_discontinuation_comments": "Discontinued in shortage ID 30365. Last lot 602909 Expires 30-Sep-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-02T06:00:08-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "MYLAN-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6BL, 30BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30365,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15672,
      "drug_code": 76396,
      "updated_date": "2025-05-15T04:11:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342513,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278359",
      "brand_name": "MYLAN-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-11-23T19:08:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278359",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2018-02-02T00:00:00-05:00",
    "actual_end_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-02T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "discontinued under ID 30362.",
    "fr_comments": "discontinued under ID 30362.",
    "en_drug_brand_name": "MYLAN-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "MYLAN-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6BL, 30BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30368,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9356,
      "drug_code": 62586,
      "updated_date": "2025-05-15T03:58:14-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8327709,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02239131",
      "brand_name": "MYLAN-IPRATROPIUM SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2017-11-23T19:10:17-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02239131",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R03BB01",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 30371 . Last lot 6G355 Expires 31-Jul-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 30371 . Last lot 6G355 Expires 31-Jul-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:00-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-IPRATROPIUM SOLUTION",
    "en_drug_common_name": "IPRATROPIUM SOLUTION",
    "fr_drug_brand_name": "MYLAN-IPRATROPIUM SOLUTION",
    "fr_drug_common_name": "IPRATROPIUM SOLUTION",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "20ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30371,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9356,
      "drug_code": 62586,
      "updated_date": "2025-05-15T03:58:14-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8327709,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02239131",
      "brand_name": "MYLAN-IPRATROPIUM SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2017-11-23T19:11:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239131",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R03BB01",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2018-07-02T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T13:39:01-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 30368",
    "fr_comments": "Discontinued in ID 30368",
    "en_drug_brand_name": "MYLAN-IPRATROPIUM SOLUTION",
    "en_drug_common_name": "IPRATROPIUM SOLUTION",
    "fr_drug_brand_name": "MYLAN-IPRATROPIUM SOLUTION",
    "fr_drug_common_name": "IPRATROPIUM SOLUTION",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "20ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30374,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8858,
      "drug_code": 61076,
      "updated_date": "2025-05-15T03:56:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8325484,
          "ingredient": {
            "id": 598,
            "ingredient_code": 11162,
            "en_name": "ACEBUTOLOL",
            "fr_name": "Acébutolol (Chlorhydrate d'acébutolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02237722",
      "brand_name": "MYLAN-ACEBUTOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131282003"
    },
    "created_date": "2017-11-23T19:12:44-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02237722",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AB04",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "discontinued in shortage ID 30377 . Last Lot 8041791 Expires 30-Nov-18",
    "fr_discontinuation_comments": "discontinued in shortage ID 30377 . Last Lot 8041791 Expires 30-Nov-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:43-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-ACEBUTOLOL",
    "en_drug_common_name": "ACEBUTOLOL",
    "fr_drug_brand_name": "MYLAN-ACEBUTOLOL",
    "fr_drug_common_name": "ACEBUTOLOL",
    "en_ingredients": "ACEBUTOLOL",
    "fr_ingredients": "ACEBUTOLOL",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30377,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8858,
      "drug_code": 61076,
      "updated_date": "2025-05-15T03:56:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8325484,
          "ingredient": {
            "id": 598,
            "ingredient_code": 11162,
            "en_name": "ACEBUTOLOL",
            "fr_name": "Acébutolol (Chlorhydrate d'acébutolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02237722",
      "brand_name": "MYLAN-ACEBUTOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131282003"
    },
    "created_date": "2017-11-23T19:14:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237722",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AB04",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2018-02-12T00:00:00-05:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 30374",
    "fr_comments": "Discontinued in ID 30374",
    "en_drug_brand_name": "MYLAN-ACEBUTOLOL",
    "en_drug_common_name": "ACEBUTOLOL",
    "fr_drug_brand_name": "MYLAN-ACEBUTOLOL",
    "fr_drug_common_name": "ACEBUTOLOL",
    "en_ingredients": "ACEBUTOLOL",
    "fr_ingredients": "ACEBUTOLOL",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30380,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3120,
      "drug_code": 17973,
      "updated_date": "2025-05-15T03:44:05-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8299861,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02137542",
      "brand_name": "MYLAN-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80185",
      "number_of_ais": "1",
      "ai_group_no": "0115008002"
    },
    "created_date": "2017-11-23T19:16:23-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02137542",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05BA12",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-01T12:39:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-ALPRAZOLAM",
    "en_drug_common_name": "ALPRAZOLAM",
    "fr_drug_brand_name": "MYLAN-ALPRAZOLAM",
    "fr_drug_common_name": "ALPRAZOLAM",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 1000BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30385,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24082,
      "drug_code": 86706,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351314,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381281",
      "brand_name": "MYLAN-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2017-11-23T19:20:49-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02381281",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 30392. Last lot 3060676 Expires 31-Oct-2018",
    "fr_discontinuation_comments": "Discontinued in shortage ID 30392. Last lot 3060676 Expires 31-Oct-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30392,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24082,
      "drug_code": 86706,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351314,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381281",
      "brand_name": "MYLAN-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2017-11-23T19:21:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381281",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T14:03:58-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 30385",
    "fr_comments": "Discontinued in ID 30385",
    "en_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "MYLAN-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30397,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10648,
      "drug_code": 66267,
      "updated_date": "2025-05-15T04:01:56-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8332508,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242519",
      "brand_name": "MYLAN-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2017-11-23T19:23:13-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242519",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-02-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last lot 3047219 Expires 31-Oct-18. Resolved/Discontinued in ID 30402",
    "fr_discontinuation_comments": "Last lot 3047219 Expires 31-Oct-18. Resolved/Discontinued in ID 30402",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:19:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "MYLAN-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30402,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10648,
      "drug_code": 66267,
      "updated_date": "2025-05-15T04:01:56-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8332508,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242519",
      "brand_name": "MYLAN-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2017-11-23T19:24:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242519",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-08-01T00:00:00-04:00",
    "actual_end_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-15T19:18:34-05:00",
    "status": "avoided_shortage",
    "en_comments": "Discontinued in ID 30397",
    "fr_comments": "Discontinued in ID 30397",
    "en_drug_brand_name": "MYLAN-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "MYLAN-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30475,
    "drug": {
      "current_status": "DORMANT",
      "id": 25190,
      "drug_code": 87682,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368831,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391473",
      "brand_name": "MAR-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2017-11-23T20:09:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391473",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-09-10T00:00:00-04:00",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-09-10T00:00:00-04:00",
    "actual_end_date": "2018-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-06T15:16:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-GABAPENTIN",
    "en_drug_common_name": "MAR-Gabapentin",
    "fr_drug_brand_name": "MAR-GABAPENTIN",
    "fr_drug_common_name": "MAR-Gabapentin",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30478,
    "drug": {
      "current_status": "DORMANT",
      "id": 25192,
      "drug_code": 87683,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368832,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391481",
      "brand_name": "MAR-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-11-23T20:10:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391481",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-09-10T00:00:00-04:00",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-09-10T00:00:00-04:00",
    "actual_end_date": "2018-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-25T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-GABAPENTIN",
    "en_drug_common_name": "MAR-Gabapentin",
    "fr_drug_brand_name": "MAR-GABAPENTIN",
    "fr_drug_common_name": "MAR-Gabapentin",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30481,
    "drug": {
      "current_status": "DORMANT",
      "id": 25192,
      "drug_code": 87683,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368832,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391481",
      "brand_name": "MAR-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-11-23T20:12:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391481",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-09-10T00:00:00-04:00",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-09-10T00:00:00-04:00",
    "actual_end_date": "2018-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-25T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-GABAPENTIN",
    "en_drug_common_name": "MAR-Gabapentin",
    "fr_drug_brand_name": "MAR-GABAPENTIN",
    "fr_drug_common_name": "MAR-Gabapentin",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30484,
    "drug": {
      "current_status": "DORMANT",
      "id": 25194,
      "drug_code": 87684,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368833,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391503",
      "brand_name": "MAR-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-11-23T20:17:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391503",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-09-10T00:00:00-04:00",
    "actual_start_date": "2017-09-10T00:00:00-04:00",
    "actual_end_date": "2018-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-06T15:14:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-GABAPENTIN",
    "en_drug_common_name": "MAR-Gabapentin",
    "fr_drug_brand_name": "MAR-GABAPENTIN",
    "fr_drug_common_name": "MAR-Gabapentin",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30487,
    "drug": {
      "current_status": "DORMANT",
      "id": 25194,
      "drug_code": 87684,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368833,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391503",
      "brand_name": "MAR-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-11-23T20:19:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391503",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-09-10T00:00:00-04:00",
    "estimated_end_date": "2018-07-27T00:00:00-04:00",
    "actual_start_date": "2017-09-10T00:00:00-04:00",
    "actual_end_date": "2018-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-GABAPENTIN",
    "en_drug_common_name": "MAR-Gabapentin",
    "fr_drug_brand_name": "MAR-GABAPENTIN",
    "fr_drug_common_name": "MAR-Gabapentin",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30490,
    "drug": {
      "current_status": "MARKETED",
      "id": 28034,
      "drug_code": 90207,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260196,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417529",
      "brand_name": "MAR-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-11-23T20:21:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417529",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-01T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T19:13:03-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-PREGABALIN",
    "en_drug_common_name": "MAR-Pregabalin",
    "fr_drug_brand_name": "MAR-PREGABALIN",
    "fr_drug_common_name": "MAR-Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30493,
    "drug": {
      "current_status": "MARKETED",
      "id": 28034,
      "drug_code": 90207,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260196,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417529",
      "brand_name": "MAR-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-11-23T20:22:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417529",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-01T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T19:12:27-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-PREGABALIN",
    "en_drug_common_name": "MAR-Pregabalin",
    "fr_drug_brand_name": "MAR-PREGABALIN",
    "fr_drug_common_name": "MAR-Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30496,
    "drug": {
      "current_status": "MARKETED",
      "id": 28038,
      "drug_code": 90209,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260198,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417545",
      "brand_name": "MAR-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2017-11-23T20:24:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417545",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-01T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T19:12:02-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-PREGABALIN",
    "en_drug_common_name": "MAR-Pregabalin",
    "fr_drug_brand_name": "MAR-PREGABALIN",
    "fr_drug_common_name": "MAR-Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30499,
    "drug": {
      "current_status": "MARKETED",
      "id": 28038,
      "drug_code": 90209,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260198,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417545",
      "brand_name": "MAR-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2017-11-23T20:25:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417545",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-01T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T19:09:06-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-PREGABALIN",
    "en_drug_common_name": "MAR-Pregabalin",
    "fr_drug_brand_name": "MAR-PREGABALIN",
    "fr_drug_common_name": "MAR-Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30502,
    "drug": {
      "current_status": "MARKETED",
      "id": 28040,
      "drug_code": 90211,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260199,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417561",
      "brand_name": "MAR-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2017-11-23T20:27:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417561",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-01T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T19:08:35-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-PREGABALIN",
    "en_drug_common_name": "MAR-Pregabalin",
    "fr_drug_brand_name": "MAR-PREGABALIN",
    "fr_drug_common_name": "MAR-Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30505,
    "drug": {
      "current_status": "MARKETED",
      "id": 28040,
      "drug_code": 90211,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260199,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417561",
      "brand_name": "MAR-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2017-11-23T20:28:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417561",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-01T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T19:08:01-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-PREGABALIN",
    "en_drug_common_name": "MAR-Pregabalin",
    "fr_drug_brand_name": "MAR-PREGABALIN",
    "fr_drug_common_name": "MAR-Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 30511,
    "drug": {
      "current_status": "DORMANT",
      "id": 19108,
      "drug_code": 80363,
      "updated_date": "2025-05-15T06:55:38-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8368208,
          "ingredient": {
            "id": 1336,
            "ingredient_code": 349,
            "en_name": "ROCURONIUM BROMIDE",
            "fr_name": "Bromure de rocuronium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02318121",
      "brand_name": "ROCURONIUM BROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126317001"
    },
    "created_date": "2017-11-23T20:36:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318121",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "M03AC09",
    "atc_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
    "actual_start_date": "2017-12-07T00:00:00-05:00",
    "actual_end_date": "2018-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-10T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROCURONIUM BROMIDE INJECTION",
    "en_drug_common_name": "ROCURONIUM BROMIDE",
    "fr_drug_brand_name": "ROCURONIUM BROMIDE INJECTION",
    "fr_drug_common_name": "ROCURONIUM BROMIDE",
    "en_ingredients": "ROCURONIUM BROMIDE",
    "fr_ingredients": "Bromure de rocuronium",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30515,
    "drug": {
      "current_status": "MARKETED",
      "id": 23702,
      "drug_code": 86356,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8258547,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8258546,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02377748",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "FOR I.V. INFUSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919007"
    },
    "created_date": "2017-11-23T20:39:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02377748",
    "company_name": "STERIMAX INC",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-01-08T00:00:00-05:00",
    "actual_start_date": "2017-11-23T00:00:00-05:00",
    "actual_end_date": "2018-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-27T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Product is available",
    "fr_comments": "Produit est disponible",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "fr_drug_brand_name": "PIPÉRACILLIN ET TAZOBACTAM POUR INJECTION",
    "fr_drug_common_name": "PIPÉRACILLIN ET TAZOBACTAM POUR INJECTION",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "0225919007",
    "drug_strength": "12G\r\n1.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30518,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24898,
      "drug_code": 87417,
      "updated_date": "2025-12-03T01:30:13-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8351779,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02388669",
      "brand_name": "LORAZEPAM INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110731004"
    },
    "created_date": "2017-11-23T20:39:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388669",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05BA06",
    "atc_description": "ANXIOLYTICS",
    "actual_start_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2018-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T02:47:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LORAZEPAM INJECTION USP",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "LORAZEPAM INJECTION USP",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10x1mL GVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30523,
    "drug": {
      "current_status": "MARKETED",
      "id": 3136,
      "drug_code": 18012,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252239,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01901982",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80224",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2017-11-23T20:45:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01901982",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2017-12-29T00:00:00-05:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T02:26:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 2%",
    "en_drug_common_name": "Lidocaine HCL 2%",
    "fr_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 2%",
    "fr_drug_common_name": "LIDOCAINE HCL 2%",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "25x20mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30577,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8900,
      "drug_code": 61179,
      "updated_date": "2025-05-15T03:56:43-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8325595,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02237820",
      "brand_name": "AMERGE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121001"
    },
    "created_date": "2017-11-24T14:55:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237820",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC02",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-05-09T00:00:00-04:00",
    "actual_start_date": "2018-01-04T00:00:00-05:00",
    "actual_end_date": "2018-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-10T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AMERGE",
    "en_drug_common_name": "naratriptan hydrochloride tablets",
    "fr_drug_brand_name": "AMERGE",
    "fr_drug_common_name": "Comprimés de chlorhydrate de naratriptan",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "NARATRIPTAN",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30586,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7482,
      "drug_code": 50130,
      "updated_date": "2025-05-15T03:51:15-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8315707,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "73.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8315706,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "94",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8315705,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02230857",
      "brand_name": "STERILE DILUENT FOR FLOLAN INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0357090001"
    },
    "created_date": "2017-11-24T15:05:37-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02230857",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "discontinuation_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-24T15:10:11-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "STERILE DILUENT FOR FLOLAN INJECTION",
    "en_drug_common_name": "pH 10.5 STERILE DILUENT FOR FLOLAN INJECTION",
    "fr_drug_brand_name": "DILUANT STÉRILE spécial pour FLOLAN",
    "fr_drug_common_name": "pH 10.5 DILUANT STÉRILE spécial pour FLOLAN",
    "en_ingredients": "SODIUM CHLORIDE\r\nWATER\r\nGLYCINE",
    "fr_ingredients": "Chlorure de sodium\r\nEau\r\nGlycine",
    "drug_strength": "73.5MG\r\n50ML\r\n94MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30611,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 32206,
      "drug_code": 9929,
      "updated_date": "2025-05-15T03:36:45-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8286069,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00804541",
      "brand_name": "PREVEX B",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69302",
      "number_of_ais": "1",
      "ai_group_no": "0106299001"
    },
    "created_date": "2017-11-24T15:13:35-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00804541",
    "company_name": "GLAXOSMITHKLINE INC",
    "discontinuation_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2017-11-24T15:15:35-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "PREVEX B",
    "en_drug_common_name": "Betamethasone valerate cream",
    "fr_drug_brand_name": "PREVEX B",
    "fr_drug_common_name": "Crème de valérate de bétaméthasone",
    "fr_ingredients": "valérate de bétaméthasone",
    "drug_dosage_form_fr": "Crème",
    "drug_route_fr": "topique",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30614,
    "drug": {
      "current_status": "MARKETED",
      "id": 12850,
      "drug_code": 71964,
      "updated_date": "2025-12-03T00:30:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254691,
          "ingredient": {
            "id": 2756,
            "ingredient_code": 6417,
            "en_name": "METHADONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthadone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247700",
      "brand_name": "METADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144621001"
    },
    "created_date": "2017-11-24T15:35:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247700",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N07BC02",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "actual_start_date": "2017-11-22T00:00:00-05:00",
    "actual_end_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-01T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METADOL",
    "en_drug_common_name": "Methadone",
    "fr_drug_brand_name": "Metadol",
    "fr_drug_common_name": "Methadone",
    "en_ingredients": "METHADONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthadone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30627,
    "drug": {
      "current_status": "DORMANT",
      "id": 23900,
      "drug_code": 86563,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 1576,
        "created_date": "2017-03-09T13:24:48-05:00",
        "updated_date": "2025-05-15T06:00:17-04:00",
        "company_code": 14461,
        "mfr_code": "",
        "name": "SEPTA PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7035 MAXWELL ROAD, UNIT # 2",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5S 1R5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368736,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379767",
      "brand_name": "SEPTA-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2017-11-24T18:04:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379767",
    "company_name": "SEPTA PHARMACEUTICALS INC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "actual_start_date": "2017-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-25T06:00:05-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "SEPTA-METFORMIN",
    "en_drug_common_name": "Metformin",
    "fr_drug_brand_name": "Septa-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500s",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30645,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28722,
      "drug_code": 90846,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354578,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423766",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/ML; 15MG/3ML; 50MG/10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2017-11-24T18:22:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423766",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD08",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-01-19T00:00:00-05:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-30T19:00:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10x1mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30648,
    "drug": {
      "current_status": "MARKETED",
      "id": 24190,
      "drug_code": 86819,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258706,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382342",
      "brand_name": "MIDAZOLAM INJECTION USP",
      "brand_name_fr": "MIDOZOLAM INJECTABLE USP",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2017-11-24T18:24:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382342",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD08",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-02-07T00:00:00-05:00",
    "actual_end_date": "2018-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-08T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10x5mL GVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30651,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7054,
      "drug_code": 4787,
      "updated_date": "2025-05-15T03:27:44-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8277292,
          "ingredient": {
            "id": 2312,
            "ingredient_code": 9011,
            "en_name": "SCOPOLAMINE HYDROBROMIDE",
            "fr_name": "Bromhydrate de scopolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00541869",
      "brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION USP",
      "brand_name_fr": "BROMHYDRATE DE SCOPOLAMINE INJECTABLE USP",
      "descriptor": "SINGLE-USE AMPOULE",
      "pediatric_flag": false,
      "accession_number": "58723",
      "number_of_ais": "1",
      "ai_group_no": "0104674001"
    },
    "created_date": "2017-11-24T18:25:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00541869",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "A04AD01",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "actual_start_date": "2017-12-29T00:00:00-05:00",
    "actual_end_date": "2018-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-10-24T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "The product has been discontinued.",
    "fr_comments": "Le produit a été discontinue.",
    "en_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML",
    "en_drug_common_name": "Scopolamine",
    "fr_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML",
    "fr_drug_common_name": "SCOPOLAMINE",
    "en_ingredients": "SCOPOLAMINE HYDROBROMIDE",
    "fr_ingredients": "Bromhydrate de scopolamine",
    "drug_strength": ".4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10x1mL AMP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30668,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18798,
      "drug_code": 80062,
      "updated_date": "2025-05-15T04:14:01-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345960,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315068",
      "brand_name": "TEVA-METHYLPHENIDATE ER-C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548004"
    },
    "created_date": "2017-11-24T20:18:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315068",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-01-21T16:09:42-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-METHYLPHENIDATE ER-C",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "TEVA-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "18MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30685,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18800,
      "drug_code": 80063,
      "updated_date": "2025-05-15T04:14:01-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345961,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "27",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315076",
      "brand_name": "TEVA-METHYLPHENIDATE ER-C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548007"
    },
    "created_date": "2017-11-24T20:30:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315076",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-01-21T16:10:13-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-METHYLPHENIDATE ER-C",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "TEVA-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "27MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30688,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18802,
      "drug_code": 80064,
      "updated_date": "2025-05-15T04:14:01-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345962,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "36",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315084",
      "brand_name": "TEVA-METHYLPHENIDATE ER-C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548005"
    },
    "created_date": "2017-11-24T20:39:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315084",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-01-21T16:10:36-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-METHYLPHENIDATE ER-C",
    "en_drug_common_name": "MTHYLPHENIDATE",
    "fr_drug_brand_name": "TEVA-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "36MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30691,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18804,
      "drug_code": 80065,
      "updated_date": "2025-05-15T04:14:01-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345963,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315092",
      "brand_name": "TEVA-METHYLPHENIDATE ER-C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2017-11-24T20:41:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315092",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-01-21T16:10:55-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-METHYLPHENIDATE ER-C",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "TEVA-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30725,
    "drug": {
      "current_status": "MARKETED",
      "id": 21428,
      "drug_code": 83820,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257658,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02352974",
      "brand_name": "OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2017-11-27T15:01:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352974",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-02-05T00:00:00-05:00",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2018-02-05T00:00:00-05:00",
    "actual_end_date": "2018-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-11T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT COMPRIMES",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30729,
    "drug": {
      "current_status": "DORMANT",
      "id": 31366,
      "drug_code": 93663,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8369352,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450496",
      "brand_name": "MYLAN-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846003"
    },
    "created_date": "2017-11-27T15:21:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450496",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08DA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2018-10-15T00:00:00-04:00",
    "estimated_end_date": "2020-06-16T00:00:00-04:00",
    "actual_start_date": "2018-10-15T00:00:00-04:00",
    "actual_end_date": "2020-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-17T17:23:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL SR",
    "fr_drug_brand_name": "MYLAN-VERAPAMIL SR",
    "fr_drug_common_name": "VERAPAMIL SR",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30754,
    "drug": {
      "current_status": "MARKETED",
      "id": 392,
      "drug_code": 10913,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251442,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251441,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00657298",
      "brand_name": "VASERETIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71053",
      "number_of_ais": "2",
      "ai_group_no": "0252326001"
    },
    "created_date": "2017-11-27T16:38:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00657298",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09BA02",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2017-12-08T00:00:00-05:00",
    "estimated_end_date": "2017-12-20T00:00:00-05:00",
    "actual_start_date": "2017-12-06T00:00:00-05:00",
    "actual_end_date": "2017-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-21T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VASERETIC",
    "en_drug_common_name": "Enalapril and Hydrochlorothiazide tablets",
    "fr_drug_brand_name": "VASERETIC",
    "fr_drug_common_name": "Comprimés d’Énalapril et d’Hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nENALAPRIL SODIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nÉnalapril sodique",
    "drug_strength": "25MG\r\n8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30793,
    "drug": {
      "current_status": "MARKETED",
      "id": 31720,
      "drug_code": 94105,
      "updated_date": "2025-05-15T02:35:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261916,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261915,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02454475",
      "brand_name": "APO-ALENDRONATE/VITAMIN D3",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251575002"
    },
    "created_date": "2017-11-27T17:16:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02454475",
    "company_name": "APOTEX INC",
    "atc_number": "M05BB03",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T09:56:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID\r\nVITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "70MG\r\n5600UNIT",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30796,
    "drug": {
      "current_status": "MARKETED",
      "id": 19100,
      "drug_code": 80356,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256691,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318059",
      "brand_name": "APO-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2017-11-27T17:17:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318059",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA09",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-06-06T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T12:58:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "APO-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30799,
    "drug": {
      "current_status": "MARKETED",
      "id": 27796,
      "drug_code": 90013,
      "updated_date": "2025-05-15T02:34:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260102,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415542",
      "brand_name": "APO-AZITHROMYCIN Z",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-11-27T17:19:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415542",
    "company_name": "APOTEX INC",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2018-04-24T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-17T13:15:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AZITHROMYCIN Z",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "APO-AZITHROMYCIN Z",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30802,
    "drug": {
      "current_status": "DORMANT",
      "id": 12994,
      "drug_code": 72246,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367645,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247936",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683001"
    },
    "created_date": "2017-11-27T17:38:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247936",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG02",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-07-31T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-27T21:21:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30805,
    "drug": {
      "current_status": "MARKETED",
      "id": 3690,
      "drug_code": 19125,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252438,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02162814",
      "brand_name": "APO-DICLO SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81416",
      "number_of_ais": "1",
      "ai_group_no": "0114417005"
    },
    "created_date": "2017-11-27T17:43:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02162814",
    "company_name": "APOTEX INC",
    "atc_number": "M01AB05",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-05-07T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-17T13:15:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLO SR",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "APO-DICLO SR",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30810,
    "drug": {
      "current_status": "MARKETED",
      "id": 7090,
      "drug_code": 48059,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253234,
          "ingredient": {
            "id": 918,
            "ingredient_code": 2047,
            "en_name": "BENZYDAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de benzydamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02229777",
      "brand_name": "PHARIXIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113801001"
    },
    "created_date": "2017-11-27T19:20:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229777",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "A01AD02",
    "atc_description": "STOMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2017-11-29T00:00:00-05:00",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-18T16:31:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARIXIA",
    "en_drug_common_name": "PHARIXIA 0.15% ORAL RINSE 250 mL",
    "fr_drug_brand_name": "PHARIXIA",
    "fr_drug_common_name": "PHARIXIA 0.15% ORAL RINSE 250 mL",
    "en_ingredients": "BENZYDAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de benzydamine",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "MOUTHWASH/GARGLE",
    "drug_dosage_form_fr": "Rince-bouche/Gargarisme",
    "drug_route": "BUCCAL",
    "drug_route_fr": "Buccale",
    "drug_package_quantity": "250ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30892,
    "drug": {
      "current_status": "MARKETED",
      "id": 17462,
      "drug_code": 78502,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256154,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8256153,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02299658",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919006"
    },
    "created_date": "2017-11-28T04:14:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299658",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-07-20T00:00:00-04:00",
    "actual_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2018-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-08-13T14:14:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN-TAZOBACTAM",
    "fr_drug_brand_name": "PIPERACILLINE-TAZOBACTAM",
    "fr_drug_common_name": "PIPERACILLINE-TAZOBACTAM",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "PIPERACILLINE-TAZOBACTAM",
    "drug_strength": "4G\r\n0.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30895,
    "drug": {
      "current_status": "MARKETED",
      "id": 20192,
      "drug_code": 81627,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257164,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8257163,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02330547",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919007"
    },
    "created_date": "2017-11-28T04:16:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330547",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2018-05-11T00:00:00-04:00",
    "actual_start_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-05-24T01:40:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN-TAZOBACTAM",
    "fr_drug_brand_name": "PIPERACILLINE-TAZOBACTAM",
    "fr_drug_common_name": "PIPERACILLINE-TAZOBACTAM",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "PIPERACILLINE-TAZOBACTAM",
    "drug_strength": "12G\r\n1.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30910,
    "drug": {
      "current_status": "MARKETED",
      "id": 21482,
      "drug_code": 83856,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257673,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353369",
      "brand_name": "LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2017-11-28T14:36:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353369",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-16T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM TABS",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM COMPRIMES",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30915,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21166,
      "drug_code": 83545,
      "updated_date": "2025-12-03T01:27:54-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348804,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350238",
      "brand_name": "OXYBUTYNIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2017-11-28T14:42:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02350238",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04BD04",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2019-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-02-06T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Demand increase for drug due to market supply issues.",
    "fr_comments": "Augmentation de la demande de médicaments en raison de problèmes d'approvisionnement sur le marché.",
    "en_drug_brand_name": "OXYBUTYNIN",
    "en_drug_common_name": "OXYBUTYNIN TABS",
    "fr_drug_brand_name": "OXYBUTYNIN",
    "fr_drug_common_name": "OXYBUTYNIN COMPRIMES",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30923,
    "drug": {
      "current_status": "MARKETED",
      "id": 6140,
      "drug_code": 42848,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252986,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184451",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9015",
      "number_of_ais": "1",
      "ai_group_no": "0104545012"
    },
    "created_date": "2017-11-28T15:38:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184451",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA01",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-04-03T00:00:00-04:00",
    "estimated_end_date": "2018-04-06T00:00:00-04:00",
    "actual_start_date": "2018-03-29T00:00:00-04:00",
    "actual_end_date": "2018-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-04T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "KADIAN",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "KADIAN",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30928,
    "drug": {
      "current_status": "MARKETED",
      "id": 680,
      "drug_code": 11465,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251538,
          "ingredient": {
            "id": 448,
            "ingredient_code": 1914,
            "en_name": "FLURBIPROFEN",
            "fr_name": "Flurbiprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01912038",
      "brand_name": "FLURBIPROFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72157",
      "number_of_ais": "1",
      "ai_group_no": "0115998001"
    },
    "created_date": "2017-11-28T16:12:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01912038",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE09",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-07T12:00:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLURBIPROFEN FC TABLETS 100MG",
    "en_drug_common_name": "FLURBIPROFEN",
    "fr_drug_brand_name": "APO-FLURBIPROFEN FC TABLETS 100MG",
    "fr_drug_common_name": "FLURBIPROFEN",
    "en_ingredients": "FLURBIPROFEN",
    "fr_ingredients": "Flurbiprofène",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30931,
    "drug": {
      "current_status": "MARKETED",
      "id": 9988,
      "drug_code": 64358,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8253799,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240769",
      "brand_name": "MICARDIS 40MG TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2017-11-28T16:12:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240769",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "C09CA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-11-28T00:00:00-05:00",
    "estimated_end_date": "2017-12-08T00:00:00-05:00",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-20T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MICARDIS 40MG TAB",
    "en_drug_common_name": "MICARDIS",
    "fr_drug_brand_name": "MICARDIS",
    "fr_drug_common_name": "MICARDIS",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30935,
    "drug": {
      "current_status": "MARKETED",
      "id": 10824,
      "drug_code": 66667,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254089,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242837",
      "brand_name": "APO-LITHIUM CARBONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101163001"
    },
    "created_date": "2017-11-28T16:14:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242837",
    "company_name": "APOTEX INC",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-10T13:35:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LITHIUM CARBONATE",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "APO-LITHIUM CARBONATE",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30938,
    "drug": {
      "current_status": "MARKETED",
      "id": 10826,
      "drug_code": 66668,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254090,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242838",
      "brand_name": "APO-LITHIUM CARBONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101163002"
    },
    "created_date": "2017-11-28T16:16:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242838",
    "company_name": "APOTEX INC",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-10T13:34:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LITHIUM CARBONATE",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "APO-LITHIUM CARBONATE",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30941,
    "drug": {
      "current_status": "MARKETED",
      "id": 6364,
      "drug_code": 43279,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253049,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02220172",
      "brand_name": "LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9610",
      "number_of_ais": "1",
      "ai_group_no": "0120669002"
    },
    "created_date": "2017-11-28T16:18:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02220172",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA02",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-09-10T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LOVASTATIN - TAB 20MG",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "APO-LOVASTATIN - TAB 20MG",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30954,
    "drug": {
      "current_status": "MARKETED",
      "id": 10026,
      "drug_code": 64498,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253819,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240907",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131003"
    },
    "created_date": "2017-11-28T18:14:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240907",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-06T02:50:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30957,
    "drug": {
      "current_status": "MARKETED",
      "id": 13770,
      "drug_code": 73646,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254957,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251531",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2017-11-28T18:16:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251531",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA05",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-03-26T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-08T13:49:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30960,
    "drug": {
      "current_status": "MARKETED",
      "id": 20618,
      "drug_code": 82362,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257287,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337975",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2017-11-28T18:18:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337975",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-27T13:55:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30963,
    "drug": {
      "current_status": "MARKETED",
      "id": 9048,
      "drug_code": 61676,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253562,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238280",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2017-11-28T18:20:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238280",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-03-14T00:00:00-04:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-23T16:16:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30967,
    "drug": {
      "current_status": "MARKETED",
      "id": 9050,
      "drug_code": 61677,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253563,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238281",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2017-11-28T18:22:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238281",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T12:29:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 250 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30971,
    "drug": {
      "current_status": "MARKETED",
      "id": 5518,
      "drug_code": 3679,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250546,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250545,
          "ingredient": {
            "id": 174,
            "ingredient_code": 8174,
            "en_name": "SULFAMETHOXAZOLE",
            "fr_name": "Sulfaméthoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00445282",
      "brand_name": "SULFATRIM DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55040",
      "number_of_ais": "2",
      "ai_group_no": "0208901003"
    },
    "created_date": "2017-11-28T18:23:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00445282",
    "company_name": "APOTEX INC",
    "atc_number": "J01EE01",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "estimated_end_date": "2018-01-08T00:00:00-05:00",
    "actual_start_date": "2018-01-01T00:00:00-05:00",
    "actual_end_date": "2018-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-10T13:41:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO SULFATRIM DS TAB",
    "en_drug_common_name": "SULFATRIM",
    "fr_drug_brand_name": "APO SULFATRIM DS TAB",
    "fr_drug_common_name": "SULFATRIM",
    "en_ingredients": "SULFAMETHOXAZOLE\r\nTRIMETHOPRIM",
    "fr_ingredients": "Sulfaméthoxazole\r\nTriméthoprime",
    "drug_strength": "800MG\r\n160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30976,
    "drug": {
      "current_status": "DORMANT",
      "id": 31672,
      "drug_code": 94025,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369394,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369393,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369392,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453703",
      "brand_name": "WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0311391002"
    },
    "created_date": "2017-11-28T19:18:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453703",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N02BE51",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2017-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-01T21:59:06-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE",
    "en_drug_common_name": "Acetaminophen/Codeine/Caffeine",
    "fr_drug_brand_name": "Wampole Acetaminophen/Codeine/Caffeine",
    "fr_drug_common_name": "Acetaminophen/Codeine/Caffeine",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n8MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30979,
    "drug": {
      "current_status": "DORMANT",
      "id": 10932,
      "drug_code": 6687,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366423,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00682020",
      "brand_name": "ERYTHRO-BASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63846",
      "number_of_ais": "1",
      "ai_group_no": "0105708003"
    },
    "created_date": "2017-11-28T19:26:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00682020",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01FA01",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2017-12-11T00:00:00-05:00",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-23T16:54:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ERYTHRO-BASE",
    "en_drug_common_name": "ERYTHRO-BASE",
    "fr_drug_brand_name": "ERYTHRO-BASE",
    "fr_drug_common_name": "Erythro Base",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30982,
    "drug": {
      "current_status": "MARKETED",
      "id": 4034,
      "drug_code": 19729,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8252565,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02194333",
      "brand_name": "TEGRETOL SUSPENSION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82025",
      "number_of_ais": "1",
      "ai_group_no": "0108674002"
    },
    "created_date": "2017-11-28T20:00:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194333",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N03AF01",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2017-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-01-08T21:45:54-05:00",
    "status": "resolved",
    "en_comments": "No shortage recorded.  Shortage resolved 2017-12-19.",
    "fr_comments": "Pas de rupture de stock.",
    "en_drug_brand_name": "TEGRETOL - SUS 100MG/5ML",
    "en_drug_common_name": "TEGRETOL SUSPENSION",
    "fr_drug_brand_name": "TEGRETOL",
    "fr_drug_common_name": "TEGRETOL SUSPENSION",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "450ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30985,
    "drug": {
      "current_status": "MARKETED",
      "id": 29112,
      "drug_code": 91144,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1786,
        "created_date": "2017-03-09T13:25:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16778,
        "mfr_code": "",
        "name": "GLENMARK PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 STEELES AVE. W., SUITE 407",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "CONCORD",
        "postal_code": "L4K 4M2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260566,
          "ingredient": {
            "id": 2630,
            "ingredient_code": 952,
            "en_name": "URSODIOL",
            "fr_name": "Ursodiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426900",
      "brand_name": "GLN-URSODIOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122789001"
    },
    "created_date": "2017-11-28T20:36:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426900",
    "company_name": "GLENMARK PHARMACEUTICALS CANADA INC.",
    "atc_number": "A05AA02",
    "atc_description": "BILE THERAPY",
    "anticipated_start_date": "2017-11-29T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-11-29T00:00:00-05:00",
    "actual_end_date": "2018-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-01-02T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "URSODIOL TABLETS USP",
    "en_drug_common_name": "Ursodiol",
    "fr_drug_brand_name": "URSODIOL TABLETS USP",
    "fr_drug_common_name": "Ursodiol",
    "en_ingredients": "URSODIOL",
    "fr_ingredients": "Ursodiol",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30989,
    "drug": {
      "current_status": "MARKETED",
      "id": 29116,
      "drug_code": 91146,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1786,
        "created_date": "2017-03-09T13:25:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16778,
        "mfr_code": "",
        "name": "GLENMARK PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 STEELES AVE. W., SUITE 407",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "CONCORD",
        "postal_code": "L4K 4M2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260568,
          "ingredient": {
            "id": 2630,
            "ingredient_code": 952,
            "en_name": "URSODIOL",
            "fr_name": "Ursodiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426919",
      "brand_name": "GLN-URSODIOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122789002"
    },
    "created_date": "2017-11-28T20:39:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426919",
    "company_name": "GLENMARK PHARMACEUTICALS CANADA INC.",
    "atc_number": "A05AA02",
    "atc_description": "BILE THERAPY",
    "anticipated_start_date": "2017-11-29T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-11-29T00:00:00-05:00",
    "actual_end_date": "2018-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-01-02T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "URSODIOL TABLETS USP",
    "en_drug_common_name": "Ursodiol",
    "fr_drug_brand_name": "URSODIOL TABLETS USP",
    "fr_drug_common_name": "Ursodiol",
    "en_ingredients": "URSODIOL",
    "fr_ingredients": "Ursodiol",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30992,
    "drug": {
      "current_status": "MARKETED",
      "id": 12992,
      "drug_code": 72245,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254746,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247935",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683005"
    },
    "created_date": "2017-11-29T01:31:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247935",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG02",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2017-12-12T00:00:00-05:00",
    "actual_end_date": "2018-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-27T21:21:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30995,
    "drug": {
      "current_status": "MARKETED",
      "id": 9634,
      "drug_code": 63352,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253724,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239864",
      "brand_name": "AA-FENO-MICRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895001"
    },
    "created_date": "2017-11-29T01:33:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239864",
    "company_name": "APOTEX INC",
    "atc_number": "C10AB05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-12-05T00:00:00-05:00",
    "estimated_end_date": "2018-07-27T00:00:00-04:00",
    "actual_start_date": "2017-12-08T00:00:00-05:00",
    "actual_end_date": "2018-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-17T12:25:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FENO-MICRO",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "APO-FENO-MICRO",
    "fr_drug_common_name": "FENOFIBRATE",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 30998,
    "drug": {
      "current_status": "MARKETED",
      "id": 11512,
      "drug_code": 68271,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254282,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244304",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2017-11-29T01:35:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244304",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-12-29T00:00:00-05:00",
    "estimated_end_date": "2018-02-23T00:00:00-05:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T13:45:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GABAPENTIN CAPSULES",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO-GABAPENTIN CAPSULES",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31001,
    "drug": {
      "current_status": "MARKETED",
      "id": 16884,
      "drug_code": 77872,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255966,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293358",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929004"
    },
    "created_date": "2017-11-29T01:37:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293358",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-12-28T00:00:00-05:00",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-22T11:56:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31004,
    "drug": {
      "current_status": "MARKETED",
      "id": 16886,
      "drug_code": 77873,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255967,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293366",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929005"
    },
    "created_date": "2017-11-29T01:39:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293366",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-12-28T00:00:00-05:00",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-22T11:57:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31007,
    "drug": {
      "current_status": "DORMANT",
      "id": 17046,
      "drug_code": 78070,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368077,
          "ingredient": {
            "id": 2948,
            "ingredient_code": 12597,
            "en_name": "GLIMEPIRIDE",
            "fr_name": "Glimépiride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295393",
      "brand_name": "APO-GLIMEPIRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146247003"
    },
    "created_date": "2017-11-29T01:42:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295393",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB12",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2019-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2019-09-21T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "All strengths of APO-GLIMEPIRIDE have been discontinued",
    "fr_comments": "All strengths of APO-GLIMEPIRIDE have been discontinued",
    "en_drug_brand_name": "APO-GLIMEPIRIDE",
    "en_drug_common_name": "GLIMEPIRIDE",
    "fr_drug_brand_name": "APO-GLIMEPIRIDE",
    "fr_drug_common_name": "GLIMEPIRIDE",
    "en_ingredients": "GLIMEPIRIDE",
    "fr_ingredients": "Glimépiride",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31010,
    "drug": {
      "current_status": "MARKETED",
      "id": 21678,
      "drug_code": 84059,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257744,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355345",
      "brand_name": "APO-IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503003"
    },
    "created_date": "2017-11-29T01:45:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355345",
    "company_name": "APOTEX INC",
    "atc_number": "L01XE01",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2018-03-26T00:00:00-04:00",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2018-03-28T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IMATINIB",
    "en_drug_common_name": "IMATINIB",
    "fr_drug_brand_name": "APO-IMATINIB",
    "fr_drug_common_name": "IMATINIB",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31013,
    "drug": {
      "current_status": "MARKETED",
      "id": 2492,
      "drug_code": 15927,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252073,
          "ingredient": {
            "id": 1184,
            "ingredient_code": 11182,
            "en_name": "MINOCYCLINE",
            "fr_name": "Minocycline (Chlorhydrate de minocycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02084090",
      "brand_name": "MINOCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77690",
      "number_of_ais": "1",
      "ai_group_no": "0131309001"
    },
    "created_date": "2017-11-29T01:47:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02084090",
    "company_name": "APOTEX INC",
    "atc_number": "J01AA08",
    "atc_description": "TETRACYCLINES",
    "anticipated_start_date": "2017-12-28T00:00:00-05:00",
    "estimated_end_date": "2018-02-23T00:00:00-05:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-22T14:29:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MINOCYCLINE CAP 50MG",
    "en_drug_common_name": "MINOCYCLINE",
    "fr_drug_brand_name": "APO-MINOCYCLINE CAP 50MG",
    "fr_drug_common_name": "MINOCYCLINE",
    "en_ingredients": "MINOCYCLINE",
    "fr_ingredients": "MINOCYCLINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31016,
    "drug": {
      "current_status": "MARKETED",
      "id": 30822,
      "drug_code": 92924,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261386,
          "ingredient": {
            "id": 2142,
            "ingredient_code": 20300,
            "en_name": "NALTREXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naltrexone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444275",
      "brand_name": "APO-NALTREXONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118591001"
    },
    "created_date": "2017-11-29T01:59:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444275",
    "company_name": "APOTEX INC",
    "atc_number": "N07BB04",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-12-12T00:00:00-05:00",
    "actual_end_date": "2018-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-17T01:58:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NALTREXONE",
    "en_drug_common_name": "NALTREXONE",
    "fr_drug_brand_name": "APO-NALTREXONE",
    "fr_drug_common_name": "NALTREXONE",
    "en_ingredients": "NALTREXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naltrexone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31019,
    "drug": {
      "current_status": "MARKETED",
      "id": 310,
      "drug_code": 10829,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251401,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00882828",
      "brand_name": "APO-PRAZO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70922",
      "number_of_ais": "1",
      "ai_group_no": "0111527002"
    },
    "created_date": "2017-11-29T02:03:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00882828",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA01",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "anticipated_start_date": "2017-12-20T00:00:00-05:00",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-12-19T00:00:00-05:00",
    "actual_end_date": "2018-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-29T12:59:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAZO TAB 2MG",
    "en_drug_common_name": "PRAZOSIN",
    "fr_drug_brand_name": "APO-PRAZO TAB 2MG",
    "fr_drug_common_name": "PRAZOSIN",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZOSIN",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31022,
    "drug": {
      "current_status": "MARKETED",
      "id": 27096,
      "drug_code": 89352,
      "updated_date": "2025-12-03T00:32:19-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259765,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259764,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408767",
      "brand_name": "APO-QUINAPRIL/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231789001"
    },
    "created_date": "2017-11-29T02:06:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408767",
    "company_name": "APOTEX INC",
    "atc_number": "C09BA06",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUINAPRIL/HCTZ",
    "en_drug_common_name": "QUINAPRIL - HCTZ",
    "fr_drug_brand_name": "APO-QUINAPRIL/HCTZ",
    "fr_drug_common_name": "QUINAPRIL/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nQUINAPRIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31025,
    "drug": {
      "current_status": "MARKETED",
      "id": 27100,
      "drug_code": 89354,
      "updated_date": "2025-12-03T00:32:19-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259769,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259768,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408783",
      "brand_name": "APO-QUINAPRIL/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231789003"
    },
    "created_date": "2017-11-29T02:10:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408783",
    "company_name": "APOTEX INC",
    "atc_number": "C09BA06",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2017-12-27T00:00:00-05:00",
    "estimated_end_date": "2018-11-02T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-02T15:47:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUINAPRIL/HCTZ",
    "en_drug_common_name": "QUINAPRIL/HCTZ",
    "fr_drug_brand_name": "APO-QUINAPRIL/HCTZ",
    "fr_drug_common_name": "QUINAPRIL/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nQUINAPRIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31028,
    "drug": {
      "current_status": "MARKETED",
      "id": 13776,
      "drug_code": 73650,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254959,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251582",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858002"
    },
    "created_date": "2017-11-29T02:12:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251582",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA05",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-12-18T00:00:00-05:00",
    "estimated_end_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T18:16:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31031,
    "drug": {
      "current_status": "MARKETED",
      "id": 20620,
      "drug_code": 82363,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257288,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337983",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-11-29T02:20:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337983",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2018-04-04T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-13T12:04:18-04:00",
    "status": "resolved",
    "en_comments": "100 BTL is available",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31034,
    "drug": {
      "current_status": "MARKETED",
      "id": 20622,
      "drug_code": 82364,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257289,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337991",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2017-11-29T02:23:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337991",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-12-15T00:00:00-05:00",
    "estimated_end_date": "2018-03-26T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-20T12:45:04-04:00",
    "status": "resolved",
    "en_comments": "90 BTL is available",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31039,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2017-11-29T02:31:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2017-12-29T00:00:00-05:00",
    "estimated_end_date": "2018-02-28T00:00:00-05:00",
    "actual_start_date": "2018-01-02T00:00:00-05:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-22T14:30:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "APO-TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31046,
    "drug": {
      "current_status": "MARKETED",
      "id": 16808,
      "drug_code": 77765,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255939,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02292297",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292008"
    },
    "created_date": "2017-11-29T03:31:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292297",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01DD04",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-11-20T00:00:00-05:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-12-15T23:13:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTRIAXONE FOR INJECTION USP",
    "en_drug_common_name": "CEFTRIxone",
    "fr_drug_brand_name": "CEFTRIAXONE",
    "fr_drug_common_name": "CEFTRIAXONE",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CEFTRIAXONE",
    "drug_strength": "10.0G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31051,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 940,
      "drug_code": 12218,
      "updated_date": "2025-12-03T01:05:38-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8289477,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "25",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00401633",
      "brand_name": "FUROSEMIDE SPECIAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73266",
      "number_of_ais": "1",
      "ai_group_no": "0101944003"
    },
    "created_date": "2017-11-29T03:35:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00401633",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-15T23:14:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FUROSEMIDE SPECIAL",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "FUROSEMIDE",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31054,
    "drug": {
      "current_status": "MARKETED",
      "id": 12422,
      "drug_code": 70995,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254572,
          "ingredient": {
            "id": 548,
            "ingredient_code": 11190,
            "en_name": "KETAMINE",
            "fr_name": "Kétamine (Chlorhydrate de kétamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02246795",
      "brand_name": "KETAMINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131360002"
    },
    "created_date": "2017-11-29T03:37:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246795",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N01AX03",
    "atc_description": "ANESTHETICS, GENERAL",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2017-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-12-15T23:18:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KETAMINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "KETAMINE",
    "fr_drug_brand_name": "KETAMINE",
    "fr_drug_common_name": "KETAMINE",
    "en_ingredients": "KETAMINE",
    "fr_ingredients": "KETAMINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31057,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25958,
      "drug_code": 88338,
      "updated_date": "2025-05-15T04:20:50-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8352503,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02398427",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "50MG/2ML & 500MG/20ML VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2017-11-29T03:39:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398427",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01BA01",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-23T00:00:00-05:00",
    "actual_end_date": "2017-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-08T21:34:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "METHOTREXATE",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRA-ARTERIAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intra-artérielle\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31060,
    "drug": {
      "current_status": "MARKETED",
      "id": 12268,
      "drug_code": 70531,
      "updated_date": "2025-05-15T02:31:21-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254521,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02246365",
      "brand_name": "TRANEXAMIC ACID INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2017-11-29T04:03:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246365",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B02AA02",
    "atc_description": "ANTIFIBRINOLYTICS",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2017-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-09T00:01:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION BP",
    "en_drug_common_name": "TRANEXAMIC ACID",
    "fr_drug_brand_name": "ACIDE TRANEXAMIQUE",
    "fr_drug_common_name": "ACIDE TRANEXAMIQUE",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 X 10ML VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31063,
    "drug": {
      "current_status": "MARKETED",
      "id": 25558,
      "drug_code": 87977,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259230,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02394634",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE VIAL. FOR IV INFUSION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315009"
    },
    "created_date": "2017-11-29T04:05:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394634",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2018-01-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-01-09T00:02:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN",
    "fr_drug_brand_name": "VANCOMYCINE",
    "fr_drug_common_name": "VANCOMYCINE",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCINE",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 X 1G VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31066,
    "drug": {
      "current_status": "MARKETED",
      "id": 25556,
      "drug_code": 87976,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259229,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02394626",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE VIAL. FOR IV INFUSION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315003"
    },
    "created_date": "2017-11-29T04:06:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394626",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2018-01-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-01-09T00:02:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN",
    "fr_drug_brand_name": "VANCOMYCINE",
    "fr_drug_common_name": "VANCOMYCINE",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCINE",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 X 500MG VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31152,
    "drug": {
      "current_status": "DORMANT",
      "id": 2984,
      "drug_code": 1734,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365865,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038245",
      "brand_name": "STERILE WATER FOR INJECTION USP",
      "brand_name_fr": "EAU STÉRILE POUR PRÉPARATIONS INJECTABLES USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43654",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2017-11-29T16:08:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038245",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2017-12-20T00:00:00-05:00",
    "estimated_end_date": "2018-01-08T00:00:00-05:00",
    "actual_end_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-27T19:52:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "WATER FOR INJECTION STERILE USP",
    "en_drug_common_name": "Sterile Water for Injection",
    "fr_drug_brand_name": "Eau stérile pour préparations injectables",
    "fr_drug_common_name": "Eau stérile pour préparations injectables",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31228,
    "drug": {
      "current_status": "MARKETED",
      "id": 26866,
      "drug_code": 89150,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259682,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02406829",
      "brand_name": "TARO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2017-11-30T14:12:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406829",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2018-03-15T00:00:00-04:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:55:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-IRBESARTAN",
    "en_drug_common_name": "RAN-IRBESARTAN",
    "fr_drug_brand_name": "RAN-IRBESARTAN",
    "fr_drug_common_name": "RAN-IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31231,
    "drug": {
      "current_status": "MARKETED",
      "id": 26868,
      "drug_code": 89151,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259683,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02406837",
      "brand_name": "TARO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2017-11-30T14:15:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406837",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2019-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-17T17:42:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-IRBESARTAN",
    "en_drug_common_name": "RAN-IRBESARTAN",
    "fr_drug_brand_name": "RAN-IRBESARTAN",
    "fr_drug_common_name": "RAN-IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31236,
    "drug": {
      "current_status": "MARKETED",
      "id": 26862,
      "drug_code": 89149,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259681,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02406810",
      "brand_name": "TARO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2017-11-30T14:18:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406810",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2017-12-08T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:53:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-IRBESARTAN",
    "en_drug_common_name": "RAN-IRBESARTAN",
    "fr_drug_brand_name": "RAN-IRBESARTAN",
    "fr_drug_common_name": "RAN-IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31239,
    "drug": {
      "current_status": "MARKETED",
      "id": 31528,
      "drug_code": 93851,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261784,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452073",
      "brand_name": "TARO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2017-11-30T14:27:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452073",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:44:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-TADALAFIL",
    "en_drug_common_name": "RAN-TADALAFIL",
    "fr_drug_brand_name": "RAN-TADALAFIL",
    "fr_drug_common_name": "RAN-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31242,
    "drug": {
      "current_status": "DORMANT",
      "id": 31530,
      "drug_code": 93852,
      "updated_date": "2025-05-15T06:55:57-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369369,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452081",
      "brand_name": "TARO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485003"
    },
    "created_date": "2017-11-30T14:29:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452081",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:43:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-TADALAFIL",
    "en_drug_common_name": "RAN-TADALAFIL",
    "fr_drug_brand_name": "RAN-TADALAFIL",
    "fr_drug_common_name": "RAN-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31270,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11194,
      "drug_code": 6753,
      "updated_date": "2025-05-15T03:30:26-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8281002,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00594636",
      "brand_name": "STATEX TABLET 25MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63970",
      "number_of_ais": "1",
      "ai_group_no": "0104545005"
    },
    "created_date": "2017-11-30T15:34:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00594636",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AA01",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-29T18:58:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "STATEX TABLET 25MG",
    "en_drug_common_name": "Statex",
    "fr_drug_brand_name": "Statex",
    "fr_drug_common_name": "Statex",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31273,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9536,
      "drug_code": 6311,
      "updated_date": "2025-05-15T03:29:43-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8280180,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00658855",
      "brand_name": "LOPRESOR SR 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62779",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2017-11-30T16:05:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00658855",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-02-06T00:00:00-05:00",
    "estimated_end_date": "2018-06-26T00:00:00-04:00",
    "actual_start_date": "2018-02-01T00:00:00-05:00",
    "actual_end_date": "2018-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-28T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "LOPRESOR SR 100MG bottles of 250 pack are available",
    "fr_comments": "LOPRESOR  SR 100MG en bouteille de 250 est disponible",
    "en_drug_brand_name": "LOPRESOR SR 100MG",
    "en_drug_common_name": "LOPRESOR SR 100MG 100'S",
    "fr_drug_brand_name": "LOPRESOR SR 100MG TABS 100'S",
    "fr_drug_common_name": "LOPRESOR",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31276,
    "drug": {
      "current_status": "MARKETED",
      "id": 884,
      "drug_code": 11969,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251588,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "01940414",
      "brand_name": "VOLTAREN OPHTHA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72938",
      "number_of_ais": "1",
      "ai_group_no": "0114417004"
    },
    "created_date": "2017-11-30T16:16:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940414",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BC03",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "estimated_end_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T06:00:07-05:00",
    "status": "resolved",
    "en_comments": "1 x 5 ml available",
    "fr_comments": "1 X 5ml est disponible",
    "en_drug_brand_name": "VOLTAREN OPHTHA",
    "en_drug_common_name": "VOLTAREN",
    "fr_drug_brand_name": "VOLTAREN OPHTHA",
    "fr_drug_common_name": "VOLTAREN",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "2 X 5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31302,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29958,
      "drug_code": 92023,
      "updated_date": "2025-05-15T04:23:26-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8355490,
          "ingredient": {
            "id": 4032,
            "ingredient_code": 22556,
            "en_name": "PARITAPREVIR",
            "fr_name": "Paritaprévir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8355489,
          "ingredient": {
            "id": 2202,
            "ingredient_code": 4,
            "en_name": "RITONAVIR",
            "fr_name": "Ritonavir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8355488,
          "ingredient": {
            "id": 4030,
            "ingredient_code": 22555,
            "en_name": "DASABUVIR",
            "fr_name": "Dasabuvir (Dasabuvir sodique monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8355487,
          "ingredient": {
            "id": 4028,
            "ingredient_code": 22554,
            "en_name": "OMBITASVIR",
            "fr_name": "Ombitasvir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436027",
      "brand_name": "HOLKIRA PAK",
      "brand_name_fr": "",
      "descriptor": "KIT INCLUDES PINK TAB. (OMBITASVIR/ PARITAPREVIR/ RITONAVIR FIXED COMBINATION), AND BEIGE TAB. (DASABUVIR)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0456390001"
    },
    "created_date": "2017-11-30T18:15:18-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02436027",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "J05AX66",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2018-08-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Per AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.",
    "fr_supply_disruption_mitigation": "Conformément à la politique de retour d’AbbVie, nous vous demandons de nous retourner les produits seulement à la date de péremption, et cela pour l’ensemble des stocks restants.",
    "en_discontinuation_comments": "This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.",
    "fr_discontinuation_comments": "Cette décision fait suite à la récente approbation des comprimés MAVIRET par Santé Canada. Ce nouvel antiviral pangénotypique d’AbbVie, indiqué pour le traitement des adultes atteints d’une infection chronique par le virus de l’hépatite C (VHC), remplacera HOLKIRA PAK, TECHNIVIE et MODERIBA sur le marché canadien.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-30T17:52:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HOLKIRA PAK",
    "en_drug_common_name": "HOLKIRA PAK 12.5/75/50/250MG TABS, 28DAY",
    "fr_drug_brand_name": "HOLKIRA PAK",
    "fr_drug_common_name": "HOLKIRA PAK 12.5/75/50/250MG TABS, 28DAY",
    "en_ingredients": "RITONAVIR\r\nOmbitasvir\r\nDasabuvir\r\nParitaprevir",
    "fr_ingredients": "Ritonavir\r\nParitaprévir",
    "drug_strength": "50MG\r\n12.5MG\r\n250MG\r\n75MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 inner cartons x 7blisters",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31316,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30018,
      "drug_code": 92075,
      "updated_date": "2025-05-15T04:23:29-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8355519,
          "ingredient": {
            "id": 1946,
            "ingredient_code": 2184,
            "en_name": "RIBAVIRIN",
            "fr_name": "Ribavirine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436418",
      "brand_name": "MODERIBA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111643002"
    },
    "created_date": "2017-11-30T18:30:05-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02436418",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "J05AB04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2018-08-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot available on market expires on Oct-31st, 2018. \r\nPer AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.",
    "fr_supply_disruption_mitigation": "Le dernier lot disponible sur le marché expire le 31 octobre 2018.\r\nConformément à la politique de retour d’AbbVie, nous vous demandons de nous retourner les produits seulement à la date de péremption, et cela pour l’ensemble des stocks restants.",
    "en_discontinuation_comments": "This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.",
    "fr_discontinuation_comments": "Cette décision fait suite à la récente approbation des comprimés MAVIRET par Santé Canada. Ce nouvel antiviral pangénotypique d’AbbVie, indiqué pour le traitement des adultes atteints d’une infection chronique par le virus de l’hépatite C (VHC), remplacera HOLKIRA PAK, TECHNIVIE et MODERIBA sur le marché canadien.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-30T18:01:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MODERIBA",
    "en_drug_common_name": "MODERIBA TABLETS 400MG",
    "fr_drug_brand_name": "MODERIBA",
    "fr_drug_common_name": "MODERIBA 400MG",
    "en_ingredients": "RIBAVIRIN",
    "fr_ingredients": "Ribavirine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56 tablets per bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31323,
    "drug": {
      "current_status": "MARKETED",
      "id": 29418,
      "drug_code": 91431,
      "updated_date": "2025-05-15T02:34:29-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260675,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429888",
      "brand_name": "MAR-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2017-11-30T19:12:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429888",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AA09",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "estimated_end_date": "2018-09-05T00:00:00-04:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-09-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-06T18:04:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-AMITRIPTYLINE",
    "en_drug_common_name": "MAR-Amitriptyline",
    "fr_drug_brand_name": "MAR-AMITRIPTYLINE",
    "fr_drug_common_name": "MAR-Amitriptyline",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31328,
    "drug": {
      "current_status": "MARKETED",
      "id": 31552,
      "drug_code": 93870,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261797,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452324",
      "brand_name": "MAR-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-11-30T19:19:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452324",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2019-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-22T15:07:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-AZITHROMYCIN",
    "en_drug_common_name": "MAR-Azithromycin",
    "fr_drug_brand_name": "MAR-AZITHROMYCIN",
    "fr_drug_common_name": "MAR-Azithromycin",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31331,
    "drug": {
      "current_status": "MARKETED",
      "id": 23100,
      "drug_code": 85687,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258342,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371731",
      "brand_name": "MAR-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120003"
    },
    "created_date": "2017-11-30T19:28:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371731",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A04AA01",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2018-05-01T00:00:00-04:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-28T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-ONDANSETRON",
    "en_drug_common_name": "Mar-Ondansetron",
    "fr_drug_brand_name": "MAR-ONDANSETRON",
    "fr_drug_common_name": "MAR-Ondansetron",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "10 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31334,
    "drug": {
      "current_status": "DORMANT",
      "id": 29142,
      "drug_code": 91166,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369131,
          "ingredient": {
            "id": 2176,
            "ingredient_code": 7942,
            "en_name": "CETIRIZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cétirizine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427133",
      "brand_name": "MAR-CETIRIZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122686001"
    },
    "created_date": "2017-11-30T19:31:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427133",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "R06AE07",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2020-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-03-25T15:41:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CETIRIZINE",
    "en_drug_common_name": "MAR-Cetirizine",
    "fr_drug_brand_name": "MAR-CETIRIZINE",
    "fr_drug_common_name": "MAR-Cetirizine",
    "en_ingredients": "CETIRIZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cétirizine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31338,
    "drug": {
      "current_status": "MARKETED",
      "id": 29144,
      "drug_code": 91167,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260571,
          "ingredient": {
            "id": 2176,
            "ingredient_code": 7942,
            "en_name": "CETIRIZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cétirizine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427141",
      "brand_name": "MAR-CETIRIZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122686003"
    },
    "created_date": "2017-11-30T19:37:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427141",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "R06AE07",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "estimated_end_date": "2018-10-01T00:00:00-04:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-06T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CETIRIZINE",
    "en_drug_common_name": "MAR-Cetirizine",
    "fr_drug_brand_name": "MAR-CETIRIZINE",
    "fr_drug_common_name": "MAR-Cetirizine",
    "en_ingredients": "CETIRIZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cétirizine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31341,
    "drug": {
      "current_status": "MARKETED",
      "id": 23124,
      "drug_code": 85700,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258353,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371871",
      "brand_name": "MAR-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243003"
    },
    "created_date": "2017-11-30T19:39:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371871",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB04",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-10-02T00:00:00-04:00",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CITALOPRAM",
    "en_drug_common_name": "MAR-Citalopram",
    "fr_drug_brand_name": "MAR-CITALOPRAM",
    "fr_drug_common_name": "MAR-Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31349,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24964,
      "drug_code": 87463,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351808,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389126",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-11-30T20:04:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389126",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2021-10-26T20:22:55-04:00",
    "anticipated_start_date": "2017-11-15T00:00:00-05:00",
    "actual_start_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T20:22:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "MAR-Olanzapine ODT",
    "fr_drug_brand_name": "MAR-OLANZAPINE ODT",
    "fr_drug_common_name": "MAR-Olanzapine ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31353,
    "drug": {
      "current_status": "MARKETED",
      "id": 31002,
      "drug_code": 93136,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261456,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02446081",
      "brand_name": "MAR-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2017-11-30T20:12:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446081",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-01T00:00:00-04:00",
    "actual_start_date": "2017-09-01T00:00:00-04:00",
    "actual_end_date": "2019-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-22T15:04:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DULOXETINE",
    "en_drug_common_name": "MAR-Duloxetine",
    "fr_drug_brand_name": "MAR-DULOXETINE",
    "fr_drug_common_name": "MAR-Duloxetine",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31356,
    "drug": {
      "current_status": "MARKETED",
      "id": 31002,
      "drug_code": 93136,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261456,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02446081",
      "brand_name": "MAR-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2017-11-30T20:13:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446081",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-01T00:00:00-04:00",
    "actual_start_date": "2017-09-01T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T18:13:22-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinued",
    "en_drug_brand_name": "MAR-DULOXETINE",
    "en_drug_common_name": "MAR-Duloxetine",
    "fr_drug_brand_name": "MAR-DULOXETINE",
    "fr_drug_common_name": "MAR-Duloxetine",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31359,
    "drug": {
      "current_status": "MARKETED",
      "id": 31004,
      "drug_code": 93137,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261457,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02446103",
      "brand_name": "MAR-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2017-11-30T20:14:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446103",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-01T00:00:00-04:00",
    "actual_start_date": "2017-09-01T00:00:00-04:00",
    "actual_end_date": "2019-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-22T15:04:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DULOXETINE",
    "en_drug_common_name": "MAR-Duloxetine",
    "fr_drug_brand_name": "MAR-DULOXETINE",
    "fr_drug_common_name": "MAR-Duloxetine",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31362,
    "drug": {
      "current_status": "MARKETED",
      "id": 31004,
      "drug_code": 93137,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261457,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02446103",
      "brand_name": "MAR-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2017-11-30T20:15:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446103",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-01T00:00:00-04:00",
    "actual_start_date": "2017-09-01T00:00:00-04:00",
    "actual_end_date": "2019-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-22T15:05:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DULOXETINE",
    "en_drug_common_name": "MAR-Duloxetine",
    "fr_drug_brand_name": "MAR-DULOXETINE",
    "fr_drug_common_name": "MAR-Duloxetine",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Capsule",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 31365,
    "drug": {
      "current_status": "DORMANT",
      "id": 31520,
      "drug_code": 93847,
      "updated_date": "2025-05-15T06:55:57-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369368,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452286",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485003"
    },
    "created_date": "2017-11-30T20:41:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452286",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T18:38:16-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-Tadalafil",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-Tadalafil",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 Tablet",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31368,
    "drug": {
      "current_status": "MARKETED",
      "id": 31522,
      "drug_code": 93848,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261781,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452278",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2017-11-30T20:51:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452278",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T14:47:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-Tadalafil",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-Tadalafil",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31371,
    "drug": {
      "current_status": "MARKETED",
      "id": 31524,
      "drug_code": 93849,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261782,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452251",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2017-11-30T20:52:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452251",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2018-07-12T00:00:00-04:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-Tadalafil",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-Tadalafil",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31374,
    "drug": {
      "current_status": "MARKETED",
      "id": 31526,
      "drug_code": 93850,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261783,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452243",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2017-11-30T20:53:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452243",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T14:46:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-Tadalafil",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-Tadalafil",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31377,
    "drug": {
      "current_status": "MARKETED",
      "id": 23790,
      "drug_code": 86441,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258574,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378620",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2017-11-30T20:55:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378620",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "hc_updated_date": "2021-10-26T20:35:02-04:00",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T20:35:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "MAR-Metformin",
    "fr_drug_brand_name": "MAR-METFORMIN",
    "fr_drug_common_name": "MAR-Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31386,
    "drug": {
      "current_status": "MARKETED",
      "id": 29548,
      "drug_code": 91579,
      "updated_date": "2025-12-03T00:32:39-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260717,
          "ingredient": {
            "id": 118,
            "ingredient_code": 10207,
            "en_name": "PHENYTOIN SODIUM",
            "fr_name": "Phénytoïne sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02431378",
      "brand_name": "PHENYTOIN SODIUM INJECTION USP",
      "brand_name_fr": "PHÉNYTOÏNE SODIQUE INJECTABLE USP",
      "descriptor": "2ML & 5ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101375003"
    },
    "created_date": "2017-11-30T21:04:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02431378",
    "company_name": "STERIMAX INC",
    "atc_number": "N03AB02",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-12-11T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-14T13:45:29-05:00",
    "status": "resolved",
    "en_comments": "Product is available",
    "fr_comments": "Produit disponible",
    "en_drug_brand_name": "PHENYTOIN SODIUM INJECTION, USP",
    "en_drug_common_name": "Phenytoin Sodium Injection USP",
    "fr_drug_brand_name": "PHENYTOINE SODIQUE POUR INJECTION",
    "fr_drug_common_name": "PHENYTOINE SODIQUE POUR INJECTION",
    "en_ingredients": "PHENYTOIN SODIUM",
    "fr_ingredients": "Phénytoïne sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "25 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31390,
    "drug": {
      "current_status": "MARKETED",
      "id": 22368,
      "drug_code": 84763,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8258012,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.375",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8258011,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.000",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02362627",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919005"
    },
    "created_date": "2017-11-30T21:09:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362627",
    "company_name": "STERIMAX INC",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-01-08T00:00:00-05:00",
    "actual_start_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2018-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-01-16T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Product is available",
    "fr_comments": "Produit est disponible",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "fr_drug_brand_name": "PIPÉRACILLINE ET TAZOBACTAM POUR INJECTION",
    "fr_drug_common_name": "PIPÉRACILLINE ET TAZOBACTAM POUR INJECTION",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "0225919005",
    "drug_strength": "3.000G\r\n0.375G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 31394,
    "drug": {
      "current_status": "MARKETED",
      "id": 22370,
      "drug_code": 84764,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8258014,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.0",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8258013,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02362635",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919006"
    },
    "created_date": "2017-11-30T21:14:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362635",
    "company_name": "STERIMAX INC",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-06-04T00:00:00-04:00",
    "actual_start_date": "2018-05-03T00:00:00-04:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-31T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "fr_drug_brand_name": "PIPÉRACILLINE ET TAZOBACTAM POUR INJECTION",
    "fr_drug_common_name": "PIPÉRACILLINE ET TAZOBACTAM POUR INJECTION",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "0225919006",
    "drug_strength": "4.0G\r\n0.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  }
]